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ABSTRACT OF THE DISSERATION
Synthetic Ion Channels: A New Class of Membrane Disruptor and Efflux
Pump Inhibitor for the Recovery of Antibiotic Potency
by
Mohit B. Patel
Doctor of Philosophy in Biology
University of Missouri-St. Louis, 2016
Dr. George W. Gokel, Advisor
Antibiotic resistance has become a world-wide health care crisis. In 2013
there were 50,000 deaths in U.S. and EU, associated with hospital acquired
bacterial infections. This problem is exacerbated by the lack of new antibiotics in
development. There was only one combination antibiotic approved by the FDA
in 2015. Here, we report that synthetic amphiphiles represent a new class of
adjuvants that rescue antibiotic potency against multidrug resistant bacteria.
Ion channel proteins maintain ion homeostasis through the cellular
membrane. Hydraphiles are amphiphiles designed and synthesized in the Gokel
lab that show many of the same properties as protein ion channels. Hydraphiles
were previously shown to have antimicrobial property against Escherichia coli,
Bacillus subtilis and Saccharomyces cerevisiae. The antimicrobial property of
hydraphile was correlated to its ability to span the bacterial membrane and
transport cations such as Na+ and K+. We report that hydraphiles can be used to
inhibit antibiotic efflux pumps and increase the bacterial membrane
permeability.
Most of the studies involving this class of molecules have been focused on
developing new structures, and assessing their effect on ion transport and
antibiotic potency. This is the first report that shows that hydraphiles recover the
activity of tetracycline and fluoroquinolones (ciprofloxacin, norfloxacin) against
two Gram negative (E. coli and Klebsiella pneumoniae) and one Gram positive
(Staphylococcus aureus) bacteria. Out of the four hydraphiles tested (C8-C14),
benzyl C14 hydraphiles is most efficient as an adjuvant. At sub-lethal
concentrations, hydraphiles do not inhibit bacterial growth, show synergy with
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existing antibiotics and transport K+ ions. Controls confirmed that the structure
and function of hydraphiles are critical for its activity.
The outer membranes of Gram negative bacteria provide for an attractive
target for antibiotic development. We showed that benzyl C14 hydraphile localize
in the E. coli and human embryonic kidney (HEK-293) cell membranes. At onehalf the minimal inhibitory concentration hydraphiles can increase the
permeability of bacterial membranes. However, they did not alter the membrane
permeability of mammalian cells. Scanning electron microscopy confirmed that
benzyl C14 hydraphiles form 100-200 nm aggregates that attach to the bacterial
surface, induce osmotic stress and cause disruption of the cytoplasmic
membrane. An advantage of this approach is that bacteria cannot readily
develop resistance to membrane-active amphiphiles as observed with benzyl C14
hydraphiles.
Efflux pumps provide resistance to multiple different classes of antibiotics
and its activity depends on existing cation gradients. Here we show that
hydraphiles can transport K+ from bacteria and inhibit the activity of norA efflux
pump in S. aureus. As a result, the accumulation of the substrate/antibiotic
increases in the S. aureus cytoplasm. This increases the antibiotic potency. We
observed that at sub-lethal concentrations of benzyl C14 hydraphile the survival
of three different mammalian cells was 80-100%. Cytotoxicity from hydraphiles
was lower than CCCP, a known efflux pump inhibitor, but its efficacy to inhibit
the efflux pump and recover antibiotic potency was far superior.
Overall, we report a novel adjuvant platform that could be used to rescue
the efficacy of existing antibiotics for the treatment of life-threatening bacterial
infections.
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CHAPTER 1
Introduction to the Antimicrobial Resistance Problem and
Hydraphile Synthetic Ion Channels
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1.1

Antimicrobial resistance (AMR). Antibiotics have been used to treat
bacterial infections and to save lives since the 1940s.1 Due to their widespread
use, bacteria have acquired resistance to all known classes of antibiotics (figure
1.1).2 We are now in the post-antibiotic era, where an infection could prove to
be fatal due to lack of an effective antibiotic treatment. In 2013, there were 23,000
deaths and 2 million illnesses caused by antibiotic resistant infections in the US
alone.3 The problem is worse in developing countries where Mycobacterium
tuberculosis has become untreatable due to AMR.4 Patients in the hospital are at a
greater risk of infections from multi-drug resistant (MDR) bacterial infections,
due to the widespread use of antibiotics in hospitals.5 In particular,
immunocompromised patients are at greater risk of being affected by MDR
bacteria.5
This problem is exacerbated by a lack of new antibiotics in development.
Whereas the period from 1951 through 2000 witnessed an average of three new
antibiotics per year, only four antibiotics have been approved since 2011.6 Only
one adjuvant-antibiotic was approved by the FDA in 2015.7 No new class of
antibiotics has been developed in the last four decades that targets Gram
negative infections.8 Absent new solutions, the number of global deaths is
estimated to reach 10 million by 2050 with productivity losses exceeding $100
trillion.9 This is equivalent to the absence of any economic contribution by UK, to
the global economy, for over 35 years. It is clear that there is not only a need for
new antibiotics, but new classes of antibiotics are desperately needed as well.

Figure 1.1. Timeline of antibiotic discovery (top) and development
of resistance to antibiotics (bottom) from reference 2.2
Chapter 1
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The ability to transfer multiple resistance genes on the same plasmid,
between bacteria, allows for the rapid spread of antibiotic resistance.10
Antibiotics that target DNA gyrase, cell wall synthesis, ribosomal subunits, etc.
have been deployed. Currently the antibiotic classes commonly used in clinics
are carbapenem, cephalosporin and linezolid. Similar to penicillin, carbapenem
and cephalosporin are also members of the β-lactam family that targets cell wall
synthesis. However, several known β-lactamase enzymes, such as New Delhi βmetallo lactamase-1 (NDM-1)11, provide resistance to carbapenems,
cephalosporin and other β-lactams.2 Therefore, antibiotics such as polymyxins
have made a comeback, after 50 years.12 Polymyxin binds to the lipid A
component (figure 1.3) of Gram negative bacteria and disrupts bacterial
membranes causing cell death. They are, however, associated with renal toxicity,
and hence used as a drug of last resort.13 An E. coli carrying a plasmid with a
resistance gene to polymyxin (mcr-1) in the US, was recently reported as well.14
This emphasizes the worldwide need for a solution to AMR.
1.2
Antibiotic resistance mechanisms. The generally accepted mechanisms of
bacterial resistance are either intrinsic (chromosomal) or acquired (plasmid).
There are three known resistance mechanisms (figure 1.2 below). 1. Bacteria can
secrete enzymes that target and degrade antibiotics. For example, β-lactamase
targets the β-lactam ring of penicillins. 2. A mutation could occur in the binding
site of the antibiotic target. For example, mutation in the DNA gyrase-A results
in resistance to fluoroquinolones such as ciprofloxacin.15 3. Efflux pumps remove
antibiotics from the cellular cytoplasm either to the periplasm or to the medium
surrounding the cells.16 For example, AcrAB, MdfA, and NorE type efflux pumps
provide resistance to multiple classes of antibiotics in a range of Gram negative
bacteria.17 The efflux pump mechanism is usually manifested in combination
with decreased permeability of the outer membrane in Gram negative bacteria.18
The additional semi-permeable bilayer membrane decreases the antibiotic
penetration in to the cell. ESKAPE pathogens are bacteria that escape the effect of
antibiotics and cause serious health concerns.19 It is an acronym for Enterococcus
faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumanii,
Pseudomonas aeruginosa and Enterobacter species. The majority of the ESKAPE
pathogens are Gram negative bacteria. Bacteria usually manifest different
combinations of the above mentioned resistance mechanisms to provide
resistance to multiple different antibiotics. Our focus is going to be increasing the
membrane permeability and inhibiting efflux pump activity. More details about these are
outlined below.
Chapter 1
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Four mechanisms of resistance: impermeable
barrier (a) blocks antibiotics (blue spheres)
because the bacterial cell membrane is now
impermeable to the drug. Target modification (b) alters the proteins inhibited by the
antibiotic, so the drug cannot bind properly.
Antibiotic modification (c) produces an enzyme that inactivates the antibiotic. Efflux
(d) employs genes coding for enzymes that
actively pump the antibiotic out of the cell.

introduce an error (called a mutation)
into the genome. Not all of these mutations are advantageous, but about
one in a billion will generate mutants
that can grow faster or tolerate higher
concentrations of antibiotics than their
predecessors. When such bacterial mutants are exposed to antibiotics, those
possessing antibiotic resistance genes
will increase in prevalence to the point
of taking over the entire population.
Multiple cycles of such mutation and
selection are often necessary to evolve
high-level antibiotic resistance.
Genes that have evolved to confer
antibiotic resistance to one type of bacteria can be transferred to another by
a mechanism known as horizontal gene
transfer. While some pathogens acquire
resistance via vertical transmission,
recent studies have suggested that
horizontal transmission may be the
dominant force behind growing antibiotic resistance. During horizontal gene
transfer, antibiotic resistance genes
catch a ride on mobile genetic elements
that carry the genetic material between
different cells. Mobile genetic elements
can be linear or circular pieces of DNA,
called plasmids, which are replicated by
the cell along with its genome.
These DNA fragments make their
way into a new cell through three mechanisms: transformation, transduction,
and conjugation. In transformation,
bacterial cells scavenge DNA remnants
from dead bacterial cells and integrate
them into their own genome. In transduction, genetic material is transferred
by bacteriophages (viruses that infect
bacteria). Bacteriophages can insert their
DNA into the genome of a host cell,
where they are maintained for many
generations before they pack up their
DNA and leave to infect another cell.
+ the way,
- the bacteriophage 3Along
may
coincidentally integrate a section of the
bacterial host cell genome into the bacteriophage genome, enabling genetic material from one cell to hitchhike a ride to
another cell on the bacteriophage.
The final way antibiotic resistance
genes can be passed from one microbe
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to another is through conjugation, also
known as bacterial sex. The discovery of this process, now thought to
be the main mechanism of horizontal
gene transfer, earned Joshua Lederberg the 1958 Nobel Prize in Physiology or Medicine. During conjugation,

that contain tens of resistance genes,
offering the host cells immunity to virtually all antibiotics.
Recent large-scale efforts sequencing the genomes of many bacterial
pathogens, by such groups as the
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Figure 1.2. Mechanisms through which bacteria develop resistance
to antibiotics (illustration from reference 20).20
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through porins (e.g. Outer Membrane Proteins, OMPs) found in the membranes
of bacteria (see figure 1.4).23

In Gram negative bacteria, the outer membrane (OM) provides an
additional challenge for entry into the cell. The OM consists of
lipopolysaccharides (LPS) and phospholipids (figure 1.3 below).18 LPS consists of
a lipid A structure, core polysaccharide, and O-antigen repeats. The LPS is
functionalized with anionic charges, is highly crosslinked and varies among
different species in the types of fatty acids and acyl groups that are present.18
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This prevents the entry of toxic molecules, such as antibiotics. Additionally, LPS
acts as an antigen and triggers an immune response in humans. Since the OMs
serve as a significant, primary barriers to antibiotic entry, their disruption could
serve as a strategy to increase antibiotic delivery/efficacy. In recent years, there
has been an increasing interest in this area of research. Membranes provide a
previously under-explored opportunity for the development of new antibiotics.

Figure 1.3. Structure of lipopolysaccharide (LPS) in the outer
membrane of Gram negative bacteria.24
1.4
Efflux pumps. In addition to OM, efflux pumps decrease the cytoplasmic
concentration of antibiotics. Overexpression of porins increases efflux of toxic
and unwanted molecules from the cells.23 However, efflux pumps are specialized
transmembrane proteins that identify and export antibiotics. Certain efflux
pumps provide multi-drug resistance.16,17,18 The multi drug resistance conferred
by efflux pumps can eventually cause acquisition of other types of resistance
such as antibiotic degrading enzymes or mutation of antibiotic target sites.25
There are five known types of efflux pumps. They are: the major facilitator
superfamily (MFS), the ATP binding cassette (ABC), the small multidrug
resistance (SMR), the resistance nodulation cell division (RND), and the multi
and toxic compound extrusion (MATE).26 The efflux pumps are classified based
on phylogenetic grouping.27 All the efflux pumps except ABC utilize either a
proton or sodium gradient as an antibiotic-cation antiport. ABC hydrolyzes an
ATP molecule to provide energy for antibiotic transport.
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Figure 1.4. Resistance developed by single component and
tripartite efflux pumps in Gram negative bacteria (illustration from
reference 26).26
Efflux pumps exist as either a single-component pump in the cytoplasmic
membrane (CM) or as a tripartite system that spans the CM, periplasmic space,
and the outer membrane (OM). See figure 1.4 above. Some of the efflux pumps
that span only the CM produce minimal resistance.27 The MFS and SMR type
efflux pumps serve as examples. Here, the lipophilic antibiotics that are effluxed
from CM can easily accumulate in and diffuse back from the periplasm into the
cytoplasm (figure 1.4). Some of these single-component efflux pumps have
strong kinetics and still produce a high level of resistance.28 For example, tetA
and AcrB efflux pumps localize in the CM and produce resistance to
tetracyclines.8 The RND type efflux pumps transport antibiotics from the cell
cytoplasm directly to the medium surrounding the cell. The RND pumps are also
located in the CM but they interact with outer membrane channels (TolC or
OprM).28 These porins are used to transport toxic molecules in all bacteria. The
periplasmic adaptor proteins or membrane fusion proteins (AcrAB or MexAB)
connect the channels in the CM to those of the OM, making a tripartite complex
that spans the CM, periplasm and OM. Some MATE, ABC, and MFS may also
function as a tripartite complex.28
The efflux pumps in Gram negative and –positive bacteria are highly
effective at keeping a low cytoplasmic concentration of antibiotics. Along with
OM, efflux pumps create a general mechanism of resistance that spans across
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various classes of antibiotics. Gram negative strains that consist of both efflux
pumps and antibiotic target site mutations do exist. However, such mechanisms
contribute independently to resistance development.29 For example, a 64-fold
recovery in the Minimal Inhibitory Concentration (MIC) of fluoroquinolones
resulted from deletion of MexAB-OprM efflux pump in a fluoroquinolone
resistant Pseudomonas aeruginosa strain that had also acquired resistance by a
mutation in DNA gyrase.30 Hence, the inhibition of efflux pump activity could
significantly increase the sensitivity of antibiotics against bacteria.
1.5
Efflux Pump Inhibitors (EPI). Five different approaches have been
reported for increasing antibiotic concentration in the cell cytoplasm of efflux
pump expressing Gram negative bacteria.30
1) Stealth. Modifying the structure of existing antibiotics decreases their
affinity for the binding site of efflux pumps. This results in an increase in the
cytoplasmic concentration of the antibiotics. For example, efflux pumps do not
recognize the tetracycline analog tigecycline.31
2) Competitive inhibition. An EPI that acts as a substrate for an efflux
pump binding site, competes for the antibiotic efflux and recovers the antibiotic
efficacy. For example, phenylalanine arginyl β-naphthylamide (PAβN) acts as a
competitive inhibitor to restore the activity of macrolides.32
3) Steric hindrance. EPI that binds strongly in the cavity of efflux pump,
creates a steric hindrance for the transport of antibiotics by the efflux pumps.
PAβN has an affinity for the binding pocket in AcrB and MexB efflux pumps. It
recovers levofloxacin efficacy against Pseudomonas aeruginosa.11 Bacteria may
develop a mutation that prevents the identification and binding of PAβN in the
efflux pumps, rendering them useless.
4) Uncoupling. As noted above, efflux pumps depend on a proton or
sodium gradient or on an ATP molecule for antibiotic antiport. Collapse of such
ion gradients or ATP production could inhibit efflux pump activity. For example,
carbonyl cyanide m-chlorophenylhydrazone (CCCP) inhibits the activity of efflux
pumps by dissipating the proton motive force required for ATP production.
Problems due to the cytotoxicity of CCCP have prevented its development for
clinical use.18
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5) Membrane permeability. Antibiotic influx could be increased by
increasing the OM permeability of Gram negative bacteria. For example, colistin,
a mixture of closely related polymyxin molecules, disrupts the cell membrane
and increases the permeability of antibiotics. Polymyxin is considered an
“antibiotic of last resort” for the treatment of MDR infections due to its
cytotoxicity.13 All of these methods are still under development. There is no EPI
available as a treatment for MDR Gram negative infections.
1.6
Our Strategy. Our focus is to develop a combination antibiotic using
strategies 4 and 5 outlined in section 1.4. The global use of Augmentin® is a
successful example for the clinical use of a combination antibiotic. Augmentin® is
a combination of amoxicillin (a β-lactam antibiotic) and potassium clavulanate, a
β-lactamase inhibitor.33 This combination defeats the β-lactamase resistance
mechanism and restores the potency of amoxicillin. We hypothesize the use of
synthetic amphiphiles as drug delivery agents and efflux pump inhibitor.
Drugs are available that targets bacterial membranes and cell walls. βLactams are not optimal for increasing membrane permeability and they suffer
from wide-spread resistance from β-lactamases. Polymyxin, which was isolated
from Bacillus polymyxa, targets lipid A in Gram negative bacteria.24 Its lipophilic
tail could protrude in the hydrophic region of the membrane that induces cell
membrane disruption.24 It has shown synergy with known antibiotics, including
carbapenems. However, polymyxins also induce kidney damage that limits its
clinical use. Much of antibiotic discovery around membrane disruptors is
focused on developing structural analogues of polymyxins that are less toxic.24
There has not been much success owing to the difficulty in manipulating
structures and predicting nephrotoxicity. A more recent antibiotic that targets
membrane is daptomycin. Daptomycin is indicated for use against Gram positive
bacteria. Daptomycin and polymyxin are both cyclic peptides that could be
classified as natural amphiphiles. Resistance from bacteria is another challenge
that plagues the development of polymyxin and daptomycin analogues.14
We outline a strategy to use synthetic amphiphiles to disrupt bacterial cell
membrane that would allow for penetration of antibiotics into the more
problematic Gram negative bacteria. The synthetic amphiphiles outlined here
could also disrupt cation gradients with the resulting inhibition of efflux pump
activity. An increase of antibiotic concentrations in the cell cytoplasm would
result in increased efficacy of antibiotics. Research in our lab has focused on the
design, synthesis, and activity of such synthetic ion transporters. The synthetic
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nature of our molecules would allow for development of numerous structural
analogues and a molecule that disrupts cell membrane with minimal
cytotoxicity.
1.7
Synthetic amphiphiles and ion channel. Amphiphiles are molecules that
consist of both hydrophobic (water-hating) and hydrophilic (water-loving)
components. Amphiphiles with a hydrophilic headgroup and a hydrophobic tail
are known to self-assemble.34 Different assemblies could be formed based on the
structure and geometry of amphiphiles.34 For example, bilayers are formed by
amphiphiles that consist of one hydrophilic head group and two long
hydrophobic chains. Cell membranes are made up of such amphiphiles called
phospholipids. Phospholipids typically comprise phosphorylated
diacylglycerol.21
Cellular membranes separate and insulate cells from their surroundings.
Membrane proteins such as receptors, transporters, and ion channel proteins
comprise 20%-30% of the human genome.35 Ion channel proteins maintain ion
homeostasis by transporting ions through the membrane’s ~30 Å hydrocarbon or
insulator regime.36 Natural channels exhibit features such as voltage gating,
rectification, ion selectivity, and open-close behavior.36 There has been an
increasing interest in designing and synthesizing molecules that show many of
the properties as amphiphiles and ion channels.37
Since the early work by Tabushi et al. in the 1980s, there has been a
dramatic increase in the number and variety of synthetic ion channels.38
Synthetic ion channels designed and developed in the Gokel lab mimic some
features of the well-known KcSA protein channel.36,39 These synthetic channels
have an entry and exit portal and a hydrated “central relay.” They are referred to
in our lab as “hydraphiles.”
1.8
Hydraphile ion channel structure. Hydraphiles typically consist of
tris(macrocyclic) structures known as crown ethers. Figure 1.5 shows 18-crown-6
(top). The units within the hydraphiles are diaza-18-crown-6 modules, where
diaza represents two nitrogen substitutions that replace oxygen atoms. The
number 18 is the total number of atoms in the ring and 6 is the number of
heteroatoms (i.e., O or N rather than C). Numerous relatively simple crown ether
derivatives are known to transport cations through bulk liquid membranes.39 In
contrast to these, hydraphiles function as channels rather than carrier
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transporters. Hydraphiles typically consist of three crown-ethers connected by
two alkyl chains (figure 1.5).

Figure 1.5. Structure of a crown ether molecule and benzyl C14
hydraphile.
Hydraphiles have the following essential features.
1) The two distal diaza-18-crown-6 groups function as entry and exit
portals. These moieties also serve as amphiphilic head groups.
2) These distal crown ethers are connected to a hydrophobic covalent
spacer chain. The length of the compound is dependent on the length of the
spacer chains. Each methylene (CH2) group adds ~1.25 Å to the overall length of
a hydraphile.
3) The spacer chains are linked to the central diaza-18-crown-6
macrocycle. This central macrocycle acts as a central relay (polar regime) that
stabilizes the cation in transit through the bilayer’s hydrophobic regime. This
feature is similar to that of the water-filled capsule in the KcSA channel.36
4) The distal macrocycles are linked to the side arms that stabilize the pore
by interacting with the phospholipid head groups. This is important for the ion
conductance ability of hydraphiles. The hydraphile shown in figure 1.5 has
benzyl group side arms and hence the named “benzyl hydraphile.” The number
of carbon atoms in the spacer chains is also included in the nomenclature. For
example, the compound illustrated has twin 14-carbon spacer chains and is
called “benzyl C14 hydraphile.”
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Figure 1.6. Sodium transport by benzyl C8-C16 hydraphiles in
liposomes (illustration from reference 25).
1.9
Hydraphile function. Hydraphiles have the following functions. Planar
bilayer studies confirm that hydraphiles transport cations (Na+, K+, H+) and
show open close behavior similar to that observed with known channel
proteins.40 Successful ion transport studies were also conducted in liposomes25
and in whole cells (patch clamp with HEK-293 cells).41 We rationalized that since
hydraphiles transport ions from liposomes and in mammalian cells, they would also
transport cations (Na+ and K +) from bacteria. The channels formed by hydraphiles
are unimolecular and non-rectifying.40 Hydraphiles are cation channels that are
four-fold selective for Na+ over K+. Hydraphiles show length dependent activity,
i.e., benzyl C12-C16 hydraphiles are better ion transporters than shorter or longer
analogs. Fully extended benzyl C12-C16 hydraphiles are estimated to span 30-40
Å. This is the approximate thickness of natural lipid bilayers. Benzyl C8
hydraphile, which is 14 Å shorter than benzyl C14 hydraphile, is not long enough
to span the bilayer and fails to form channels. Longer hydraphiles are poorer
transporters, probably owing to a less organized conductance state (figure 1.6).40
The benzyl C14 hydraphile was the most efficient ion transporter tested. It
is unknown if the ions are transported through the pore formed by hydraphile or
through a disruption caused by the hydraphiles. Computational studies by
others suggest the former.42 Upon addition of membrane thickening agents such
as cholesterol to liposomes, it was observed that the spectrum of activity (ion
transport) of hydraphiles shifted towards the longer spacer chain lengths.43 This
study showed that changes in membrane composition, such as addition of
cholesterol, could change the activity of hydraphiles. We rationalize that since the
membrane compositions of bacteria and mammalian cells vary widely, hydraphiles could
have different ion transport and toxic effects in different cell types.
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1.10 Hydraphile biological activity. Amphiphilic hydraphiles localize in the
bilayer membrane and mimic some ion-conducting properties of protein
channels. A fluorescently tagged (dansyl) hydraphile localizes in the periphery of
Escherichia coli (figure 1.7).43

Figure 1.7. Localization of dansyl C12 hydraphile in the membrane
of E. coli cells. Aggregation is observed after 5 minutes (right)
(illustration from reference 43).
Sodium and potassium are the most common cations in vivo. Altering ion
homeostasis of these two cations would have a detrimental effect on the viability
of cells. Hydraphiles showed antimicrobial activity against E. coli, Bacillus subtilis
and Saccharomyces cerevisiae as confirmed with the Kirby Bauer and the Minimal
Inhibitory Concentration (MIC) experiments.43 Hydraphiles had greater
antimicrobial activity against Gram positive than Gram negative bacteria. The
MICs of benzyl C12, C14, and C16 hydraphiles against E. coli and B. subtilis were
lower than those of benzyl C8, C10, C18 and C20 hydraphiles.44 A correlation
between the spacer chain length of hydraphile, ion transport and antibiotic
efficacy was apparent. If the hydraphile was too short, it failed to transport ion
and inhibit bacterial growth. Hydraphiles with spacer chains longer than 16carbons atoms are inefficient in ion transport and bacterial growth inhibition.43
As seen in the figure 1.8, the hydraphiles that showed greatest sodium release
from liposomes (C12, C14 and C16) also showed the lowest MICs.45
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Figure 1.8. Correlation between antibiotic activity and ion transport
by hydraphiles. The graph represents sodium transport (open
circles) mediated by hydraphiles from liposomes. The filled circles
are the MIC of hydraphiles against E. coli and the open squares are
the MIC against B. subtilis (illustration from reference 45).45
A structure activity relationship study showed that replacing the -NH
with oxygen in the distal macrocycles resulted in the loss of both antimicrobial
and ion transport activity.44 Numerous studies showed that the antimicrobial
activity of hydraphiles correlates to their ability to localize in membranes and to
transport ions.43,44,45 At their bactericidal concentrations, the benzyl C12 and C14
hydraphiles killed half of E. coli populations in 8.5 and 9.1 minutes.44 For
comparison, kanamycin kills half the E. coli population in 44.8 minutes. This
shows that hydraphiles rapidly cause cell death, most likely by the disruption of
ion homeostasis.
An important preliminary study and rationale for this research is reported
in Chemical Communications 2010.46 There, hydraphiles were administered at ½
[MIC] to DH5α E. coli cells, along with four different antibiotics. The antibiotics
used for this study were kanamycin, tetracycline, erythromycin and rifampicin.
These antibiotics are different in structure and have different cellular targets. It
was reported there that hydraphiles, at sub-lethal concentrations, could increase
the efficacy of four structurally and functionally different antibiotics against E.
coli (DH5α) and B. subtilis.46 For example, in the presence of 1 µM benzyl C16
hydraphile, the MIC of rifampicin decreased from 50 µM to 3 µM (figure 1.9).5
This exhibited an enhancement of rifampicin activity by 16-fold. Activity of
erythromycin was recovered by 8-fold, tetracycline by 4-fold and kanamycin by
2-fold. Similar results were observed with benzyl C14 hydraphile and alkyl
substituted C12 hydraphile.46 Since enhancement was observed with four
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different antibiotics, a more general mechanism of enhancement was
hypothesized. This warrants the investigation of hydraphiles as membrane
permeabilizing agents and for drug delivery.

Figure 1.9. Enhancement of erythromycin and rifampicin by C12,
C14 and C16 hydraphiles against DH5α E. coli (illustration from
reference 46).46
We hypothesize that if hydraphiles localize in the membrane of E. coli and span
the bilayer, they will increase the membrane permeability of Gram negative bacteria.
Altered OM permeability would allow for increased influx of antibiotics into the
periplasm and the cytoplasm.
Hydraphiles have been reported to show activity in a variety of cell types.
In colon carcinoma cell lines, the benzyl C12 hydraphiles induced apoptosis at 80
µM.47 The benzyl C14 hydraphile was shown to induce blebbing in mammalian
cells, a property attributed to apoptosis.47 Another study showed that
hydraphiles could be used for direct injection chemotherapy. Hydraphiles
induced tumor tissue damage in mice.48 This damage was localized to the tumor
tissue and did not spread to the surrounding tissue.47 The concentration of
hydraphile used for this study was much greater (40X) than its MIC observed
against E. coli and B. subtilis. It is critical for any potential drug application to
determine the selectivity of hydraphiles between bacteria and mammalian cells
at lower concentrations.
We recently reported that hydraphiles show a chain length dependence on
plants. In this study, benzyl C14 hydraphile at 20 µM and 50 µM decreases the
primary root length and increases the lateral root density of Arabidopsis thaliana
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roots.49 Shorter, inefficient benzyl C8 hydraphile, showed no effect on the root
architecture at 50 µM. No effect of hydraphiles was observed on the germination
of A. thaliana seeds. Auxin transport and transcription repressor mutants were
used to rule out their involvement in the auxin pathway. It is hypothesized that
hydraphiles alter the potassium ion homeostasis in plant roots, which is known
to have a dramatic effect on root development in A. thaliana.49
Overall, hydraphile ion channels affect multiple different types of cells,
likely due to disruption of cation (Na+ and K+) gradients. However, a detailed
and systematic study of hydraphile’s application as an antimicrobial or an
antibiotic-adjuvant has not been conducted. In addition, such study is lacking not
only with hydraphiles but also with any of the reported synthetic amphiphiles or
synthetic ion channels. We explore the use of hydraphiles as membrane
permeabilizing agents and as efflux pump inhibitors. This will allow for
antibiotic accumulation in the cell cytoplasm and rescue antibiotic activity
against both antibiotic-resistant and -sensitive bacteria.
1.11 Rationale and hypothesis. Efflux pumps depend on cation antiport to
transport the antibiotics from the periplasm or the cell cytoplasm. We therefore
rationalize that since hydraphiles can transport cations across a variety of membranes,
they could also disrupt the sodium or proton gradient required by the efflux pumps for
antibiotic antiport. This would result in the uncoupling of efflux pumps from the
energy source and decrease the efflux of antibiotics from the cell cytoplasm. We
hypothesize that if hydraphiles can form channels and transport ions in bacteria, then
they would result in uncoupling of efflux pump activity. Hence, a combination of
hydraphiles and antibiotic could be used to rescue the activity of antibiotics
against resistant, efflux pump expressing Gram negative bacteria.
The amphiphilic nature of hydraphiles could also disrupt the
phospholipids at the site of hydraphile insertion in the membrane. This would
allow for an increase in membrane permeability. We rationalize that since
hydraphiles could increase antibiotic efficacy against DH5α E. coli, they could
increase the bacterial cell membrane permeability. We hypothesize that if
hydraphiles localize in the cell membrane of bacteria, then they could increase the cell
membrane permeability to antibiotics. Ion carriers transport ions through
membranes by diffusion of the carrier●ion complex through the bilayer. The
difference in structures and functions of channels and carriers may result in
different effects on membrane permeability, efflux pump inhibition, and rescue
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of antimicrobial potency. We will therefore use lariat ethers, a structural
analogue of hydraphile, which is known to function as ion carrier, as a control.
Antibiotics can selectively inhibit bacterial cell growth. There are few
antibiotics, such as polymyxin, that are also toxic to human cells. It is therefore
critical to distinguish between the effect of hydraphiles as membrane
permeabilizing agents in bacteria and mammalian cells. The cytotoxicity of
hydraphiles to various mammalian epithelial cell lines was also be surveyed.
One of the major concerns today in new antibiotic development is the
development of resistance. Antibiotic stewardship programs are being
implemented in hospitals to limit the use of antibiotics and to prevent resistance
development. Bacteria would have to change the cell membrane composition or
the membrane biosynthesis pathway in order to develop resistance to
amphiphilic compounds. We therefore hypothesize that if hydraphiles are membrane
active molecules, then bacteria would take much longer to develop resistance to
hydraphiles than an antibiotic with a specific cytoplasmic target.

Chapter 1

16

M. B. Patel

1.12

References

1

Schlaes, D. M., Antibiotics the perfect storm, Springer, New York, 2010, 1
pp.
Clatworthy, A. E., Pierson, E., Hung, D. T.; Targeting virulence: a new
paradigm for antimicrobial therapy, Nat. Chem. Bio., 2007, 3, 541-548.
Center for Disease Control and Prevention, Antibiotic Resistance Threats
in the United States, 2013.
World Health Organization, Drug resistant tuberculosis is now at record
levels, 2010.
Richards, M. J.; Edwards, J. R.; Culver, D. H.; Gaynes, R. P., Nosocomial
infections in medical intensive care units in the United States. National
nosocomial infections surveillance system. Critic. Care Med., 1999, 27, 887892.
Spellberg, B.; Powers, J. H.; Brass, E. P.; Miller, L. G.; Edwards, J. E.,
Trends in antimicrobial drug development: implications for the future,
Clinic. Infec. Dis., 2004, 38, 1279-1286.
Woodcock, J.; Novel drugs summary 2015, FDA, 2015.
(http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DrugInnov
ation/ucm474696.htm)
Brown, D., Antibiotic resistance breakers: can repurposed drugs fill the
antibiotic discovery void? Nat. Rev. Drug Discov., 2015, DOI:
10.1038/nrd4675.
O’Neill, J.; Review on antimicrobial resistance, Wellcome Trust and HM
Government, May 2016.
Courvalin, P., Transfer of antibiotic resistance genes between Gram
positive and Gram negative bacteria, Antimicrob. Agents Chemother., 1994,
38, 1447-1451.
Rolain, J. M.; Parola, P.; Cornaglia, G., New Delhi metallo beta-lactamase
(NDM-1): towards a new pandemia? Clinc. Microbio. Infec., 2010, 16, 16991701.
Garonzik S. M.; Li J.; Thamlikitkul V.; Paterson D. L.; Shoham S.; Jacob J.;
Silviera F. P.; Forrest A.; Nation R. L., Population pharmacokinetics of
colistin methanesulfonate and formed colistin in critically-ill patients from
a multi-center study provide dosing suggestions for various categories of
patients. Antimic. Agents and Chemother., 2011, 55, 3284-94.
Trifi, A.; Abdellatif, S.; Daly, F.; Mahjoub, K.; Nasri, R.; Oueslati, M.;
Mannai, R.; Bouzidi, M.; Lakhal, S. B., Efficacy and toxicity of high-dose

2
3
4
5

6

7

8

9
10

11

12

13

Chapter 1

17

M. B. Patel

14

15

16
17

18

19

20
21
22

23

24

25

colistin in multi-drug resistant Gram negative Bacilli infection: a
comparative study of matched series, Chemother., 2015, 16, 190-196.
McGann, P.; Snesrud, E.; Maybank, R.; Corey, B.; Ong, A. C.; Clifford, R.;
Hinkle, M.; Whitman, T.; Lesho, E.; Schaecher, K. E., Escherichia coli
harboring mcr-1 and blaCTX-M on a novel lncF plasmid: first report of
mcr-1 in the United States, Antimicrob. Agents Chemother., 2016, 60, 44204421.
Hooper, D. C.; Wolfson, J. S.; Ng, E. Y.; Swartz, M. N., Mechanism of
action of and resistance to ciprofloxacin. The Am. Jour. Med., 1987, 82, 1220.
Poole, K.; Efflux mediated multiresistance in Gram negative bacteria,
Clinic. Microbiol. Infec. 2004, 10, 12-26.
Yang, S., Clayton, S. R., Zechiedrich, E. L.; Relative contribution of the
AcrAB, MdfA and NorE efflux pumps to quinolone resistance in
Escherichia coli, Jou. Antimic. Chemther. 2003, 51, 545-556.
Zgurskaya, H. I., Lopez, C. A., Gnanakaran, S.; Permeability barrier of
Gram negative cell envelopes and approaches to bypass it, ACS Infect. Dis.
2015, DOI:10.1021/acsinfecdis.5b00097.
Boucher, H. W.; Talbot, G. H.; Bradley, J. S.; Edwards, J. E.; Gilbert, D.;
Rice, L. B.; Scheld, M.; Spellberg, B.; Bartlett, J., Bad bugs, no drugs: no
ESKAPE! An update from the infectious disease society of America, Clinic.
Infect. Dis., 2009, 48, 1-12.
Dantas, G., Sommer, O. A.; How to fight back against antibiotic resistance,
Amer. Scient., 2014, 102, 42-51.
Singer, S. J.; Nicolson, G. L., The fluid mosaic model of the structure of cell
membranes. Science, 1972, 175, 720-731.
Murata, K.; Mitsuoka, K.; Hirai, T.; Walz, T.; Agre, P.; Heymann, J. B.;
Engel, A.; Fujiyoshi, Y., Structural determinants of water permeation
through aquaporin-1. Nature, 2000, 407, 599-605.
Pagès, J.; James, C. E.; Winterhalter, M., The porin and the permeating
antibiotic: a selective diffusion barrier in Gram negative bacteria. Nat. Rev.
Microbio. 2008, 6, 893-903.
Brown, D. G.; Drug discovery strategies to outer membrane targets in
Gram negative pathogens, Bioorg. Med. Chem., 2016,
http://dx.doi.org/10.1016/j.bmc.2016.05.004.
Pages, J., Alibert-Franco, S., Mahamoud, A., Bolla, J., Davin-Regli, A.,
Chevalier, J., Garnotel, E.; Efflux pumps of Gram negative bacteria, a new
target for new molecules, Curr. Top. In Medic. Chem. 2010, 10, 1848-1857.

Chapter 1

18

M. B. Patel

26

27
28
29

30

31

32
33
34

35

36
37

38
39

Li, X., Pleslat, P., Nikaido., H.; The challenge of efflux mediated antibiotic
resistance in Gram negative bacteria, Clin. Microbiol. Rev., 2015, 28, 337418.
Poole, K.; Overcoming multidrug resistance in Gram negative bacteria,
Curr. Opin. Invest. Drugs. 2003, 4, 128-139.
Nagano, K., Nikaido, H.; Kinetic behavior of the major multidrug efflux
pump AcrB of Escherichia coli, Proc. Nat. Acad. Sci. 2009, 106, 5854-5858.
Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M.,
Blais, J., Cho, D., Chamberland, S., Renau, T., Leger, R., Hecker, S.,
Watkins, W., Hoshino, K., Ishida, H., Lee, V. J.; Identification and
characterization of inhibitors of multidrug resistance efflux pumps in
Pseudomonas aeruginosa: novel agents for combination therapy,
Antimicrob. Agents Chemother., 2001, 45, 105-116.
Mahamoud, A., Chevalier, J., Alibert-Franco, S., Kern, W. V., Pages, J.;
Antibiotic efflux pumps in Gram negative bacteria: the inhibitor response
strategy, Jour. Antimicrob. Chemther., 2007, 59, 1223-1229.
Lomovskaya, O., Bostian, K. A.; Practical applications and feasibility of
efflux pump inhibitors in the clinic – A vision for applied use, Biochem.
Pharmacol. 2006, 71, 910-918.
Opperman, T. J., Nguyen, S. T.; Recent advances towards a molecular
mechanism of efflux pump inhibition, Front. Microbio. 2015, 421, 1-16.
Rolinson, G. N., The history and background of Augmentin, SA Med. Jour.,
1982, 62, 3-4.
Israelachvili, J. N., Mitchell, D. J. & Ninham, B. W. Theory of self-assembly
of hydrocarbon amphiphiles into micelles and bilayers. J. Chem. Soc.,
Faraday Trans. 2 72, 1525-1568 (1976).
Babcock, J. J., Li, M.; Deorphanizing the human transmembrane genome:
A landscape of uncharacterized membrane proteins, Acta Pharmaco. Sinica.
2014, 35, 11-23.
Gokel, G. W., Negin, S.; Syntehtic membrane Active amphiphiles, Adv.
Drug Deliv. Rev. 2012, 64, 784-796.
Lamb, J. D.; Christensen, J. J.; Izatt, S. R.; Bedke, K.; Astin, M. S.; Izatt, R.
M., Effects of salt concentration and anion on the rate of carrier-facilitated
transport of metal cations through bulk liquid membranes containing
crown ethers, J. Am. Chem. Soc. 1980, 102, 3399-3403.
I. Tabushi, Y. Kuroda and K. Yokota, Tetrahedron Lett. 1982, 4601–4604.
Inoue, Y.; Gokel, G. W., Cation Binding by Macrocycles, Marcel Dekker,
New York, 1990, 761 pp.

Chapter 1

19

M. B. Patel

40

41

42
43

44

45

46

47

48

49

Leevy, W. M.; Weber, M. E.; Schlesinger, P. H.; Gokel, G. W., NMR and
ion selective electrode studies of hydraphile channels correlate with
biological activity in E. coli and B. subtilis, Chem. Commun. 2005, 89-91.
Leevy, W. M., Huettner, J. E., Pajewski, R., Schlesinger, P. H., Gokel, G.W.;
Synthetic ion channel activity documented by electrophysiological
methods in living cells, J. Am. Chem. Soc., 2004, 126, 15747-15753.
Srinivas, G.; Lopez, C.; Klein, M., Membrane bound hydraphiles facilitate
cation translocation, J. Phys. Chem. B., 2004, 108, 4231-4235.
Leevy, W. M.; Donato, G. M.; Ferdani, R.; Goldman, W. E.; Schlesinger, P.
H.; Gokel, G. W., Synthetic hydraphile channels of appropriate length kill
Escherichia coli; J. Am. Chem. Soc. 2002, 124, 9022-9023.
Leevy, W. M.; Gammon, S. T.; Levchenko, T.; Daranciang, D. D.; Murillo,
O.; Torchilin, V.; Piwnica-Worms, D.; Huettner, J. E.; Gokel, G. W.,
Structure-activity relationships, kinetics, selectivity, and mechanistic
studies of synthetic hydraphile channels in bacterial and mammalian cells,
Org. Biomol. Chem. 2005, 3, 3544-3550.
Gokel, G. W.; Daschbach, M. M., Coordination and transport of alkali
metal cations through phospholipid bilayer membranes by hydraphile
channels, Coordinat. Chem. Rev., 2008, 252, 886-902.
Atkins, J. L.; Patel, M. B.; Cusumano, Z.; Gokel, G. W., Enhancement of
antimicrobial activity by synthetic ion channel synergy, Chem. Commun.
2010, 46, 8166-7.
Smith, B. A.; Gammon, S. T.; Xiao, S.; Wang, W.; Chapman, S.; McDermott,
R.; Suckow, M. A.; Johnson, J. R.; Piwnica-Worms, D.; Gokel, G. W.; Smith,
B. D.; Leevy, W. M., In Vivo Optical Imaging of Acute Tissue Damage
Using a Near-Infrared Fluorescent Zinc-Dipicolylamine Probe, Molecular
Pharmaceutics 2011, 8, 583-590.
Smith, B. A., Daschbach, M. M., Gammon, S. T., Xiao, S., Chapman, S. E.,
Hudson, C., Suckow, M., Piwnica-worms, D., Gokel, G. W., Leevy, W. M.;
In vivo cell death mediated by synthetic ion channels, Chem. Commun.
2011, 47, 7977-7979.
Patel, M. B., Stavri, A., Curvey, N. S., Gokel, G. W.; Hydraphile synthetic
ion channels alter root architecture in Arabidopsis thaliana, Chem.
Commun. 2014, 50, 11562-4.

Chapter 1

20

M. B. Patel

CHAPTER 2
Hydraphiles Increase the Potency of Tetracycline, Kanamycin, Erythromycin,
and Rifampicin Against Antibiotic-Sensitive Escherichia Coli, Pseudomonas
Aeruginosa, and Bacillus Subtilis

This chapter has minor changes to the published version:
Patel, M. B.; Garrad, E. C.; Stavri, A.; Gokel, M. R.; Negin, S.; Meisel, J W.;
Cusumano, Z.; Gokel, G. W., Hydraphiles enhances antibiotic potency against
Escherichia Coli, Pseudomonas Aeruginosa and Bacillus Subtilis, Bioorganic and
Medicinal Chemistry, 2016, 24, 2864-2870.
Following changes were made to the published version:
1. Figure 2.3 has been updated.
2. The description of figures 2.2, 2.3, 2.4 and 2.5 have been updated to add
the number of trials and statistical analysis.
3. The paragraph preceding the figures has number of trials and description
of standard deviation.
4. One new paragraph has been added to the introduction.
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2.1.

Introduction.
Since the development of the sulfa drug Prontosil in the 1930s, antibiotic
therapy has produced a revolution in the treatment of infections.1 Sulfa drugs
were largely replaced in the 1940s by penicillin derivatives and a range of
subsequent antibiotics such as the cephalosporins and the fluoroquinolones. By
the 1960s, it was generally believed that the bacterial infection war had been
won. In the interim, the emergence of antibiotic resistance has become an
international crisis.2 Both the Centers for Disease Control and Prevention (CDC)3
and the World Health Organization (WHO)4 have issued extensive advisories
and discussions concerning the current problems.
The problem has been exacerbated by the lack of new antibiotic
derivatives and antibiotic classes (new chemical entities or “NCE”). Encouraging
recent results have appeared, however, with the reports of teixobactin5 and
aspergillomarasmine A.6 In addition, such antibiotic peptides7 as magainin8 and
derivatives along with various cationic amphiphiles9 have been extensively
studied in recent years. Combinations of antibiotics and peptide antibiotics have
been used against both Gram negative and Gram positive bacteria.10
Notwithstanding, the problem of antibiotic resistance persists and its threat to
worldwide health is increasing.
Hydraphiles have been reported to inserted in to the lipid bilayer and
formed non-rectifying cation channels. Since hydraphiles insert in the bilayer
membranes, we hypothesized that they could increase the membrane
permeability. This could allow penetration of antibiotics through the bacterial
membranes and increase in their potency. To test this hypothesis, we determined
the potency of antibiotics in the presence of hydraphiles.
In a preliminary report,11 we showed that hydraphiles,12 when coadministered with various antibiotics, enhanced the potency of drugs against
microbes. The original hypothesis that potency enhancement was possible was
based on the membrane activity of hydraphiles.13 It was surmised that the
insertion of hydraphiles into a bacterial boundary layer would create an opening
or defect that might permit other molecules to more readily penetrate it. We
chose antibiotics as the test substance because bacteriostatic or bactericidal
activity would serve as a useful metric to evaluate the hypothesis. We report here
an extensive elaboration of our original study to a number of
antibiotic/amphiphile/organism combinations. In some cases, potency
enhancements were found to be as high as 30-fold.
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2.2.

Compounds used.
The work reported here used three different hydraphiles.14 They are
illustrated in Figure 2.1 as 1-3. The spacer chains represented in Figure 2.1 by
(CH2)n had values of n equal to 8, 14, and 16. In all cases, the two distal
macrocycles were benzyl-terminated. We refer to these hereinafter as benzyl C8
(1), benzyl C14 (2) and benzyl C16 (3) hydraphiles. All three compounds used
have been fully characterized and all are previously known.15,22
The antibiotics used were kanamycin sulfate [4, kanamycin D, mixture of
(predominantly) A, B, and C], tetracycline (5), erythromycin (6) and rifampicin
(7). These four antibiotics were obtained from commercial suppliers in the purest
form available and used as received. They were selected because their chemical
structures are very different. For each of the antibiotics, the mechanism of action
is both well-established and different from any of the other compounds used in
this study. Kanamycin A is an aminoglycoside that inhibits protein synthesis and
cell respiration and causes potassium cation leakage to occur.15 Tetracycline,
which is produced in vast quantities annually, binds to the 30S ribosomal
subunit, which inhibits peptide synthesis.16 To the extent that any of the
structures are related, it is erythromycin and rifampicin, both of which are
macrolides. The ring sizes are different as are the substitution patterns and
modes of action. Erythromycin17 inhibits protein synthesis by binding to the
ribosomal 50S subunit. Rifampicin,18 in contrast, inhibits RNA synthesis.
Although both erythromycin and rifampicin ultimately inhibit protein synthesis,
they do so by distinctly different interactions and mechanisms. Their different
modes of action are reflected in their different indications. Rifampicin is a first
line treatment for tuberculosis19 and erythromycin is prescribed for such
conditions as bronchitis and pertussis.20 What all four antibiotics do have in
common is that they all must infiltrate the cell cytoplasm to inhibit bacterial
growth.
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Figure 2.1. Structures of benzyl C8, C14 and C16 hydraphile (1-3),
kanamycin (4), tetracycline (5), erythromycin (6), rifampicin (7) and
Triton X-100 (8).
2.3.

Bacteria used.
Four different microbial strains were used to study antibacterial activity.
All of the synergy studies previously reported with benzyl C14 hydraphile and
antibiotics were against the DH5α E. coli strain.11 This non-pathogenic strain of E.
coli has been optimized for laboratory use in molecular biology experiments.
Results are recorded herein for that strain but new results are presented for E. coli
(Migula) Castellani and Chalmers (MG1655) K-12 strain. K-12 E. coli is derived from
a human stool sample and is generally considered to be more robust than DH5α
E. coli. The other two bacteria studied were Gram negative Pseudomonas
aeruginosa and Gram positive B. subtilis. Pseudomonas is often found in biofilms21
and is a common infection in patients using hospital breathing machines (i.e.
ventilator-associated pneumonia). We used B. subtilis to assess the efficacy of our
combination therapy in a Gram positive bacterium.
2.4.

Results and Discussion.
In the nearly half century since the discovery of crown ethers,22 there have
been numerous reports of biological activity. Early studies showed, for example
that exposure to 12-crown-4 caused testicular atrophy in mice.23 More extensive
studies showed that the simple crowns 12-crown-4, 15-crown-5, and 18-crown-6
had LD50 values (male white rats) of 3200, 1000, and 700 mg/kg, respectively.24
Antibacterial25 and antifungal26 activities of widely varied crown structures were
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reported in the early 1980s. Additional antimicrobial activity of various crown
ether derivatives has been reported up to the present day.27 The diverse ranges of
structures and organisms that have been studied make it difficult to generalize
about crown toxicity in the absence of other substances. To the extent a
conclusion can be articulated, it is that crown toxicity to Gram positive
organisms such as B. subtilis is likely to be greater than to Gram negative
organisms such as E. coli. Indeed, this trend is often observed with
antimicrobials.
Our own studies of antimicrobial activity of hydraphiles showed the
presence of the amphiphilic pore formers in the E. coli boundary layer.28 A study
of activity against E. coli and B. subtilis revealed a correlation between hydraphile
length and toxicity.13 Hydraphile length also correlates to efficacy of ion
transport.29 Because of the correlation that we observed between ion transport
activity and toxicity to E. coli, we examined a shorter-chained hydraphile that
should be a poor channel-former to test its effect. The results of these studies are
described below.
The activities of all compounds were assayed by determining the
minimum inhibitory concentrations (MICs) under specified conditions. All MIC
determinations were conducted according to the protocols provided by the
Clinical and Laboratory Standards Institute: M07-A9.30 We note for the reader
unfamiliar with this assay that the procedure depends on bacterial growth
observed in a sequence of serial dilutions. Thus, a minimum inhibitory
concentration may be 4 µM in one determination, 8 µM in a second, and 2 µM in
a third. In our studies, we typically conducted between 3-5 replicates to
determine a reproducible MIC, which would be reported as 4 µM for the
example given above.
The MIC was also determined for the commercial amphiphile Triton X-100
(8). This is a common neutral detergent that has been reported to be membrane
active.31 It was included as a control to assess whether the effects observed for
hydraphiles are essentially generic and would be manifested by any membrane
active amphiphile. The choice of Triton X-100 was also based on reports of
channel-like function under certain conditions in liposomal membranes.32,33 The
oligoethylene glycol chain of Triton X-100 varies from 9–10 units, giving an
average molecular weight of 625 Daltons. This value was used in minimum
inhibitory concentration (MIC) determinations.
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2.4.1 Determination of hydraphile MIC. We determined the MICs for each
compound against E. coli (DH5α), E. coli (K-12), P. aeruginosa and B. subtilis. Gram
negative DH5α E. coli was used as a control and to compare the synergy data of
benzyl C8 hydraphile (1) to that of the values previously reported for benzyl C14
hydraphile (2).34 This is important to be sure that bacterial strains kept in storage
have not been compromised. The MIC data are recorded in Table 2.1 for the
hydraphiles (1-3), the antibiotics (4-7), and Triton X-100 (8).
Table 2.1. MICs of hydraphiles and antibiotics against E. coli (DH5α and K-12), P.
aeruginosa and B. subtilis.
Benzyl
hydraphile used
C8 hydraphile (1)
C14 hydraphile (2)
C16 hydraphile (3)
Kanamycin (4)
Tetracycline (5)
Erythromycin (6)
Rifampicin (7)
Triton X-100 (8)

E. coli
(DH5α, µM)

E. coli
(K-12, µM)

P. aeruginosa
(µM)

300
200
2
2.5
4
ND
30
35
5
5
200
700
55
16
>512
>512
ND means not determined

ND
2
2
ND
12
200
25
ND

B. subtilis
(µM)
ND
0.5
ND
ND
3
0.3
ND
ND

The results reported in table 2.1, were accumulated from atleast three
replicates. The MIC experiments were conducted using serial dilution
concentrations. Hence, the errors in the results could by 2-fold dilution.
However, the results were reproduced three times to confirm the reported MIC
above.
To the extent a conclusion can be reached from the MIC screening, it is
that benzyl C14 hydraphile is generally more toxic to Gram positive than to Gram
negative strains. Note that the potency difference between benzyl C16
hydraphiles against E. coli DH5α and P. aeruginosa is a single dilution in the MIC
analysis, although variation in responses of different strains of bacteria to
xenobiotics is common.
2.4.2. Synergy against E. coli (DH5α and K-12), P. aeruginosa and B. subtilis.
Three hydraphiles were tested against DH5α E. coli in the preliminary report of
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this work.11 Two of those are included here, benzyl C14 (2) and benzyl C16
hydraphiles (3), along with the shorter benzyl C8 hydraphile (1). In the present
study, we compare these three closely related benzyl-terminated hydraphiles
that differ only in overall length, with the four structurally unrelated antibiotics
noted above, against four different bacterial strains.
In each experiment, bacteria were infused with the indicated amount of
hydraphile and the MIC was determined for the antibiotic in its presence. The
amount of additive was always a fraction of the measured MIC value for that
compound. The MIC value for Triton X-100 was >512 µM against DH5α E. coli
and the amount used in the study was arbitrarily set at 64 µM. The results are
recorded in Table 2.2. Each entry reflects a minimum of 3 replicates and typically
is 5-10.
The results reported in table 2.2, were accumulated from five replicates. The MIC
experiments were conducted using serial dilution concentrations. Hence, the
errors in the results could by 2-fold dilution. However, the results were
reproduced three times to confirm the reported MIC above.
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Table 2.2. Enhancement of antimicrobial activity by benzyl C8, C14, and C16
hydraphiles (1-3) and Triton X-100 (8) against E. coli (DH5α and K-12), P.
aeruginosa, and B. subtilis.
Hydraphile used

[Hydraphile]
Antibiotic
(µM)
used
E. coli (DH5α)

[Antibiotic]
(µM)

Fold
Increase

C8 hydraphile (1)
C8 hydraphile (1)
C8 hydraphile (1)
C8 hydraphile (1)
C8 hydraphile (1)
C8 hydraphile (1)
C8 hydraphile (1)
C8 hydraphile (1)
Triton X-100 (8)
Triton X-100 (8)

150 (½ [MIC])
Kanamycin
75 (¼ [MIC])
Kanamycin
150 (½ [MIC])
Tetracycline
75 (¼ [MIC])
Tetracycline
150 (½ [MIC]) Erythromycin
75 (¼ [MIC]) Erythromycin
150 (½ [MIC])
Rifampicin
75 (¼ [MIC])
Rifampicin
64
Kanamycin
64
Rifampicin
E. coli (K-12)

8
12
1
2
15
25
3
3
30
55

3-fold
2-fold
5-fold
2-fold
13-fold
8-fold
18-fold
18-fold
none
none

C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)

1.25 (½ [MIC])
0.6 (¼ [MIC])
1.25 (½ [MIC])
0.6 (¼ [MIC])
1.25 (½ [MIC])
0.6 (¼ [MIC])
1.25 (½ [MIC])
0.6 (¼ [MIC])

Kanamycin
Kanamycin
Tetracycline
Tetracycline
Erythromycin
Erythromycin
Rifampicin
Rifampicin

15
30
1
3
75
300
0.5
4

2-fold
none
5-fold
2-fold
9-fold
2-fold
30-fold
4-fold

C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C14 hydraphile (2)
C16 hydraphile (3)
C16 hydraphile (3)

P. aeruginosa
1 (½ [MIC])
Tetracycline
0.5 (¼ [MIC])
Tetracycline
1 (½ [MIC])
Erythromycin
0.5 (¼ [MIC]) Erythromycin
1 (½ [MIC])
Rifampicin
0.5 (¼ [MIC])
Rifampicin
1 (½ [MIC])
Erythromycin
0.5 (¼ [MIC]) Erythromycin

3.13
6.25
25
50
2.35
4.7
25
50

4-fold
2-fold
8-fold
4-fold
11-fold
5-fold
8-fold
4-fold

1.56
0.16

2-fold
2-fold

B. subtilis
C14 hydraphile (2)
C14 hydraphile (2)
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2.4.3. Comparison of benzyl C8 hydraphile (1) to benzyl C14 hydraphile (2). Our
initial assumption was that enhancement of antibiotic potency against bacteria
was related to membrane penetration and ion transport efficacy. In our previous
study,11 we did not compare channel and non-channel amphiphiles. Because
earlier results showed that benzyl C8 hydraphile did not transport Na+ ions
through liposomal membranes, we expected the antibiotic’s MIC value to be
indifferent to the presence of benzyl C8 hydraphile (1). Surprisingly, 1 enhanced
the potency of kanamycin, tetracycline, erythromycin, and rifampicin against
DH5α E. coli between 2- and 18-fold, to extents dependent on the antimicrobial
that was co-administered.
The bar graph in Figure 2.2 compares the observed enhancements of
antibiotic potency by 1 and 2. Each pair of bars reflects the potency enhancement
of the indicated antibiotic, mediated by ½ [MIC] of 1 or 2 against DH5α E. coli.
The error bars represent the standard deviation in the MICs determined over five
replicates. Results were considered significantly different only if the error bars
did not overlap. Both compounds enhanced the potency of each antibiotic to
some extent. Benzyl C8 hydraphile (1) appears marginally more active in each
case than is 2. We therefore infer that the increase in antibiotic potency is
independent of the compound’s ability to form ion channels. Since the four
antibiotics are so structurally different, it is unlikely for hydraphiles to interact
with (complex with, form clusters with) the antibiotics and act as a carrier to
increase their efficacy.

Figure 2.2. Fold enhancements of tetracycline, kanamycin,
erythromycin and rifampicin by ½ [MIC] of benzyl C8 (1) and
benzyl C14 (2) hydraphiles against DH5α E. coli. The error bars

Chapter 2

29

M. B. Patel

represent the standard deviation in the MICs determined over five
replicates. Data for benzyl C14 hydraphile were reported in
reference 11.
2.4.4. Comparison of antimicrobial enhancement between K-12 E. coli and
DH5α E. coli. As noted above, our previous work was limited to the nonpathogenic DH5α “laboratory strain” of E. coli. In the preliminary report of this
effort, we also reported one example each of activity assayed with B. subtilis and
P. aeruginosa. A comparison of the data obtained earlier with the DH5α strain of
E. coli with the K-12 strain was of obvious interest. The graph of Figure 2.3
compares the potency enhancements observed for the four antibiotics against the
two bacterial strains. The error bars represent the standard deviation in the MICs
determined over five replicates. Results were considered significantly different
only if the error bars did not overlap. In all cases, benzyl C14 hydraphile (2) was
the additive or mediator. The observed potency enhancements for K-12 E. coli
with all four antibiotics were equal to or greater than against DH5α E. coli. In K12 E. coli, the MIC of benzyl C14 hydraphile was 2.5 µM compared to 2.0 µM
against DH5α.
It is interesting to note that the MICs of rifampicin were different against
K-12 E. coli from DH5α E. coli. This difference has been attributed to the absence
of the O-antigen from the bacterium’s lipopolysaccharide shell. This enhances the
membrane permeability of bacteria to hydrophobic compounds.35

Figure 2.3. Fold enhancement (indicated by numbers atop the
columns) of tetracycline, kanamycin, erythromycin and rifampicin
mediated by ½ [MIC] of benzyl C14 hydraphile (2) against DH5α E.
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coli and K-12 E. coli. The error bars represent the standard deviation
in the MICs determined over five replicates. Results were
considered significantly different only if the error bars did not
overlap. Data for C14 hydraphile were reported in reference 11.
2.4.5. Growth curve with benzyl C14 hydraphile and erythromycin. An obvious
question concerning the results reported here is whether or to what extent, the
bacteria under study suffer toxicity effects at the concentrations used. In order to
address this question, we obtained growth curves for the combination of
erythromycin and benzyl C14 hydraphile (2) to determine the effect of the latter
on E. coli (DH5α). We measured the optical density of E. coli at 600 nm every 15
minutes for 12 h (720 min). The life cycle of E. coli is typically 22-23 min so the
data reflect between 31 and 36 generations. By its nature, the study also revealed
whether the antibiotic activity enhancement was a synergistic or additive effect.
The results are shown below in Figure 2.4.

Figure 2.4. Graph showing the effect of benzyl C14 hydraphile (2)
on the potency of erythromycin administered against DH5α E. coli.
Each point represents the average of three separate determinations.
Error bars indicating standard deviations did not overlap, hence
have been omitted for clarification.
It is clear from the data graphed in Figure 2.4 that at ½ [MIC] (open
squares), benzyl C14 hydraphile (2) does not affect the growth of DH5α E. coli
(filled circles). Erythromycin was administered at 25 µM (1/8 [MIC]) and 50 µM
(¼ [MIC]). At 25 µM erythromycin, the effect on growth was minor (filled
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squares). When the antibiotic’s concentration was doubled to 50 µM (filled
triangles), inhibition of growth was about twice that at the lower concentration.
However, when ½ [MIC] of 2 and 25 µM erythromycin were combined, the
growth of E. coli was dramatically reduced (open circles). This confirms that
there is synergy between hydraphiles and antibiotics. It also indicates that
hydraphiles are enhancing the potency of this antibiotic against the E. coli cells.
It is interesting to compare the antimicrobial potency of rifampicin with
incremental amounts of benzyl C8 (1) and benzyl C14 (2) hydraphiles against K-12
E. coli. The graph of Figure 2.4 shows that 2 enhances the potency of
erythromycin against DH5α E. coli. The K-12 strain of E. coli is not only more
robust than DH5α, it is more susceptible to rifampicin than DH5α E. coli is to
erythromycin. The graph of Figure 2.5 (and Table 2.1) shows that the MIC of
rifampicin is 16 µM in the absence of any hydraphile. Each point represents the
average of three separate determinations. Error bars indicating standard
deviations did not overlap, hence have been omitted for clarification. At a
concentration of 2.5 µM, the maximum concentration studied, 1 has no effect on
rifampicin potency against the bacteria. Thus, fewer concentration studies were
conducted with benzyl C8 hydraphile. When 2 is co-administered in a
concentration range from 0-2.5 µM, clear evidence is obtained for a synergistic
interaction. The dotted line in the graph connects the maxima on the two axes
and would indicate a simple additive effect if followed by the experimentally
determined data.36

Figure 2.5. Graph showing the effect of added hydraphiles 1 and 2
on the potency of rifampicin against the K-12 strain of E. coli. The
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dotted line predicts the profile of an additive, rather than a
synergistic, effect.
2.4.6. Enhancement of potency against B. subtilis and Pseudomonas aeruginosa.
Compounds 1, 2, and 3 all mediate potency enhancements when co-administered
with erythromycin, kanamycin, rifampicin, or tetracycline against DH5α and K12 E. coli. Based on the somewhat diverse literature on crown toxicity to
bacteria,13-19 we anticipated that Gram positive B. subtilis would be the most
susceptible organism to hydraphiles and the most likely to show potency
enhancements when exposed to low hydraphile doses and antibiotics. In fact, the
potency of either erythromycin or tetracycline against B. subtilis (see Table 2.2)
was enhanced only marginally by 2 (administered at ¼ [MIC]). In contrast, at the
¼ [MIC] concentration, the potency of erythromycin against DH5α E. coli was
enhanced 8-fold by benzyl C8 hydraphile 1. We note that Triton X-100,
administered at concentrations as high as 64 µM showed no effect on DH5α E.
coli in the presence of either kanamycin or rifampicin.
The most dramatic increase in potency was observed for the combination
of 2 at ½ [MIC] with rifampicin against K-12 E. coli. This is a very encouraging
result because the 30-fold potency enhancement was observed when only 1.25
µM 2 was co-administered. Compound 2 also enhanced the potency of rifampicin
by 11-fold against P. aeruginosa at the same [2] = 1.25 µM concentration.
Potency enhancement by 1 of 13-fold and 18-fold when administered
against E. coli at ½ [MIC] with erythromycin or rifampicin, respectively, was also
surprising as 1 is a poor ionophore. Of course, the ½-[MIC] concentration of 1
represents a much larger number of molecules than ½ [MIC] of either 2 or 3. We
conclude that our original hypothesis that potency enhancement correlated with
pore formation or ionophoretic activity is not substantiated, at least as the sole
contributor to potency enhancement. The appealing hypothesis was always
somewhat speculative considering the enormous difference between the
boundary layers (membrane, cell wall) of Gram negative and Gram positive
bacteria.
An alternate explanation for the enhancement is that a particular or
selective interaction occurs between hydraphiles and antibiotics. Tetracycline is
water-soluble and the H-bonding ability of such a polar solvent could easily
mask any supramolecular interaction. We therefore decided to exclude solvent to
the greatest extent possible and undertook a mass spectrometric analysis of the
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interaction between 3 and tetracycline (figure 2.6). Electrospray ionization was
used to moderate the experimental conditions. The experiment was conducted in
a duplicated, where the same outcome was observed. When excess tetracycline
was added to 3, no hydraphile-antibiotic adduct or cluster was observed. The
major ion of 3 alone is the [3•Na]+ adduct. The only change observed in the
spectrum of 3 with the addition of tetracycline hydrochloride was the
appearance of the tetracycline ([5•H]+ and [5•DMSO•H]+) peaks as well as
various adducts of 3 with protons, sodium cations, and chloride anions.

Figure 2.6. Electrospray mass spectra of the combination of benzyl
C14 hydraphile (3) alone, tetracycline (5) alone and 3 and 5 in
combination in 3:5 ratios of 2 and 4.
A caveat in the consideration of mechanism is that the enhancements of
potency apparent with ½ or ¼ [MIC] of 1 involve larger amounts of compound
than needed either for 2 or 3. For example, at ¼ [MIC], the concentrations of 1
and 2 are ~90 µg/mL and ~700 ng/mL. Given the >100-fold difference in
concentration, 1 could be operating differently from 2 or 3. Further, the ability to
form channels does not preclude 2 and/or 3 from interacting with the membrane
to enhance permeability. There could be supramolecular interaction(s) not
detected by mass spectrometry. The formation of supramolecular complexes or
adducts is plausible within the low polarity regime of a bilayer membrane. Even
if such interactions were detectable in a liposomal membrane where the
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phospholipids produce a relatively homogeneous bilayer, it is unclear that the
same chemistry would occur in the more complex boundary layers of bacteria.
2.5.

Conclusions
We present data that demonstrate an enhancement of antibiotic potency
mediated by three hydraphiles interacting with four structurally diverse
antibiotics in four different microbes. Both benzyl C8 (1) and C14 (2) hydraphiles
significantly enhance the potency of antibiotics, in one case by up to 30-fold.
Where significant potency enhancements occur, the evidence for synergy is clear.
The potency enhancements observed for 1 appear to discount an exclusive ion
transport-related mechanism. We infer this because 1 is inactive as Na+transporting ion channel in liposomal and planar bilayer experiments. A more
general and nonspecific increase in bacterial membrane permeability seems to be
the more likely explanation for the activity, although a combination of channel
formation and enhancement membrane permeability cannot be discounted.
Several mechanisms have been suggested to account for the efficacy of
antimicrobial peptides in fostering the transport of hydrophobic substrates. One
is that the peptide binds to the membrane to form an ion channel.37 A second
postulate is that the peptides infiltrate the membrane according to the carpet
model,38 causing extensive membrane disruption and permeability increase. A
recent report of synergy between such cell penetrating peptides as magainin and
polymyxin with antibiotics such as piperacillin or clarithromycin suggests
enhanced membrane permeability as an important mechanistic possibility.39
Notwithstanding, a very recent report links polymyxin permeability to a
membrane receptor.4041 An increase in permeability mediated by hydraphiles
seems plausible in the present case, but channel formation may also alter
membrane structure or function or both. Studies are underway with structurally
related amphiphiles not known to form channels to further define the scope of
such enhancements.
2.6.

Experimental section.

2.6.1. Hydraphiles. Benzyl hydraphiles having spacer chains of 8- 14- and 16methylene groups have been prepared and reported previously.14 Benzyl C8, C14
and C16 hydraphiles for use in this study were synthesized according to a
recently reported procedure.24 All the hydraphiles were dissolved in DMSO
before use. The final concentration of DMSO in each experiment was kept
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constant at 0.5%-by volume whether or not the co-solvent was required for
solubility.
2.6.2. Antibiotics and bacteria used. All antibiotics were obtained from SigmaAldrich Chemical Company. Rifampicin and erythromycin were dissolved in
DMSO before use. Tetracycline and kanamycin were dissolved in autoclaved
milli-Q H2O. The compounds purchased were the purest available and were
used as received.
E. coli (DH5α and K-12), B. subtilis and P. aeruginosa were obtained from
the American Type Culture Collection (ATCC) and were used for MIC and coadministration procedures. All bacteria were cultured in L.B. Miller media and
used at exponential growth phase as outlined in the MIC procedure below.
2.6.3. Minimal inhibitory concentration (MIC). The MIC and co-administration
studies were performed according to the procedure outlined in Clinical and
Laboratory Standards Institute.30 Bacteria were grown overnight from one colony
forming unit (CFU) in L.B. Miller media. Compounds were prepared by serial
dilutions in either DMSO or milli-Q H2O. The compound or antibiotic [10 µL]
was added to 1970 µL of L.B. Miller media in the test tubes. The bacteria were
knocked back to O.D. (600 nm) = 0.600 before use and 20 µL of dispersion was
added to each test-tube. The test tubes were vortexed before and after adding
bacteria and incubated overnight at 37 °C and 200 RPM, before collecting the
results. Visual turbidity of the liquid in the test tubes was used to determine
growth or no growth. The lowest concentration that inhibited the growth of
bacteria completely, was considered to be the MIC. The data were reproduced at
least three times at the MIC concentration.
2.6.4. Co-administration of hydraphiles and antibiotics. The co-administration
of hydraphiles and antibiotics experiments were performed as outlined in the
Clinical and Laboratory Standards Institute protocols.28 The bacteria were
prepared at O.D. 600 nm = 0.600, as outlined in the MIC procedure above. The
MIC of each antibiotic was determined by using the serial dilution technique in
the presence of an amount of hydraphile determined to be ½ or ¼ of the
hydraphile’s MIC. In a test tube, L.B. Miller media was added followed by
hydraphiles and antibiotics. The final volume of compounds added was kept
constant at 0.5%-by volume (DMSO or dH20) as needed. The bacteria were
knocked back and 20 µL of the dispersion was added to each test-tube. The test
tubes were incubated overnight at 37 °C while stirring at 200 RPM, before
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collecting the results. Growth or no growth of the bacteria was determined by
visual inspection. The MIC of antibiotics in the presence of hydraphiles was
replicated a minimum of three times.
2.6.5. Growth curve. Growth curves were performed with benzyl C14
hydraphile and erythromycin against DH5α E. coli. The growth curves were
performed in a 2 mL culture. E. coli was grown overnight from one CFU in L.B.
Miller media and knocked back to O.D. 600 nm = 0.600 before use. Media was
added (L.B. Miller) to a test tube followed by desired concentration of hydraphile
or erythromycin or a combination of both. The concentration (volume) of DMSO
was kept constant at 0.5%-by volume. To each test tube, knocked back E. coli was
added and the samples were vortexed. Contents of the test tubes were incubated
at 37 °C and 200 RPM and its optical density was determined at λ = 600 nm every
15 minutes for 12 hours. The results are presented as optical density vs. time.
2.6.6. Electrospray ionization mass spectrometry. Spectra were obtained on a
JEOL JMS-700 mass spectrometer. Samples were injected directly into the
instrument at 1 mL/min and ionized by electrospray with a tip voltage of 2 kV.
A mass range of 100 to 2400 m/z was scanned in the positive polarity mode. No
significant peak was observed past 1700 m/z. Benzyl C16 hydraphile 3 (in DMSO,
0.25-0.5 mM final concentration) was added to tetracycline 5 (hydrochloride salt
in 18.2 MΩ H2O, 1 mM final concentration). Controls were performed with
hydraphile 3 and antibiotic 5 alone. In each case the final DMSO:H2O ratio was
9:1 by volume.
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CHAPTER 3
Hydraphile Synthetic Ion Channels Rescue Antimicrobial Potency Against
Efflux Pump Expressing Antibiotic Resistant Gram Negative Bacteria

The data reported in this chapter has not been published yet but is covered
under two patent applications:
PCT Patent Application Number PCT/US2015/034550
Provisional Application Number 15/186,070 (CIP US2015/034550)
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3.1.

Introduction.
Antibiotic resistance has become a world-wide crisis.1 With the emergence
of multi-drug resistant (MDR) bacteria, we have entered the post-antibiotic era.1
With only one antibiotic approved in 2015, the rate of antibiotic discovery is at an
all-time low.2 A patient infected with MDR bacteria has few treatment options
including surgery and amputations. In some cases, due to lack of an effective
antibiotic treatment, the infection proves to be fatal. In 2013, in U.S. alone, there
were 2 million hospital acquired infections. These infections proved to be fatal
for 23,000 patients.3
Two fatal diseases caused by MDR bacteria are pneumonia and urinary
tract infections (UTI). In about 1 million people that are hospitalized with
pneumonia, 50,000 people die.4 In addition, hospital associated pneumonia
(HAP) and ventilator associated pneumonia (VAP) are on the rise.5 UTI affects
150 million people per year around the world and 10.5 million people per year in
U.S.A.6 Increased mortality is associated with catheter related UTIs. The primary
causative agents for UTI and pneumonia are Escherichia coli and Klebsiella
pneumoniae.7 Both of these are Gram negative bacteria and their treatment has
become increasingly difficult owing to antibiotic resistance.
Antibiotics commonly used for the treatment of UTI and pneumonia are
ciprofloxacin (fluoroquinolones), third and fourth generation cephalosporins and
carbapenems.8 Treatment with these antibiotics has become difficult due to the
acquisition of extended spectrum β-lactamase (ESBLs) enzymes and efflux
pumps.9 Plasmids encoding ESBLs and efflux pumps are easily acquired by the
bacteria, which allows for a rapid spread of antibiotic resistance.10 In addition to
the resistance mechanisms, Gram negative bacteria have an outer membrane
(OM). This OM acts as a barrier for the antibiotic’s entry in to the cell. The
lipopolysaccharide (LPS) in the OM is made up of a lipidA structure, core
polysaccharides, and O-antigen repeats.11 This not only prevents the passage of
antibiotics, but also acts as an antigen. The majority of virulent ESKAPE
pathogens12 are Gram negative pathogens.7 Polymyxin targets lipidA of LPS and
disrupts the OM.13 It is associated with renal toxicity, hence it is used as a drug of
last resort.13 Recently, an Escherichia coli strain was found in the U.S., carrying a
polymyxin resistance gene, mcr-1.14 There are no other antibiotics available that
could target the membrane of Gram negative bacteria.
Due to increasing resistance, research and clinical use of combination
therapy has increased dramatically. The only antibiotic approved in 2015 was
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Avycaz, a combination of avibactam (a β-lactamase inhibitor) and a ceftazidime
(a third generation cephalosporin).15 It is one of the very few combination drugs
that is indicated for use against Gram negative infections such as K. pneumoniae.
Augmentin, the first combination antibiotic, is another successful example of this
approach. Combination antibiotics provide the ability to use the existing arsenal
of antibiotics for the treatment of MDR infections. However, bacterial enzymes
(NDM-1) that can evade the effect of all known β-lactamase inhibitors have been
reported.3,15 We therefore investigated the use of hydraphile synthetic ion
channels as adjuvants to rescue the efficacy of existing antibiotics. In particular,
the ability of hydraphiles to rescue antibiotic potency against efflux pump
expressing, MDR Gram negative bacteria was explored.
Crown ethers of different sizes have been known to form stable and
selective complexes with metal and organic cations.16,17,18 Numerous structural
variations of these macrocyclic compounds have been shown to transport ions
through bilayer membranes, either as carriers or as channels.19 Most of the
reported studies focused on developing new crown-ether based molecules that
could mimic natural ion transport proteins such as valinomycin and
gramicidin.20 Valinomycin is a K+ carrier21 whereas gramicidin forms a
dimerized cation selective protein channel in the membrane.21 Biological activity
for some of the macrocyclic compounds has also been reported.22 These studies
focus on their application either as an antimicrobial23 or chemotherapeutic
drug.24 The antimicrobial studies were limiting in the fact that they typically
could only conclude that the crown ether based molecules were more active
against Gram positive rather than Gram negative bacteria. There was no
mechanism determined or further studies reported.
We have developed and extensively studied a family of crown ether based
synthetic ion channels that we have called hydraphiles (figure 3.1).25 Hydraphiles
typically consist of three diaza-18-crown-6 residues connected by alkyl spacer
chains of appropriate length.27 Numerous studies have confirmed that the two
distal macrocyclic crown ethers of hydraphiles align in the mid-polar region of
the bilayer membrane and the central ring is in the region of lowest polarity of
the membrane (the midplane). The central macrocycle (central relay) acts as the
energy lowering portal for the transfer of cations through the hydrophobic
region.27 We have confirmed that hydraphiles having appropriate spacer chain
lengths csan form a channel that conducts cations, specifically Na+ and K+ ions.26
They form non-rectifying channels, hence transporting ions based on cation
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gradients. The ability of hydraphiles to transport cations depends on the
concentration, length and composition of the bilayer membrane.27
Hydraphiles have been known to show antimicrobial potency against
Escherichia coli, Bacillus subtilis and Saccharomyces cerevisiae.28 Hydraphiles with
spacer chain lengths of [(CH2)n] = 12, 14 or 16 are excellent ion transporters and
have antimicrobial properties.29 However, when the spacer chain length was as
short as octylene (n = 8), they were not efficient ion transporters or bactericidal.
Hence, the toxicity of hydraphiles to bacteria has been related to their chain
length and ion transport capability. It was therefore hypothesized that
hydraphiles channels disrupted cation homeostasis in bacteria, causing cell
death. Studies have shown that the hydraphiles also induce apoptosis in
cancerous cells30 and increase lateral root density of Arabidopsis thaliana plant31.
We recently reported that C14 benzyl hydraphile, C16 benzyl hydraphile
and alkyl substituted C12 hydraphiles could rescue the activity of rifampicin,
erythromycin, kanamycin, and tetracycline against both DH5α and K-12 E. coli.32
The greatest recovery was observed with rifampicin (16-fold) and erythromycin
(8-fold). Rifampicin33 and erythromycin34 are both hydrophobic antibiotics that
cannot effectively penetrate through the outer membrane (OM) of Gram negative
infections. We also reported that the activity of these antibiotics was enhanced
against Pseudomonas aeruginosa and B. subtilis.35 When C8 benzyl hydraphile was
used as a control, we observed that rifampicin activity was not recovered at
concentrations similar to that of C14 benzyl hydraphile, i.e. 2.5 µM. However, at
150 µM of C8 hydraphile (1/2 [MIC]), the activity of rifampicin was enhanced by
18-fold. Again, a length dependent effect of hydraphiles was apparent. At sublethal concentration of Benzyl C14 hydraphile, growth of DH5α E. coli was
similar to E. coli alone control. There was no interaction observed in mass
spectrometry studies between hydraphiles and tetracycline. We therefore
hypothesized that hydraphiles increase permeability of Gram negative bacteria,
allowing for antibiotic diffusion into the bacterial cytoplasm.
So far no study has been reported about hydraphile’s activity against
multi-drug resistant bacterial strains. Specifically, no studies have investigated
the ability of hydraphile or synthetic ion transporters as an antibiotic adjuvant or
an efflux pump inhibitor. Bacterial efflux pumps provide a resistance mechanism
that affects multiple classes of antibiotics.36 Acquisition of efflux pump-based
resistance usually leads to the acquisition of other types of resistance
mechanisms (e.g. target mutation and antibiotic-degrading enzymes). Such
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mechanisms contribute independently to resistance development.37 All efflux
pumps utilize either a cation gradient (proton or sodium) or hydrolysis of an
ATP molecule for active antibiotic efflux.38,39 Antimicrobial resistance in Gram
negative bacteria is a combination of second membrane diminished influx and
increased efflux of antibiotics.40 Numerous approaches have been reported for
increasing antibiotic concentration in the cell cytoplasm of efflux pump
expressing bacteria.41 For example, phenylalanine arginyl β-naphthylamide
(PAβN) recovers levofloxacin efficacy against P. aeruginosa.41 Here we report a
novel approach that recovers antimicrobial potency against efflux pump
expressing Gram negative bacteria.
We hypothesized that if hydraphiles increase the membrane permeability
and inhibit efflux pump activity, then the activity of antibiotics could be
recovered by hydraphiles against efflux pump expressing resistant Gram
negative bacteria. Here, we report that at sub-lethal concentrations, hydraphile
synthetic ion channels recover the activity of tetracycline and ciprofloxacin
against resistant E. coli and K. pneumoniae. Both strains were confirmed to have
efflux pumps specific to tetracycline. Ciprofloxacin resistance occurred from both
efflux pump and target site mutation (DNA Gyrase A). A synergy between
hydraphiles and antibiotics was confirmed. Growth curve studies showed that ½
[MIC] of Benzyl C14 hydraphile extended the lag phase but did not inhibit the
growth of E. coli. These results were similar to that of colistin (polymyxin E) but
different than the common detergent triton X-100. Hydraphile analogue lariat
ethers, which were thought to be ion carriers, also recovered tetracycline activity
by 16-fold. A chain length dependent effect of hydraphiles on antibiotic recovery
was observed.

3.2

Compounds used.
This study included four hydraphiles that varied in the spacer chain
lengths: benzyl C8-C14 hydraphiles (compounds 1 – 4). The benzyl C12 and C14
hydraphiles are known to span the membrane and efficiently transport cations.33
Benzyl C8 and C10 hydraphile are not optimal to span the membrane and
inefficient at ion transport as observed by liposomal release experiments.33
Hence, benzyl C8 and C10 hydraphile are used as controls for this study.
Lariat ethers are synthetic ionophores that act as carriers. They have a
central 18-crown-6 macrocycle connected to two alkyl chains (figure 3.1).
Compared to the hydraphile structure, lariat ethers lack the two distal
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macrocycles present in hydraphiles. We therefore used C8-C16 lariat ethers (5 - 9),
expecting them to be ion carriers that were structurally similar to the
hydraphiles. However, very recent results show that lariat ether may also act as
pore formers.42
The rescue of tetracycline (10) efficacy was examined in the presence of
hydraphiles. Tetracycline binds to the 30S subunit of the ribosomes and inhibits
peptide elongation.43 Tetracycline has a broad spectrum of activity against both
Gram positive and –negative bacteria. Due to increasing resistance, their use in
humans has been limited.48 Regardless, their use in the animal feed market has
been increasing. This further contributes to the resistance development by
bacteria to tetracyclines. Efflux pumps are the primary reason for resistance
development to tetracycline.48 Successful recovery of tetracycline could bring this
effective antibiotic back to the clinic.
Another antibiotic included in this study was ciprofloxacin (11).
Ciprofloxacin targets the DNA gyrase A that belongs to the fluoroquinolone class
of antibiotics.44 The activity of ciprofloxacin was determined against K.
pneumoniae. Clinical use of ciprofloxacin has decreased due to the mutations in
DNA gyrase and the resistance-nodulation division (RND) type efflux pumps.49
The OM of K. pneumoniae also decreases the permeability of ciprofloxacin. The
efficacy of ciprofloxacin in the presence of hydraphiles and control was
determined.
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Figure 3.1. Structures of compounds used for the study. C8-C14
hydraphiles (1-4), lariat ethers (5-9), tetracycline (10), ciprofloxacin
(11), reserpine (12), CCCP (13), valinomycin (15), triton X-100 (16)
and colistin (17).
Known efflux pump inhibitors45 reserpine (12) and carbonyl cyanide 3chlorophenylhydrazone (CCCP, 13) were used as controls. Reserpine blocks the
efflux pumps preventing substrate transport where as CCCP dissipates proton
motive force in bacteria resulting in uncoupling of efflux pumps from their
energy source. Protein ionophores such as gramicidin-D (14) and valinomycin
(15) were used as controls. Triton X-100 (16) was used as control for its known
detergent like effect. Colistin (17), a Gram negative membrane disruptor was also
used a control.
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3.3.

Results and Discussion.

3.3.1. Minimal Inhibitory Concentrations (MICs). Our aim was to determine if
the activity of antibiotics could be rescued against Gram negative bacteria in the
presence of synthetic amphiphiles. For this purpose, we first determined the
MICs on all the compounds mentioned above against K. pneumoniae (ATCC BAA
2146) and E. coli (tetracycline resistant). Both the strains used have efflux pumps.
3.3.1.1. Bacteria used.
TetR E. coli. TetR E. coli was made by transforming competent JM109 E.
coli with pBR322 plasmid. This plasmid consists of the tetA [class C] gene46 that
expresses the tetA efflux pump. The tetA efflux pump localizes in the
cytoplasmic membrane (CM).51 It provides tetracycline resistance by transporting
tetracycline from the cell cytoplasm into the periplasmic space. It utilizes the
bacterial proton gradient that exists across CM, to efflux tetracycline.47 This
plasmid also expresses the β-lactamase gene. The MIC of tetracycline against
TetR E. coli was 900 µM and that of ampicillin was > 1000 µM. The MIC of
tetracycline against non-resistant K-12 E. coli was 6 µM. This confirms that the
pBR322 plasmid is expressed and the TetR E. coli is resistant to tetracycline and
ampicillin. The tetA efflux pump is highly specific and efficient at exporting
tetracycline from the cell cytoplasm. It does not even recognize the tetracycline
analogue-minocycline as its substrate. The MIC of minocycline against TetR E.
coli was 15 µM, which is similar to the sensitive K-12 E. coli.
Bacteria isolated from patients usually possess multiple different types of
efflux pumps and other resistance mechanisms targeted towards the same
antibiotic. It is therefore difficult to study the effect of hydraphiles on one efflux
pump in patient isolated strains. The TetR E. coli strain provides a control strain
with one efflux pump targeting tetracycline, which is used to test the effect of
hydraphiles.
K. pneumoniae. The K. pneumoniae strain used in these studies was
acquired from ATCC (ATCC BAA 2146). This bacterium was isolated from a
patient with UTI and is resistant to more than 30 different antibiotics.48 It
expressed the tetA (MFS type), ABC and RND type efflux pumps. In addition, it
also has binding site mutations and New Delhi β Metallo-lactamase (NDM-1)
enzyme that provides resistance to multiple different classes of antibiotics.53 This
K. pneumoniae is a robust strain as it has already developed resistance to range of
antibiotics and was isolated from a patient. Infections caused by K. pneumoniae
Chapter 3

49

M. B. Patel

are difficult to treat with existing antibiotics, even with adjuvants (β-lactamase
inhibitors). No NDM-1 inhibitors have yet been developed. The MIC of
ciprofloxacin was 700 µM in this strain. The resistance to ciprofloxacin can be
attributed to a combination of efflux pumps and mutations in DNA gyrase A.
The MIC of tetracycline was 1000 µM, which is a result of tetA efflux pump.
Development of a new antibiotic therapy against K. pneumoniae is of clinical
significance against this and related strains. The results of MIC are shown in
Table 3.1 below. The MICs reported in table 3.1 are the average of 5 trials. The
standard deviation was calculated and represented as ‘±’ the average MIC.
Table 3.1: Minimal Inhibitory Concentration (MIC) in µM
Compounds used

K. pneumoniae

C8 hydraphile (1)
C10 hydraphile (2)
C12 hydraphile (3)
C14 hydraphile (4)
Tetracycline (10)
Ciprofloxacin (11)
Colistin (17)
CCCP (13)
Reserpine (12)
N.D. = not determined

200 ± 10
56 ± 5
35 ± 3
10 ± 2
1000 ± 100
700 ± 100
0.5 ± 0.25
N.D.
N.D.

E. coli (TetR)
250 ± 10
35 ± 3
5±1
2±1
900 ± 100
0.5 ± 0.25
0.25 ± 0.25
56 ± 5
> 128

We first determined the MIC of benzyl C8-C14 hydraphiles (1-4) against the
both Gram negative bacteria. The MIC of Benzyl C14 hydraphile against TetR E.
coli was 2 µM and against K. pneumoniae it was 10 µM. For comparison, the MIC
of tetracycline against E. coli was 6 µM. Benzyl C12 hydraphile and C14 hydraphile
were equally active. However, C10 and C8 hydraphiles (compounds 3 and 4) were
less active. This trend follows the ion transport and membrane spanning ability
of hydraphiles: C14 hydraphile ≥ C12 hydraphile > C10 hydraphile > C8
hydraphile.
Colistin, a membrane disruptor, was more active than Benzyl C14
hydraphile. Colistin is also associated with renal toxicity. The MIC of colistin
against E. coli was 0.25 µM and against K. pneumoniae it was 0.5 µM. The efflux
pump inhibitors CCCP (12) and reserpine (13) are not efficient antimicrobials as
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both of their MICs were > 56 µM. CCCP is known to be more active against
Gram positive bacteria than Gram negative bacteria. Compared to the TetR E. coli,
K. pneumoniae was less susceptible to the hydraphiles and antibiotics. The
differences might be attributed to the differences in the cell membrane
compositions among the two strains. K. pneumoniae also has a greater number of
resistance mechanisms and genes that decrease the antibiotic efficacy.
3.3.2. Combination studies. Through the MIC screening, we determined the
antimicrobial properties of each compound. Antibiotic (tetracycline and
ciprofloxacin) MICs were greater than those of hydraphiles. If hydraphiles rescue
antibiotic potency, then the MIC of antibiotics would decrease in the presence of
sub-lethal (< MIC) concentrations of hydraphiles. We therefore determined the
MIC of antibiotics, in the presence of different fractional MIC concentrations of
hydraphiles.
TetR E. coli. TetR E. coli expresses the tetA efflux pump. The tetA efflux
pump belongs to the MFS class of efflux pumps.51 It localizes in the inner
membrane of the E. coli. TetA efflux pumps selectively transport tetracycline
molecules in exchange for a proton. The tetA efflux pump is highly selective.
Hydraphiles and tetracycline are structurally and functionally distinct molecules.
It is unlikely that the hydraphiles could be a substrate of the tetA efflux pump.
The hydraphiles used for this study were: benzyl C8-C14 hydraphiles. If
hydraphile disrupted the cell membrane and inhibited the efflux pump activity,
the activity of tetracycline would be recovered. To prevent any toxic effect from
hydraphiles, we determined the MIC of tetracycline in the presence of either 1/2
or 1/4 the [MIC] of hydraphiles. The results of three replicates are shown below
in table 3.2. The MICs reported in table 3.2 are the average of 3 trials. The
standard deviation was calculated and represented as ‘±’ the average MIC. A
decrease in the MIC was considered significant only in the error in the data did
not overlap. The fold enhancement was determined using the average MICs
shown in column 3, hence no errors are shown. However, enhancement greater
2-fold were only considered significant.
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Table 3.2: Recovery of tetracycline activity against TetR E. coli by hydraphiles
Amphiphile
used

[Amphiphile]
µM

No amphiphile
C8 hydraphile
C8 hydraphile
C8 hydraphile
C10 hydraphile
C10 hydraphile
C10 hydraphile
C12 hydraphile
C12 hydraphile
C12 hydraphile
C14 hydraphile
C14 hydraphile

1
62.5 (¼[MIC])
125 (½[MIC])
1
8.75 (¼[MIC])
17.5 (½[MIC])
1
1.25 (¼[MIC])
2.5 (½[MIC])
0.5 (¼[MIC])
1 (½[MIC])

[Antibiotic]
µM

900 ± 100
600 ± 100
82 ± 15
30 ± 8
600 ± 100
200 ± 20
40 ± 5
300 ± 75
400 ± 50
55 ± 5
360 ± 40
220 ± 25
> 1000
C14 hydraphile
1 (½[MIC])
(Ampicillin)
a, see below for a discussion of the FIC index

Fold
enhancement

FIC
indexa

n/a
1.5-fold
11-fold
30-fold
1.5-fold
5-fold
23-fold
3-fold
2-fold
16-fold
3-fold
4-fold

n/a
0.73
0.34
0.53
0.69
0.69
0.54
0.53
0.69
0.56
0.65
0.74

0-fold

n/a

As seen in table 3.2 above, the activity of tetracycline was recovered in the
presence of benzyl C8-C14 hydraphiles against TetR E. coli. In the presence of 1 µM
benzyl C14 hydraphile, the MIC of tetracycline decreased from 900 ± 100 µM to
250 ± 25 µM. This documents the recovery of tetracycline activity by 4-fold. Here,
the fold-enhancement was calculated by dividing the MIC of antibiotic alone, by
the MIC of antibiotic determined in the presence of hydraphiles. In the presence
of ½ [MIC] of benzyl C8, C10, C12 and C14 hydraphiles tetracycline activity was
recovered by 30, 23, 16 and 4-fold, respectively. At ¼ [MIC] of benzyl C8, C10, C12
and C14 hydraphiles tetracycline activity was recovered by 11, 5, 2 and 3-fold,
respectively. In the presence of 125 µM benzyl C8 hydraphile, the tetracycline
MIC was as low as 30 µM. It may appear that benzyl C8 hydraphile is the most
efficient hydraphile at recovering the tetracycline activity. However, it is
important to note that the MIC of benzyl C8 hydraphile is much greater than
benzyl C14 hydraphile. So a large amount of compound was required at the same
fraction of MIC (one-half).
To compare the efficacy of hydraphiles with each other, an experiment
was performed at the lowest ½ [MIC] value of all the hydraphiles used, i.e. 1 µM.
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At 1 µM, benzyl C8, C10, C12 and C14 hydraphiles recovered tetracycline activity
by 1.5, 1.5, 3 and 4-fold, respectively. From this experiment it was revealed that
C14 hydraphile, the most potent ion transporter, was also the most efficient at
recovering tetracycline activity against TetR E. coli.
There was no recovery of ampicillin activity in the presence of benzyl C14
hydraphiles. Ampicillin resistance in the TetR E. coli was a result of β-lactamase
enzymes. The recovery of antibiotic activity observed in the presence of
hydraphiles appears to be limited to efflux pump inhibition. However, the
disruption of ion gradients by hydraphiles could affect the secretion or
biosynthesis of β-lactamase enzymes. The failure of ampicillin recovery by the
benzyl C14 hydraphiles, the most potent ion transporter in this series, shows that
the inhibition of any pathway involving β-lactamase is unlikely.
The fractional inhibitory concentration (FIC) index49 was calculated for each
combination tested and the values are reported in table 3.2. The FIC index is a
theoretical means of determining synergy, additive, or antagonist effects between
two compounds. It is calculated by adding the fractional MICs of the two
compounds used. A FIC index of 0.5 or lower is conservatively defined as
synergism. However, a FIC index of 1 or lower is also considered a more general
definition of synergy. In a broader sense, all the hydraphiles showed some
synergy with tetracycline. Most of the hydraphiles tested had FIC index of
approximately 0.5. The FIC data show that only benzyl C8 hydraphile at ¼ [MIC]
(11-fold recovery) fits the narrow definition of synergy. FIC > 1 is considered
antagonism, which was not observed with any hydraphile tested.
3.3.3. Growth curve. The FIC index discussed above showed that hydraphiles
may only show moderate synergy with tetracycline. We wanted to determine if
sub-lethal concentrations of hydraphiles affected the growth of TetR E. coli. We
therefore performed growth curve studies shown in figure 3.2. The compounds
used for growth curve study were C14 hydraphile and tetracycline against the
TetR E. coli. The TetR E. coli was treated with either 1 µM C14 hydraphile (1/2
[MIC]), 2 µM C14 hydraphile (MIC), 220 µM tetracycline (1/4 [MIC]), 900 µM
tetracycline (MIC) and the combination of 1 µM C14 hydraphile + 220 µM
tetracycline. Untreated TetR E. coli and TetR E. coli treated with 0.5% (v/v) DMSO
were used as controls. The growth of TetR E. coli was monitored every 30 minutes
by measuring the optical density (O.D.) of the cultures at λ = 600 nm.
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Figure 3.2. Growth curve of TetR E. coli in the presence of C14
hydraphiles and tetracycline. Growth of TetR E. coli was monitored
in the presence of 1 µM and 2 µM C14 hydraphile, 220 µM and 900
µM tetracycline and the combination of 1 µM C14 hydraphile + 220
µM tetracycline. Error bars represent the standard deviation in 3
replicates. Results were considered significant if the error bars did
not overlap.
As seen in figure 3.2, the TetR E. coli has a lag phase (~2 hours),
exponential growth phase and a stationary phase. When TetR E. coli is treated
with benzyl C14 hydraphile at 2 µM (MIC; purple line), the growth of TetR E. coli
is completely inhibited. However, when the TetR E. coli is treated with ½ [MIC] of
benzyl C14 hydraphile (1 µM), the lag phase is extended to ~3 hours. After 3
hours, the growth of TetR E. coli treated with ½ [MIC] hydraphile recovers and
parallels that of untreated TetR E. coli. During the exponential phase, the growth
rate of E. coli alone was calculated at 0.692/hr, which is within experimental
error of 0.658/hr in the presence of 1 µM benzyl C14 hydraphile. The lag phase
could have been extended because of the death in the TetR E. coli population
caused by half-[MIC] benzyl C14 hydraphile. It is also likely that the TetR E. coli
took longer to prepare for the exponential phase due to osmotic stress caused by
non-rectifying hydraphile channels. Similar growth rates during the exponential
growth phase and complete recovery of TetR E. coli growth support the osmotic
stress hypothesis.
In the presence of tetracycline at 220 µM, TetR E. coli growth was inhibited.
This was not surprising because it has been previously reported that Salmonella
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typhimurium expressing the tetA efflux pump had increasing inhibition of growth
with increasing concentration of tetracycline.50 In the presence of 900 µM
tetracycline, TetR E. coli growth was completely inhibited. However, when the
combination of ½ [MIC] of benzyl C14 hydraphile and ¼ [MIC] of tetracycline
was tested, completely inhibition of TetR E. coli growth was observed. This
proves a synergistic activity between benzyl C14 hydraphile and tetracycline,
regardless of the FIC index > 0.5. Two key observations are made here. First that
the half-[MIC] of benzyl C14 hydraphile increases lag phase by 1 hour but does
not inhibit the bacteria growth. Second, there is synergy between half-[MIC]
benzyl C14 hydraphile and tetracycline against the tetA efflux pump expressing
E. coli.
3.3.4. Checkerboard. To investigate the recovery of tetracycline activity by
hydraphiles in detail, we performed checkerboard experiments. The
checkerboard experiment is a detailed combination study in which numerous
concentrations (serial dilutions) of one compound are tested against numerous
concentrations (serial dilutions) of the antibiotic of interest. For example, six
concentrations of benzyl C14 hydraphile (1, 1/2, 1/4, 1/8, 1/16 and 1/32 [MIC])
were tested against tetracycline at 1, 1/2, 1/4, 1/8, 1/16 and 1/32 [MIC]. The
results are presented as heat maps in figure 3.3. The results could further be
analyzed to draw isobolograms. We performed checkerboard experiments with
benzyl C8-C14 hydraphiles against tetracycline in TetR E. coli.
The results of checkerboard experiments with benzyl C8-C14 hydraphiles
against tetracycline in TetR E. coli are shown in figure 3.3 below. The
checkerboard experiment was conducted in duplicates. Each cell in figure 3.3
(red/green) shows percent inhibition of cell growth in the presence of respective
concentrations of tetracycline and hydraphiles. Any growth inhibition of greater
than 80% was considered as the MIC and were highlighted in green. Any MIC
lower than ½ [MIC] concentration of both the compounds was considered as
synergistic. With benzyl C8 hydraphile, the recovery of tetracycline activity is
observed with concentrations as low as ~ 8 µM and the synergy is observed at a
concentration as low as 31 µM (1/8 [MIC]).
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Figure 3.3. Checkerboard experiment with benzyl C8-C14
hydraphile and tetracycline against TetR E. coli. Values show
percent inhibition of bacterial growth in the presence of respective
concentrations of hydraphile+tetracycline shown. Inhibition on
bacterial growth considered at MIC are shown in green and others
are shown in red. Hydraphiles and tetracyclines were used at 1/32,
1/16, 1/8, 1/4, 1/2 and 1x [MIC].
The checkerboard experiment revealed that a recovery of tetracycline
activity is observed with 2 µM, 0.625 µM and 0.500 µM concentrations of benzyl
C10, C12 and C14 hydraphiles, respectively. Synergy with benzyl C10 hydraphile at
8.75 µM was clear. Antibiotic recovery was apparent with all four hydraphiles at
lower concentrations as well. As observed in the growth curve experiments,
benzyl C14 and benzyl C12 hydraphiles may not affect the growth of TetR E. coli at
sub-lethal concentrations. Hence, it could be concluded that by the measure of
both the growth curves and the FIC index, benzyl C8-C14 hydraphiles show
synergy.
3.3.5. Isobologram. Results from the checkerboard experiment were used to
draw comparisons between hydraphiles. An isobologram was drawn (figure 3.4)
that shows the concentrations of hydraphiles used on the x-axis and the
concentration of tetracycline used on the y-axis. Each data point represents the
MIC of tetracycline in the presence of the corresponding MIC of the hydraphile
used. A comparison could be made between hydraphiles for their ability to
recover the tetracycline potency. To recover the tetracycline efficacy 8-fold from
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900 µM to 112.5 µM in TetR E. coli, 1 µM benzyl C14 hydraphile is required.
However, to observe similar recovery with benzyl C8 hydraphile, a concentration
> 50 µM would be necessary. The isobologram revealed the following trend
regarding the hydraphile’s ability to rescue the tetracycline potency (figure 3.4):
benzyl C14 hydraphile ≥ benzyl C12 hyraphile > benzyl C10 hydraphile > benzyl
C8 hydraphile.

Figure 3.4. Isobolograms of C8-Benzyl C14 hydraphiles in TetR E.
coli. The x-axis represents the concentration of hydraphiles used in
µM and the y-axis represents the concentrations of tetracycline in
µM. Each data point represents the MIC of tetracycline in the
presence of the corresponding hydraphile used. This is a theoretical
representation of checkerboard and hence no error bars shown.
Overall, the checkerboard experiment showed the limit and efficacy of
each hydraphile for the recovery of tetracycline activity against TetR E. coli. We
had previously reported a trend for the ability of benzyl C8- C14 hydraphiles to
transport sodium from liposomes.30 The trend for sodium ion transport from
liposomes for benzyl hydraphiles was C14 ≥ C12 > C10 >C8 hydraphile.30 A direct
correlation between the spacer chain length, liposomal sodium transport and the
recovery of tetracycline activity against resistant strains could be observed. It
was hypothesized that benzyl C14 and C12 hydraphiles are optimal for spanning
the bacterial membrane and transporting ions, which affects both the efflux
pump activity and transport of antibiotics into the cell cytoplasm. These
hydraphiles may also increase membrane permeability, further affecting
antibiotic transport. On the other hand, benzyl C10 and C8 hydraphile are poor
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ion transporters and may not span the bilayer. For this reason, a higher
concentration of benzyl C8 and C10 hydraphile is required to observe the same
effect on tetracycline recovery. Different concentrations of hydraphiles may also
affect the aggregation properties of hydraphiles. We have addressed the
mechanistic questions in subsequent chapters. Below are the results of various
controls that represent our attempt to confirm our conclusions. We have also
determined the extent of antimicrobial recovery to different strains and
antibiotics.
3.3.6. Controls. We first used various compounds to determine if a specific
function and structure of hydraphile is critical to have an effect on tetracycline
activity in TetR E. coli. Hydraphiles form ion channels in the cell membrane,
rather than functioning as carriers. The well-known ion carrier, valinomycin, and
ion channel, gramicidin-D, were used to determine if antimicrobial recovery was
a function of ion transport. The activity of known efflux pump inhibitors such as
CCCP and reserpine was also compared to hydraphiles. The activities of the
detergent, triton X-100, and a specific membrane disruptor, colistin, were also
compared to those of hydraphiles.
Functional controls. Hydraphiles were designed to and shown to perform
many of the same functions as a protein ion channels. Hydraphiles insert in the
membranes, selectively transport cations, specifically Na+ and K+ and show
open-close behavior.30 We wanted to compare the activity of hydraphiles to the
compounds that were structurally different, but had a similar function. An ion
carrier, ion channel, and a detergent were used. As seen in table 3.3 below, we
first tested valinomycin, gramicidin-D, and triton X-100. Valinomycin and
gramicidin-D are both peptides that transport potassium. Triton X-100 is an
oligomer detergent. Hydraphile is neither a peptide nor a polymer.
The combination studies with valinomycin and gramicidin-D were
conducted at 20 µM. The concentrations of some of the compounds were limited
due to low solubility in dH2O or DMSO. The MICs of gramicidin-D and
valinomycin were > 128 µM, where as that of triton X-100 was > 1 mM. At 20 µM,
valinomycin and triton X-100 recovered the efficacy of tetracycline by 2-fold.
Valinomycin, an ion carrier, binds potassium and transports it across
membranes. We did not expect a high antimicrobial recovery by valinomycin, as
it is an ion carrier. It does not localize in the membrane to cause membrane
disruption. Gramicidin-D needs to dimerize in the membrane to form a channel
and transport ions. Therefore, the antimicrobial recovery by gramicidin-D
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depends on its ability to dimerize in the bacterial membrane to form a channel.
Gramicidin-D did not recover tetracycline potency. These results showed that
hydraphile did not act similar to a dimerized ion channel, an ion carrier, or a
simple detergent. None of them had FIC < 1. In this regard, the hydraphile
structure has a unique function. We do note that a known ion channel that does
not require to dimerize in the membrane of bacteria would be a better control.
We partly addressed this issue with the use of colistin. However, such channel
formers are also considered as membrane disruptors. The functional control data
described as summarized in table 3.3. The results of three replicates are shown
below in table 3.3. The MICs reported in table 3.3 are the average of 3 trials. The
standard deviation was calculated and represented as ‘±’ the average MIC. A
decrease in the MIC was considered significant only in the error in the data did
not overlap. The fold enhancement was determined using the average MICs
shown in column 3, hence no errors are shown. However, enhancement greater
2-fold were only considered significant.
Table 3.3: Recovery of tetracycline activity by controls against TetR E. coli
Amphiphile
used

[Amphiphile]
µM

[Tetracycline]
µM

Fold
enhancement

FIC
index

No
amphiphile
CCCP
CCCP
CCCP
Reserpine
Reserpine
Colistin
Colistin
GramicidinD
Valinomycin
Triton X-100
Triton X-100

-

900 ± 100

n/a

1
21
42
64
128
0.03125
0.0625
20

900 ± 100
450 ± 50
225 ± 25
450 ± 50
225 ± 25
225 ± 25
56 ± 5
900 ± 100

1-fold
2-fold
4-fold
2-fold
4-fold
4-fold
16-fold
1-fold

1
0.75
0.75
1
1
0.52
0.31
1

20
20
1700 (0.1%)

450 ± 100
450 ± 100
450 ± 100

2-fold
2-fold
2-fold

1
1
1

We compared hydraphiles with the known efflux pump inhibitors,
reserpine and CCCP. Reserpine blocks the efflux pump channel and CCCP
dissipates the proton gradient required for antibiotic efflux. CCCP is a better

Chapter 3

59

M. B. Patel

control for hydraphiles, since both of them disrupt ion gradients. Both reserpine
and CCCP recovered tetracycline activity by 4-fold (table 3.3). The FIC index of
reserpine was 1, whereas CCCP was 0.75. CCCP may show some synergy, but its
use limited by high cytotoxicity. It has been reported that CCCP and reserpine
are more effective against Gram positive than Gram negative bacteria. These
results are comparable to that of benzyl C14 hydraphile. The benzyl C14
hydraphile showed 4-fold tetracycline recovery at 1 µM. Hence, benzyl C14
hydraphile affords the same results as known EPIs, but at ~ 100-fold lower
concentration.
Colistin, a Gram negative specific membrane disruptor was also used as a
control. In the presence of ¼ [MIC] (0.0625 µM) of colistin, the activity of
tetracycline was recovered by 16-32 fold. Colistin was tested at various
concentrations to draw the isobologram shown in figure 3.5 below. Any data
point that falls on the line connecting the two MICs is considered as additive.
Any data point below this line is synergistic, whereas above the line is
considered antagonism. Colistin shows synergy with tetracycline at nanomolar
(< 100 nM) concentrations. It could be concluded that in efflux pump expressing
Gram negative bacteria, membrane disruption results in greater recovery of
antimicrobial activity rather than EPIs that disrupt ion gradients. Benzyl C8
hydraphile at half-[MIC] recovered tetracycline activity by 30-fold. We speculate
that C8 hydraphile acts primarily as a membrane disruptor at ½ [MIC] rather
than as an ion transporter. This result of tetracycline recovery by benzyl C8
hydraphile is similar to that of colistin, albeit at a much higher concentration. The
efficient ion transporter benzyl C14 hydraphile, recovers activity by 4-fold, which
is similar to that of CCCP, an EPI. However, both the hydraphiles could be
functioning as a combination of membrane disruptor and an indirect inhibitor of
efflux pump activity.
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Figure 3.5. Isobologram of colistin against TetR E. coli. This x-axis
represents the concentration of colistin used (in µM) whereas the yaxis represents the concentrations of tetracycline (in µM). Each data
point represents the average of three replicates of the MIC of
tetracycline in the presence of the corresponding hydraphile used.
The error bars represent the standard deviation in the MICs of
tetracycline.
Structural controls. We next tested to determine if hydraphile structure
was important to observe the recovery of antimicrobial efficacy. For this purpose,
we determined the recovery of tetracycline activity against TetR E. coli using
lariat ethers, dibenzyl diazacrown, and quaternary ammonium compounds such
as C8 and C12 trimethyl ammonium salts (figure 3.6 below). The results of three
MIC replicates are shown below in table 3.4. The standard deviation was
calculated and represented as ‘±’ the average MIC. A decrease in the MIC was
considered significant only in the error in the data did not overlap. The fold
enhancement was determined using the average MICs shown in column 3, hence
no errors are shown. However, enhancement greater 2-fold were only considered
significant.
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Figure 3.6. Structures of dibenzyl diazacrown and C8 and C12
trimethyl ammonium salts used as structural controls.
Table 3.4: Activity of lariat ethers, di benzyl di-aza-crown and trimethyl
ammonium salts against TetR E. coli
Amphiphile
used

[Amphiphile]
µM

[Antibiotic]
µM

Fold
enhancement

FIC
index

No amphiphile
C8 lariat ether
C8 lariat ether
C10 lariat ether
C10 lariat ether
C12 lariat ether
Dibenzyl diaza
crown
CH3(CH2)7NMe
3Br
CH3(CH2)11NM
e3Cl

60 (½[MIC])
40 (¼[MIC])
9 (½[MIC])
6 (¼[MIC])
128 (½[MIC])

900 ± 100
175 ± 25
233 ± 25
56 ± 5
225 ± 25
450 ± 50

n/a
5-fold
4-fold
16-fold
4-fold
2-fold

n/a
0.7
0.5
0.56
0.5
1

128

900 ± 100

1-fold

1

128

450 ± 50

2-fold

1

128

225 ± 25

4-fold

1

Lariat ethers have one central macrocycle connected to two alkyl chains.
Lariat ethers lack the two distal macrocycles that are found in hydraphiles.
Numerous derivatives of lariat ethers have been studied and reported to
transport cations, specifically Na+ and K+. They have been report to transport
cations by a carrier mechanism. In addition to ion transport, lariat ethers also
possess biological activity. The reports of their applications include antimicrobial
activity,51 chemotherapy,52 and recently as modulators of the plant root
architecture (data not published). Lariat ethers are not only the structural
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analogues of hydraphiles, they also provide a control for an ion carrier that is
structurally similar to hydraphiles. As shown in table 3.4 above, C8, C10, and C12
lariat ethers recovered tetracycline activity by 5, 16 and 4-fold, respectively. The
FIC index indicated synergy with both C8 and C10 lariat ethers.
Another structural analogue that was used was dibenzyl diazacrown
(compound 12). Compound 12 has one macrocycle and no alkyl chain linkers
(see figure 3.6 above). It shows no ion transport activity or antimicrobial
property. Compound 12 showed no recovery of tetracycline activity.
It is well known that the positive charge and hydrophobic tail of colistin
and other antimicrobials are critical for activity.15 Loss of the positive charges or
the hydrophobic tails results in loss of colistin antimicrobial property.15 We
therefore hypothesized that the nitrogen atom linked to the alkyl chains was
important for hydraphile activity. To test this hypothesis, we utilized
trimethylammonium bromide salts: CH3(CH2)7NMe3Br- and CH3(CH2)11NMe3Cl-.
Such quaternary ammonium compounds with long alkyl chains (≥ C16) are used
as sterilizing agents in clinics.53 The MICs of C8 and C12 trimethylammonium
salts were > 128 µM. Tetracycline recovery with C8 and C12 trimethylammonium
bromides was only 2-4 fold at 128 µM (table 3.4), whereas C8 and C12 hydraphiles
showed 30- and 16-fold recovery at ½ [MIC] concentrations. Hence, hydraphiles
are more active as antimicrobials and adjuvants compared to the lariat ethers,
dibenzyl diazacrown and quaternary ammonium compounds.
These data for structural controls show that the combined elements of
hydraphile structure are important to observe the recovery of antimicrobial
activity. Their function is different than that of the quaternary ammonium
compounds. Amongst all the structural variations of hydraphiles studied, benzyl
C8-C14 hydraphiles (1-4) and colistin were the most effective compounds.
3.3.7. Activity against Klebsiella pneumoniae. We used a K. pneumoniae (ATCC
BAA 2146) strain to investigate the extent and applicability of hydraphiles as
adjuvants. This strain of K. pneumoniae was isolated from a patient, is resistant to
> 30 antibiotics and expresses genes for tetA, RND, and ABC type efflux pumps.
It is also resistant to carbapenems (penicillins) due to the presence of the NDM-1
gene. We wished to determine if hydraphiles could recover tetracycline activity
in a robust Gram negative strain that expresses multiple different types of efflux
pumps including tetA.
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As seen in table 3.5 below, benzyl C8-C14 hydraphile recovered tetracycline
activity against MDR K. pneumoniae. The MICs of benzyl C8-C14 hydraphiles
against K. pneumoniae are reported in table 3.1 above. The MICs of hydraphiles
against K. pneumoniae were greater than those observed against TetR E. coli. The
results of three MIC replicates are shown in the table below. The standard
deviation was calculated and represented as ‘±’ the average MIC. A decrease in
the MIC was considered significant only in the error in the data did not overlap.
The fold enhancement was determined using the average MICs shown in column
3, hence no errors are shown. However, enhancement greater 2-fold were only
considered significant. In the presence of ½ and ¼ [MIC] of benzyl C8 hydraphile,
tetracycline’s MIC reduced from 1000 µM to 25 µM and 250 µM, respectively.
This represents a recovery of 40- and 4-fold. Similarly, half-[MIC] benzyl C10, C12
and C14 hydraphiles recovered the tetracycline activity by 8, 8 and 16-fold.
Benzyl C14 hydraphile recovered tetracycline activity by 4-fold against TetR E. coli
and 16-fold against K. penumoniae. This change might be due to the higher
concentration of benzyl C14 hydraphiles used against K. pneumoniae i.e. 5 µM. In
either case, it was apparent that hydraphiles recover the activity of tetracycline
against tetA efflux pump expressing E. coli and K. pneumoniae. The results of
three MIC replicates are shown below in table 3.5. The standard deviation was
calculated and represented as ‘±’ the average MIC. A decrease in the MIC was
considered significant only in the error in the data did not overlap. The fold
enhancement was determined using the average MICs shown in column 3, hence
no errors are shown. However, enhancement greater 2-fold were only considered
significant.
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Table 3.5: Recovery of tetracycline activity against K. pneumoniae by hydraphiles.
Amphiphile
used
No amphiphile
C8 hydraphile
C8 hydraphile
C8 hydraphile
C10 hydraphile
C10 hydraphile
C10 hydraphile
C12 hydraphile
C12 hydraphile
C12 hydraphile
C14 hydraphile
C14 hydraphile
C14 hydraphile
No amphiphile
C8 hydraphile
C12 hydraphile
C12 hydraphile
C14 hydraphile
C14 hydraphile

[Amphiphile]
µM

[Antibiotic]
µM

Fold
enhancement

Antibiotic used: Tetracycline
1000 ± 100
n/a
2.5
1000 ± 100
1-fold
50 (¼[MIC])
250 ± 50
4-fold
100 (½[MIC])
25 ± 10
40-fold
2.5
900 ± 100
1.1-fold
14 (¼[MIC])
300 ± 50
3-fold
28 (½[MIC])
125 ± 25
8-fold
2.5
500 ± 50
2-fold
8.75 (¼[MIC])
300 ± 25
3-fold
17.5 (½[MIC])
125 ± 25
8-fold
2.5 (¼[MIC])
350 ± 50
3-fold
5 (½ [MIC])
62.5 ± 25
16-fold
Antibiotic used: Ampicillin
5 (½[MIC])
> 1000
0-fold
Antibiotic used: Ciprofloxacin
700 ± 100
n/a
100 (½[MIC])
70 ± 20
10-fold
8.75 (¼[MIC])
300 ± 25
2-fold
17.5 (½[MIC])
175 ± 25
4-fold
2.5 (¼[MIC])
400 ± 50
2-fold
5 (½ [MIC])
250 ± 25
3-fold

FIC
index
n/a
1
0.5
0.53
1
0.58
0.63
0.57
0.58
0.63
0.58
0.56
n/a
n/a
0.6
0.67
0.75
0.82
0.85

We also determined if the recovery of antimicrobial potency was
extensible to a different class of antibiotic or if it was specific to tetracyclines. The
RND type of efflux pump is a tripartite system that spans both the bacterial
membranes and is capable of transporting multiple different classes of
antibiotics.40 The K. pneumoniae strain was reported to be resistant to
ciprofloxacin, a fluoroquinolone class of antibiotic.53 Resistance to ciprofloxacin
could be resulting from both target site mutation and RND type efflux pump. It
has been reported that resistance to an antibiotic from two different mechanisms
are independent and not synergistic.47 We determined if hydraphiles could
recover ciprofloxacin activity against K. pneumoniae. Table 3.5 shows the recovery
of ciprofloxacin activity by benzyl C8, C12 and C14 hydraphile. Benzyl C10
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hydraphile was not tested. All three hydraphiles recovered ciprofloxacin activity.
The greatest ciprofloxacin recovery of 10-fold was observed with benzyl C8
hydraphile. Benzyl C14 hydraphile showed a recovery of 3-fold at ½ [MIC]. The
recovery of ciprofloxacin activity (10-fold) was much lower than that observed
against tetracycline (40-fold). Ciprofloxacin and tetracycline are different in
structures and have different cytoplasmic targets. Both of the antibiotics are
hydrophilic and need to localize in the cell cytoplasm in order to bind to their
targets. We hypothesize that the additional ciprofloxacin resistance could be a
result of a mutation in the DNA gyrase A. Hydraphiles may not be able to
recover resistance caused by target site mutation. A direct comparison between
antibiotic recovery of two Gram negative strains is shown in figure 3.7. This is a
theoretical representation of the MIC values reported in table 3.5 above. Hence
no error bars are shown.

Figure 3.7. A comparison of recovery of tetracycline activity against
TetR E. coli and K. pneumoniae (ATCC BAA 2146) by benzyl C8-C14
hydraphiles. Benzyl C8-C14 hydraphiles were used at 1 µM against
TetR E. coli (open circles) and 2.5 µM against K. pneumoniae (open
squares).
3.3.8. Hydraphile activity against K. pneumoniae and E. coli. To compare the
activity of each hydraphile against K. pneumoniae, a study was conducted at the
lowest ¼ [MIC] of any hydraphile used, which was 2.5 µM. These data were also
compared to the controlled concentrations study performed with benzyl C8-C14
hydraphiles against TetR E. coli at 1 µM. The results of the tetracycline recovery
study are represented in the graphical format in figure 3.6 above. In the K.
pneumoniae strain, when the concentration was kept constant at 2.5 µM, the
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following trend was apparent: benzyl C14 hydraphile > C12 hydraphile > C10
hydraphile > C8 hydraphile. This trend paralleled that of hydraphiles against
TetR E. coli. However, the efficacy of hydraphiles to recover tetracycline activity
against TetR E. coli was greater, at lower concentration, than against K.
pneumoniae. This feature could be due to the fact that the E. coli strain used for
study was a genetically modified laboratory strain. The membranes of the two
strains have different compositions. The more robust MDR K. pneumoniae may
already have some mutations that alter the phospholipids and lipid A in the cell
membrane. These changes could decrease the efficacy of the amphiphilic
compounds such as hydraphiles and colistin. Resistance mechanisms other than
efflux pump may also provide additional tetracycline resistance in K. pneumoniae.
In either case, tetracycline activity was clearly recovered in both Gram negative
bacteria.
3.4.

Summary and conclusions.
Synthetic amphiphiles have been studied for their ability to transport ions
either as a channel or a carrier.19-21 Hydraphiles have been studied and
determined for their ability to form cation channels.29 It was hypothesized that
the disruption of ion homeostasis in bacteria caused by hydraphiles resulted in
cell death and this accounted for the antimicrobial property. Regardless of the
numerous structural and biological studies with crown ether-based molecules,
no previous systematic study addresses their use as antimicrobial or antibiotic
adjuvants. We recently reported that hydraphiles enhance the potency of four
different classes of antibiotics against sensitive strains of Gram positive and
Gram negative bacteria.36,39 Out of four antibiotics tested, the potency of two
hydrophobic antibiotics, rifampicin and erythromycin, was enhanced the
most.36,39 This observation was hypothesized to be an effect of membrane
disruption caused by hydraphiles localizing in the membrane of bacteria.
A greater healthcare concern is caused by the antibiotic resistant Gram
negative bacteria.1-9 Multi drug resistant Gram negative infections are the
primary cause of diseases such as urinary tract infection and pneumonia.7,8 The
resistance is primarily caused by the presence of secondary outer membrane and
efflux pumps that decreases the cytoplasmic concentration of antibiotics.13 There
are no efflux pump inhibitors developed for clinical use. There is no study
reported about the activity of synthetic amphiphiles against multi-drug resistant
bacteria. Our extensive data reported here supports the statement that
hydraphiles of appropriate spacer chain length can recover the activity of
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tetracycline and fluoroquinolone against efflux pump expressing resistant E. coli
and K. pneumoniae.
All four hydraphiles studied, benzyl C8, C10, C12 and C14 hydraphiles
rescued antimicrobial potency. TetA efflux pump expressed in the TetR E. coli are
highly selective and effective at effluxing tetracycline molecules. Recovery of
tetracycline activity in TetR E. coli is only possible if the cytosolic concentration of
tetracycline is increased to an effective level. Hence, it could be concluded that
hydraphiles successfully rescue tetracycline activity, possibly by increasing the
cytosolic concentrations of tetracycline. It may appear that benzyl C8 hydraphile
is most effective at recovering antibiotic activity. This was an attribute of the high
concentration of C8 hydraphile used. Upon further investigation, following trend
was confirmed for the efficacy of antimicrobial recovery by benzyl hydraphiles:
C14 hydraphile > C12 hydraphile > C10 hydraphile > C8 hydraphile (figures 3.4
and 3.7). However, tetracycline activity recovery was observed with benzyl C8
and C10 hydraphile at concentrations as low as 8 µM and 3 µM, respectively
(figure 3.3).
Synergy between hydraphiles and tetracyclines was confirmed using the
FIC index and growth curves. Growth curves showed no inhibition of TetR E. coli
growth by the highest concentration of benzyl C14 hydraphile used for
combination studies, i.e. 1 µM (½ [MIC]). Here, the increase in lag-phase
observed could be due to the ion transport ability of hydraphiles causing an
osmotic stress. The extent of the antibiotic recovery by hydraphiles was
successfully extended to patient isolated MDR K. pneumoniae and a different class
of antibiotic, fluoroquinolones.
Comparisons to structural variations showed that hydraphiles were most
effective amongst lariat ether, trimethylammonium salts and dibenzyl
diazacrown at recovering antimicrobial potency. Lariat ethers, previously
characterized as ion carrier, did show remarkable recovery of tetracycline
activity against TetR E. coli (table 3.4). However, K. pneumoniae was completely
resistant to all lariat ethers. Lariat ethers may only increase antibiotic potency by
disrupting membrane integrity. Lariat ethers were previously shown to form
aggregates in aqueous solution, of 100-200 nm in size. It is possible that lariat
ethers organize in the membrane to form a pore, a previously uncharacterized
property.
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Amongst all the functional controls tested, the activity of hydraphiles was
found to be comparable to that of CCCP and colistin. Both CCCP and colistin are
known to affect ion gradients and transport in bacteria.13,45 CCCP is commonly
used as an efflux pump inhibitor in laboratory studies but its use in clinic is
limited due to cytotoxicity.45 This prompts the need for study of hydraphiles on
mammalian cells, which is addressed in chapter 4. These controls show that
hydraphiles either disrupt ion gradients in bacteria or disrupts membrane
integrity providing the antibiotic access to the bacterial cytosol. Mechanistic
studies are addressed in Chapter 5. A combination of two mechanisms is also
possible, but would be difficult to distinguish from the individual effect.
Colistin (polymyxins) is used as a drug of last resort for the treatment of
MDR infections. A recent study reported the first colistin resistant E. coli in US.14
This shows the need to preserve colistin as an antibiotic for future use. Our
results for tetracycline recovery by colistin (16-32 fold) against TetR E. coli shows
that natural amphiphiles such as polymyxins, not only synthetic amphiphiles,
could be used as adjuvants or EPI. A new use of natural amphiphiles as efflux
pump inhibitors is contemplated based on the results reported here.
3.5

Experimental Methods

3.5.1. Compounds and antibiotics used. Two classes of synthetic amphiphiles
were used in this study. First class of compounds are called hydraphiles.
Hydraphiles were synthesized in the Gokel lab and purity was confirmed by
NMR and mass spectrometry. Four hydraphiles differing in its spacer chain
lengths were used. We used benzyl C8, C10, C12 and C14 hydraphile. Similarly,
five lariat ethers were used for this study, benzyl C8-C16 lariat ethers. Dibenzyl
diazacrown was also used as a control. The antibiotics of choice were
tetracycline, ampicillin, ciprofloxacin, and colistin. CCCP and reserpine, known
efflux pump inhibitors were also used as controls. All the antibiotics and known
EPI were received from Sigma-Aldrich and used as received.
3.5.2. Bacteria used. There were two strains of bacteria used for this study. TetR
E. coli was prepared by transforming the competent JM109 E. coli with pBR322
plasmid (Carolina Biological). The transformation was performed using heatshock method as outlined by the manufacturer (Promega). The resulting E. coli
cells were tetracycline and ampicillin resistant and designated TetR E. coli. The
TetR E. coli expressed tetA efflux pump and β-lactamase enzyme. The Klebsiella
pneumoniae (ATCC BAA 2146) strain was acquired from ATCC. It is a clinical
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strain (BSL-2) isolated from a patient’s urine sample. The K. pneumoniae is
reported to be resistant to more than 30 different antibiotics including classes
such as carbapenems, fluoroquinolones, cephalosporins, macrolides and
tetracyclines. It expresses efflux pumps from three different classes: RND, ABC
and MFS. TetA is the MFS type efflux pump expressed in the K. pneumoniae,
which is used for the combination study.
3.5.3. Minimal Inhibitory Concentrations (MIC). TetR E. coli was grown in L.B.
Miller media containing 100 µg/mL Ampicillin. K. pneumoniae was grown in the
cation adjusted Mueller Hinton II (MHII) media. The cells were grown overnight
from one colony forming unit (CFU) in 2 mL media. On the day of the
experiment, bacteria were knocked back to O.D.600 = 0.100 and incubated at 37 °C
until the O.D.600 reached 0.500 (4 x 108 CFU/mL). These cells were diluted 100fold by adding 20 µL cells in 1980 µL MH-II media (without antibiotics) to get 4 x
106 CFU/mL. The 20 µL diluted cells were added to each well (final volume/well
= 200 µL) after the addition of antibiotics or synthetic amphiphiles. The final cell
concentration per well was approximately 4 x 105 CFU/mL (or 8 x 104
CFU/well).
Compounds were either dissolved in DMSO or dH2O. In sterile 1.5 mL
micro-centrifuge tubes, compounds were serially diluted to form stock
concentrations. Dilution(s) of compounds added to each well. Compounds were
always administered at a constant volume such that the final DMSO
concentration in each well was 0.5% volume/volume (1 µL of final 200 µL).
In a 96-well plate, first the media was added followed by addition of the
compounds. The final volume of each well was 200 µL. For combination studies,
after the addition of amphiphiles, antibiotics were added. The compounds or
antibiotics that were dissolved in dH2O, 10 µL/well was used. In the case of
DMSO alone control, 1µL of DMSO was added to each well. For dH2O control, 10
µL of dH2O was added to each well. No compound or solvent were added for
cells alone and media alone control. Contents of the well were mixed well by
pipetting up and down three times. After mixing, 20 µL cells at 4 x 106 CFU/mL
were added to each well. Contents were mixed again by pipetting up and down
3 to 4 times. Empty wells were filled with 200 µL Phosphate Buffered Saline
(PBS) to minimize evaporation. The plates were incubated at 37°C for 18-20
hours. Results were collected by determining the O.D. at λ = 600 nm using a plate
reader (BioTek Cytation 3) in Dr. Lon Chubiz’s lab. Each compound was tested in
triplicate per plate. Percent inhibition was calculated by comparing to the cell
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alone control. Growth inhibited of ≥ 90% was considered as the MIC. The data
was reproduced 2 more times on two separate plates.
3.5.4. Checkerboard. In a checkerboard experiment, each column of the plate
had different concentration of the amphiphile increasing by serial dilution. Two
amphiphiles were tested per plate. Each row of the checkerboard experiment had
different concentrations of antibiotics increasing by serial dilutions. The
concentrations of amphiphile and antibiotic tested were 1/2, 1/4, 1/8, 1/16 and
1/32 the [MIC]. E. coli and K. pneumoniae were tested using the checkboard
experiment. The MIC procedure used for the checkerboard experiment was the
same as outlined above. Cells and compound alone controls were also used. The
checkerboard experiment did not have a biological replicate but the data was
reproduced three times before reporting. The data was represented as a heat map
and as a isobologram.
3.5.5. Growth Curve. The growth curve experiment was performed using TetR E.
coli. The compounds studied using growth curves were benzyl C14 hydraphile
and tetracycline. Here, the E. coli was grown overnight from one CFU in L.B.
Miller media containing 100 µg/mL Ampicillin. On the day of the experiment the
cells were knocked back in L.B. Miller media containing 100 µg/mL Ampicillin,
to O.D. 600 = 0.550 before use. In a sterile 250 mL flask, 50 mL L.B. media was
added, followed by benzyl C14 hydraphile and tetracycline. The concentrations of
benzyl C14 hydraphile tested were 1 and 2 µM. The concentrations of tetracycline
tested were 220 and 900 µM. In addition, a growth curve containing a
combination of benzyl C14 hydraphile (1 µM) and tetracycline (220 µM) was also
tested. Cells only and DMSO (0.5% v/v) alone controls were also performed.
Compounds were mixed by swirling the flask. To each flask, knocked back cells
were added so that the final cell concentration in each flask was approximately 4
x 105 CFU/mL. The flasks were incubated at 37 °C and 200 RPM. A 2 mL sample
was taken every 30 minutes (for next 24 hours) to determine the O.D. at λ = 600
nm. A graph was plotted for O.D. vs. time to generate a growth curve.
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CHAPTER 4
Hydraphiles Localizes in the Bacterial Cell Membrane and Selectively
Increases Bacterial Membrane Permeability

The data reported in this chapter have not been published.
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4.1.

Introduction
Antibiotic resistance is a world-wide crisis. The Center for Disease Control
and Prevention (CDC)1, the World Health Organization (WHO)2, the Wellcome
trust3, the White House4, and similar organizations around the world have
issued reports outlining the threat from antibiotic resistant bacteria. We have
now entered a post-antibiotic era, in which the antibiotics that were once lifesaving treatments, have now become ineffective. In 2013, in the U.S. alone, there
were more than 2 million illnesses caused by antibiotic resistant infections
acquired in hospitals.1 Due to the lack of effective antibiotics, bacterial infections
proved to be fatal for 23,000 patients.1 World-wide bacterial infections cause
700,000 deaths each year.3,5 It has been estimated that in the absence of any
solution, this number may increase to 10 million deaths per year by 2050.3 It is
clear that there is an urgent need to address the antibiotic resistant bacterial
infections.
The problem of antibiotic resistance has been exacerbated by the lack of
antibiotics in development. Whereas the period from 1951 through 2000
witnessed an average of three new antibiotics per year, only four antibiotics have
been approved since 2011.6 Soon after the introduction of a new antibiotic in
clinical use, bacterial resistance to the antibiotic has been reported.7 The spread of
resistance between different strains of bacteria is rapid. This is facilitated by the
plasmids encoding these resistance genes.8 Development of new antibiotics is
critical to keep up with the development and the spread of antibiotic resistance.
However, only one adjuvant-antibiotic was approved by the FDA in 2015.9 No
new class of antibiotic has been developed in the last four decades that targets
Gram negative infections.10 The last class of antibiotics developed for targeting
Gram negative bacteria was tetracycline. Today, wide spread resistance to
tetracycline has limited its use in clinic.
There are three mechanisms of antibiotic resistance: antibiotic degrading
enzymes, binding site mutation, and efflux pumps.11 Bacteria are known to
produce enzymes such as β-lactamase that degrade β-lactam ring of the
penicillin antibiotics. Currently, the majority of new antibiotic research is based
on developing β-lactamase inhibitors. Antibiotics such as penicillin, ampicillin,
and first and second generation cephalosporins have lost their efficacy due to the
development of new types of β-lactamases such as New Delhi Metallo βlactamase (NDM-1).12 Mutations in the DNA gyrase or ribosomes prevent
binding of fluoroquinolones, macrolides, and tetracycline to its binding site.13 So
far, only one class of antibiotic resistance inhibitor is available on the market: βChapter 4
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lactamase inhibitors. Our interest is to inhibit efflux pumps and increase
membrane permeability.
Bacterial efflux pumps decrease the cytoplasmic concentration of toxic
substances including antibiotics.14 Overexpression of porins increases efflux of
toxic and unwanted molecules from cells.15 However, efflux pumps are
specialized transmembrane proteins that may specifically export antibiotics.
Certain efflux pumps provide multi-drug resistance.16 The multidrug resistance
conferred by efflux pumps can eventually cause acquisition of other types of
resistance such as antibiotic degrading enzymes or mutation of antibiotic target
sites.17 All the efflux pumps except ATP binding cassette (ABC) utilize either a
proton or sodium gradient as an antibiotic-cation antiport.16 ABC hydrolyzes an
ATP molecule to provide energy for antibiotic transport. The efflux pumps in
Gram negative and –positive bacteria are highly effective at keeping a low
cytoplasmic concentration of antibiotics.18 Along with the outer membrane of
Gram negative bacteria, efflux pumps create a general mechanism of resistance
that spans across various classes of antibiotics.
The outer membranes of Gram negative bacteria provide for an attractive
target for antibiotic development. The majority of antibiotics need to pass
through the membrane and bind to its cytoplasmic target to inhibit bacterial
growth. Some of the antibiotics diffuse through the membranes, others pass
through porins (e.g. outer membrane proteins, OMPs) found in membranes.19
The outer membrane consists of lipopolysaccharide (LPS) and phospholipids.20
LPS consists of a lipid A structure, core polysaccharide and O-antigen repeats.
The LPS is replete with anionic charges, is highly crosslinked and varies among
different species in the types of fatty acids and acyl groups that are present.20
This prevents the entry of toxic molecules, such as antibiotics. Additionally, LPS
acts as an antigen and triggers an immune response in humans. Pathways
involved in the outer membrane protein trafficking and assembly; and
localization and transport of lipoproteins have been used as molecular targets for
antibiotic development.10 Since the OM serves as a significant and primary
barrier to antibiotic entry, their disruption could serve as a strategy to increase
antibiotic delivery/efficacy. However, there has been little success in developing
antibiotics that target bacterial membranes.
Colistin (polymyxin) is the only antibiotic available on the market that
targets and disrupts the outer membrane of Gram negative bacteria.21
Polymyxin, isolated from Bacillus polymyxa, binds to the lipid A component of the
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Gram negative bacteria. This cyclic peptide could be considered a natural
amphiphile that disrupts bacterial cell membranes inducing cell death. They are
used as a last line of defense in the treatment of multidrug resistant infections.10
Polymyxins are associated with renal toxicity.22 For effective Pseudomonas
aeruginosa killing, 0.5 µg/mL (0.28 µM) - 2 µg/mL (1.14 µM) plasma
concentration of colistin is required.23 Studies have shown that trough
concentrations greater than 2.2 µg/mL (1.25 µM) results in 65-85%
nephrotoxicity.24
It has been hypothesized that the hydrophobic tail of polymyxin results in
mammalian cell toxicity. Replacement of the long hydrophobic tail with Nphenyl pyridone and Cl-phenyl urea has resulted in a greater therapeutic margin
but decreased its antimicrobial efficacy.25 A polymyxin analogue with a
decreased number of positive charges resulted in lower cytotoxicity but
maintained MIC90 of 1 µg/mL. The majority of the antibiotic studies in this area
focuses on either developing safer polymyxin analogs or new peptides. No new
structure or approach has been developed to target Gram negative membranes
since polymyxins. Bacterial resistance to polymyxins has been negligible. An
Escherichia coli carrying a plasmid with resistance gene to polymyxin (mcr-1), was
recently reported in the U.S.26 There is a need to identify novel membrane
disruptors before wide-spread resistance to colistin is developed. Here, we report
that hydraphiles disrupt E. coli membrane integrity and increase membrane
permeability.
Hydraphiles are synthetic ion channels that conduct cations, specifically
Na+ and K+ ions.27 Since the early work by Tabushi et al. in the 1980s, there has
been a dramatic increase in the number and variety of synthetic ion channels.28
Hydraphile synthetic ion channels designed and developed in the Gokel lab
mimic some features of the well-known KcsA protein channel.29,30 These
synthetic channels have an entry and exit portal and a hydrated “central relay.”
Computational and biophysical studies suggested that hydraphiles are
membrane bound.31 Planar bilayer studies confirm that hydraphiles transport
cations (Na+, K+, H+) and show open-close behavior similar to that observed with
known channel proteins.32,33 Hydraphiles form non-rectifying channels, hence
transporting ions based on cation gradients.34 Hydraphiles show length
dependent ion transport35 and antimicrobial activity36. Benzyl C12-C16
hydraphiles are better ion transporters than shorter or longer analogs. Fully
extended C12-C16 hydraphiles are estimated to span 30-40 Å. This is the
approximate thickness of natural lipid bilayers. C8 hydraphile, which is 14 Å
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shorter than C14 hydraphile, is not long enough to span the bilayer and fails to
form channels. Longer hydraphiles are poorer transporters, probably owing to a
less organized conductance state.
A dimethyl aminonapthalenesulfonyl (dansyl) substituted C12 hydraphile
was previously used to visualize the localization of hydraphiles in E. coli.36 Three
key observations were made in this experiment. First, dansyl C12 hydraphile was
primarily localized in the membrane or on the membrane surface (figure 4.1).
The cytoplasmic localization was also observed but it was much lower. It was
however unclear if the hydraphiles were localized in the membrane or on the
surface of the bacteria. Second, the membrane localization was observed at 12
µM of dansyl C12 hydraphile, a value closer to its minimal inhibitory
concentration (MIC). Third, after 5 minutes of treatment time with dansyl C12
hydraphile, an increased fluorescence was localized to certain regions/spots in
the membrane. This increased fluorescence could indicate aggregation of
hydraphile in the membrane. This hypothesis has not been tested. The membrane
localization of hydraphiles in E. coli has not been confirmed with co-localization
of a known membrane stain. Localization of hydraphiles in the mammalian cells
has also not been investigated.
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aeruginosa. These antibiotics are hydrophobic and cannot penetrate the Gram
negative cell membrane. It was therefore hypothesized that the hydraphiles
increase the outer membrane permeability to antibiotics. In the following study,
we showed that hydraphiles rescue tetracycline and ciprofloxacin activity against
efflux pump expressing resistant E. coli and Klebsiella pneumoniae. A synergy
between hydraphiles and antibiotics was confirmed. The rescue of antibiotic
potency by hydraphiles was chain length dependent; benzyl C14 hydraphile was
the most potent adjuvant. It was hypothesized that hydraphiles increase
cytoplasmic concentration of antibiotics by uncoupling efflux pumps from the
ion gradients and increasing the membrane permeability of the Gram negative
bacteria. We have tested the ‘increase in membrane permeability’ hypothesis
here.
It was hypothesized that if hydraphiles localize in the cell membrane of the
bacteria, then they could disrupt the membrane integrity and increase membrane
permeability. Here, we report that dansyl labeled C14 hydraphile localizes in the
membrane of TetR E. coli and human embryonic kidney (HEK-293) cells. The
membrane localization was similar to that of well-known membrane localizing
stain FM4-64 FX. Higher concentration of dansyl C14 hydraphile (32 µM) was
used for microscopy, however membrane localization was confirmed at 2 µM.
Cytoplasmic localization of dansyl C14 hydraphile was also observed in both the
TetR E. coli and HEK-293 cells. However, this could be the effect of cell death or
increase in membrane permeability caused by hydraphile itself. After 5 minutes
of treatment, hydraphile aggregates were observed in the E. coli membrane. This
was confirmed using scanning electron microscopy (SEM). SEM also revealed
membrane disruption of TetR E. coli cells caused by hydraphiles. An increase in
the membrane permeability and membrane disruption of TetR E. coli was
observed with benzyl C8-C14 hydraphiles at half-[MIC]. Membrane permeability
was confirmed with potassium and nucleic acid release. No increase in the
permeability of HEK-293 membranes was observed at 2x [MIC] of benzyl C8-C14
hydraphiles.
4.2.

Compounds used.
In the combination studies, benzyl C14 hydraphile was the most potent
compound. We therefore used C14 hydraphile for localization studies. Our
previous success36 with dansyl tagged hydraphiles, rationalized the use of the
dansyl-tag for the membrane localization experiments outlined below. The
localization of amphiphiles was determined by preparing fluorescent C14
hydraphiles. The benzyl side arms in the benzyl-C14 hydraphile was substituted
Chapter 4

82

M. B. Patel

with the fluorescent dansyl group. The structures of dansyl C14 hydraphile (1) is
shown in figure 4.2. Dansyl group is fluorescent itself, and hence provides dansyl
C14 hydraphile an ability to fluoresce that could be observed under a confocal
microscope. A well-known membrane localizing stain FM4-64 FX (6) was used as
a control.39 FM4-64 FX stains were acquired from Thermo-Fischer. These
compounds were used to study membrane localization of hydraphiles.

Figure 4.2. Structures of the dansyl C14 hydraphile (1), benzyl C8C14 hydraphiles (2-5), FM4-64 FX (6), propidium iodide (7) and
fluorescein diacetate (8).
The membrane permeability was studied with four hydraphiles: benzyl C8
– benzyl C14 (compounds 2-5). We previously showed that benzyl C8-C14
hydraphiles recovered antimicrobial potency against tetracycline resistant E. coli
and multi-drug resistant K. pneumoniae. We therefore tested compounds 2-5 for
their ability to increase membrane permeability. Propidium iodide, a membrane
impermeable stain (7), and fluorescein diacetate (8), a cell viability stain were
used to study membrane permeability. Scanning electron microscopy was
performed to determine the effect of hydraphiles on cell membrane surface.
4.3.

Bacteria used.
All the studies reported here were conducted with a genetically modified
strain of E. coli. The competent JM109 E. coli was transformed with pBR322
plasmid that expressed the tetA efflux pump and the β-lactamase enzyme. The
resulting strain was labeled TetR E. coli and was resistant to tetracycline and
ampicillin. We previously proved that hydraphiles rescue tetracycline activity
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against TetR E. coli and show synergy with tetracycline. The same strain is used
here to test the hypothesis that hydraphiles localize in the bacterial cell
membrane and increase membrane permeability.
4.4.

Results and Discussion.

4.4.1. Membrane localization. It was previously reported that dansyl C12
hydraphile localized in the periphery of DH5α E. coli (figure 4.1 above).
However, it was unclear if the hydraphiles were in the membrane or on the
surface of E. coli. A single image of the bacteria was produced. It was unclear if
the majority of the E. coli cell population exhibited similar membrane localization
of hydraphile. To date the localization of C14 hydraphile, our most potent
adjuvant, has never been studied. We therefore synthesized dansyl labeled C14
hydraphiles. Co-localization of these compounds were studied in TetR E. coli and
HEK-293 mammalian cells. Here, we test the hypothesis that if hydraphiles
localize in the membrane of bacteria, then they disrupt the membrane integrity
and increase the membrane permeability.
4.4.1.1. Localization in bacterial cells. Dansyl labeled hydraphile was added to
TetR E. coli along with a known membrane localizing stain. A lipophilic molecule,
FM4-64 FX, was used to conduct co-localization studies (figure 4.2). 39 FM4-64 FX
exhibits low fluorescence when in dissolved water. However, when it localizes in
the outer leaflet of the bilayer membrane, its fluorescence intensity increases. Its
excitation and emission peaks are 515 nm and 640 nm.39 We contemplated using
DAPI as a cytoplasmic stain as well. DAPI fluoresces after it binds to the AT
region of the DNA.40 It is commonly used as a counterstain to mark cell
cytoplasm in the bacteria. The excitation and emission peaks of DAPI are 358 nm
and 461 nm, respectively. Its peaks are distinct from FM4-64 FX but overlap with
those of the dansyl groups of compound 1. The excitation and emission peaks of
dansyl group were ~ 335 nm and 500 nm, respectively. Hence, DAPI and dansyl
labeled hydraphiles could not be used for a co-localization study.
Controls. We first performed the control with TetR E. coli individually
treated with either FM4-64 FX or dansyl C14 hydraphile. Here, the exponential
phase E. coli were concentrated at O.D.600 ~ 1.3 and suspended in phosphate
buffered saline (PBS). A desired concentration of either FM4-64 FX or dansyl C14
hydraphile was added to the bacteria. The cells treated with FM4-64 FX were
incubated for 10 minutes, washed and observed under a confocal microscope. E.
coli treated with dansyl C14 hydraphile were observed under the microscope,
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immediately after adding the hydraphile. The results are reported as the
unaltered images acquired under the Zeiss LSM 700 confocal microscope with
640X magnification (figure 4.3.1). Under magnification greater than 640X, the
image did not focus well due to the small size of E. coli cells. Instead we digitally
magnified the images and added as inserts with yellow boundary in the figure
4.3 to show clear localization of the stains. The top row of figure 4.3.1 indicates
bright field image of the cells, fluorescence in the middle row and overlay of
these two in the third row.
A clear membrane localization of FM4-64 FX (5 µg/mL, red) is observed
10 minutes after incubation with TetR E. coli (figure 4.3.1). This confirms that the
membrane localization in bacteria could be observed under a confocal
microscope. Next we determined the localization of dansyl C14 hydraphile at 2, 8
and 32 µM. The high concentration of the hydraphile used corresponds to the
high concentration (O.D.600 ~ 1.3) of cells required for this experiment. We
confirmed that the MIC of benzyl C14 hydraphile was 8 µM at this E. coli cell
concentration. At 2 µM of compound 1, only 2 to 3 cells/frame were observed
with the dansyl fluorescence. Only one E. coli was observed with clear membrane
localization (data not shown). We therefore tested higher concentrations of 8 and
32 µM.
At 8 µM of dansyl C14 hydraphile, an increased number of the TetR E. coli
had dansyl fluorescence. These cells showed clear membrane localization
(middle column, figure 4.3.1). Cytoplasmic localization was also observed.
However, no aggregation of hydraphiles was apparent at 8 µM. When manually
counted, 38% of the fluorescent cells had membrane localization with
hydraphiles. In comparison 100% of fluorescent cells had membrane localization
with FM4-64 FX. This could be due to the lower fluorescence intensity of dansyl
as compared to the FM4-64 FX. We therefore determined localization at 32 µM of
dansyl C14 hydraphile. Two key observation were made. First, greater number of
cells were fluorescent with dansyl labeled C14 hydraphile. Second, membrane
and cytoplasmic localization was observed clearly (right column, figure 4.3.1).
When manually counted, 55% of the fluorescent cells had membrane localization
with hydraphiles at 32 µM. Similarly, images from three different trials (data not
shown) were analyzed and a standard deviation of 10% was observed. We
therefore used 32 µM for the co-localization studies reported in figure 4.3.2.
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Figure 4.3.1. Independent localization of FM4-64 FX (5 µg/mL) and
dansyl C14 hydraphile (8 µM and 32 µM) in TetR E. coli. Images
were acquired on confocal microscope immediately after treating
the cells. The scale is 10 µm.

Figure 4.3.2. Co-localization of dansyl C14 hydraphile (32 µM) with
FM4-64FX (5 µg/ml) in TetR E. coli. FM4-64 FX and dansyl C14
hydraphile were fixed after 30 seconds and 5 minutes with 4%
(v/v) formaldehyde. In 30 seconds membrane localization and in 5
minutes, aggregates and, membrane and cytoplasmic localization
was observed. The scale is 10 µm.
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Co-localization. For co-localization studies TetR E. coli cells were first
treated with FM4-64 FX (5 µg/mL) for 10 minutes and fixed with ice cold 4%
(v/v) formaldehyde. These cells were washed and treated with 32 µM dansyl C14
hydraphile for either 30 seconds or 5 minutes. The stain was fixed with
formaldehyde, washed with phosphate buffered saline and observed under a
confocal microscope. One of the images from a Z-stack of 30 seconds and 5minute treatment is shown in figure 4.3.2 above. The larger images are digitally
magnified to clearly indicate localization of the stains. At 30 seconds, membrane
localization of both dansyl C14 hydraphile (green) and FM4-64 FX (red) was
observed. In the overlay image for 30 seconds, a yellow (red + green) color in the
membrane confirms membrane localization of hydraphiles. Cytoplasmic
localization could also be observed in these cells.
After 5-minute the fluorescence the image was clear, without any
background. Three observations were made after 5 minutes of treatment with
hydraphiles. First, membrane localization is further confirmed in the overlay
image with yellow color in the periphery of the bacteria. Second, some cells had
cytoplasmic localization of dansyl C14 hydraphile. This could be an effect of cell
death or increase in membrane permeability caused by hydraphiles itself. Third,
as reported previously, aggregates of hydraphiles were clear in the membrane of
the TetR E. coli. These aggregates were either on the surface of the bacteria or in
the membrane. We further analyzed these aggregates in the SEM study below
under membrane disruption. Co-localization studies confirmed that the dansyl
C14 hydraphile localizes in the membrane of E. coli, as early as 30 seconds after
treatment. Dansyl C14 hydraphile aggregates in or on the membrane around 5
minutes after treatment. E. coli with cytoplasmic localization of dansyl C14
hydraphiles was also observed.
Overall, dansyl C14 hydraphile clearly showed localization in the
periphery of the TetR E. coli. It is possible that this localization of hydraphile
depends on the concentration and time of the treatment. We therefore observe a
mixture of cell population with either membrane localization, cytoplasmic
localization and both.
4.4.1.2. Localization in mammalian cells. Hydraphiles have been previously
shown to form channels even in mammalian cells.33 For hydraphiles to form
channels in the mammalian cell membrane, they have to localize in the
membrane. Eukaryotic cells have multiple organelles that are surrounded by
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membranes, such as mitochondria, endoplasmic reticulum, nucleus, etc. If
hydraphiles do localize in the cytoplasm of mammalian cells, they could also
insert in to the membranes of any of the membrane covered organelles.
Hydraphiles could also affect the endocytosis pathway. We hypothesized that if
hydraphiles localize in the cytoplasmic membrane of mammalian cells, then they
could form ion channels in the mammalian cells. Benzyl C14 hydraphile was
shown to form channels in HEK-293 cells.33 To test the localization in mammalian
cells, we used dansyl labeled C14 hydraphile. FM4-64 FX was used to tag
membranes.
Controls. We first performed controls with HEK-293 cells either treated
with no stain, FM4-64FX or dansyl C14 hydraphile. The results of the controls are
shown in figure 4.4 below. Here, each stain was studied as a separate
experiment and does not represent a co-localization study. The results are
divided into three rows, bright field, fluorescence and overlay. The ‘bright field’
shows the image of the HEK-293 cells without any excitation of the fluorescent
tags. The ‘fluorescent’ image shows the localization of the fluorescent tags
whereas the ‘overlay’ images are the overlay of bright field and the fluorescent
image. In each case the cells in the bright field image appears healthy, except
maybe for dansyl C14 hydraphile. No study was performed here to confirm
viability of the cells. Higher concentrations dansyl C14 hydraphile (32 µM) were
required to observe optimal fluorescence from the dansyl groups. These
conditions might not be optimal for the viability of the cells. The FM4-64 FX
shows localization in the cell membrane of HEK-293 cells, as seen with
fluorescent and overlay images.
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Figure 4.4. Localization of FM4-64FX (red), and dansyl labeled C14
hydraphile (green) in mammalian cells. The magnification is 400-X
and the scale is 10 µm.
When dansyl tagged C14 hydraphile was added to the HEK-293 cells, two
observations were made. First, all the cells showed either membrane or nucleus
localization. In a few cells, only membrane localization was observed. Second, in
at least two cells localization in the nucleus was observed. These cells might be
undergoing cell death allowing hydraphiles to enter the cytoplasm and the
nucleus. Overall, dansyl C14 hydraphile was observed in the cytoplasmic
membrane of HEK-293 cells. In some cases, cytoplasmic or nuclear localization is
also possible. Membrane localization is confirmed with co-localization with FM464 FX below.
Co-localization of FM4-64 FX and dansyl C14 hydraphile. To confirm that
hydraphiles were in the cell membrane of HEK-293 cells, a co-localization study
was performed. Here, the optimally cultured HEK-293 cells were suspended in
PBS containing FM4-64 FX and dansyl C14 hydraphile (32 µM). The localization
of cell membrane stain FM4-64 FX along with dansyl C14 hydraphile would
confirm plasma membrane localization. It is possible that localization of FM4-64
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FX in the membrane could affect the localization or the fluorescence properties of
the dansyl C14 hydraphile. The FM4-64 FX localizes only in the outer leaflet of the
bilayer. It only fluoresces in the hydrophobic regime. Dansyl C14 hydraphile
spans the lipid bilayer. The distal crowns and the attached fluorescent dansyl
groups localize in the midpolar region of the bilayer, in both leaflets. The dansyl
fluorescence however may or may not be effected by the polarity. If hydraphiles
disrupt the membrane structure, the fluorescence of FM4-64 FX may be affected
and vice versa. The results of these experiments are shown below in figure 4.5.

Figure 4.5. Co-localization of dansyl C14 hydraphile (green) with
FM4-64 FX (red).
When FM4-64 FX was added along with dansyl C14 hydraphile, both
stains were found in the plasma membrane (figure 4.5). Dansyl C14 hydraphile
was observed in the cell membrane. Some hydraphiles were also found in the cell
cytoplasm and nucleus. The nuclear staining could be caused by cell death. Few
of the cells’ membranes that were fluorescent with FM4-64 FX were not
fluorescent with dansyl C14 hydraphile. It was also observed that in the overlay,
only a few cells were observed with both FM4-64 FX and dansyl C14 hydraphile
(yellow staining). These results confirm that hydraphiles do localize in the
cytoplasmic membranes of mammalian cells. It is also likely that hydraphiles can
be found in the cell cytoplasm and nucleus. This staining by hydraphile was
similar to that observed in the bacteria. The concentration of hydraphiles
required in HEK-293 and TetR E. coli was 32 µM. Membrane localization in E. coli
was also observed at concentration as low as 2 µM. This shows that there should
be some selectivity in membrane localization between bacteria and mammalian
cells at the concentration used for synergy, i.e. 1 µM.
Hydraphiles do localize in the cellular membranes. They could also
localize in the cell cytoplasm. However, the cytoplasmic localization could be an
artifact of cell death induced by hydraphiles localized in the membrane.
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4.4.2. E. coli membrane disruption. The combination studies showed that all
four benzyl hydraphiles (C8 - C14) rescued antibiotic potency against efflux pump
expressing resistant E. coli and K. pneumoniae. The activity of hydraphiles was
similar to that of CCCP and colistin. Colistin is a well-known membrane
disruptor and it showed 16- to 32-fold tetracycline recovery against TetR E. coli.
We hypothesized that if hydraphiles localize in the membrane of E. coli cells,
then it could disrupt membrane integrity and increase the permeability of
bacterial membranes. Localization studies showed that hydraphiles do localize in
the membranes of mammalian and bacterial cells. They were also found in the
cell cytoplasm. We next wanted to observe if hydraphiles caused disruption of
membrane integrity in TetR E. coli. We hypothesized that if ½ [MIC] hydraphiles
caused disruption of E. coli cell membrane, then the changes in the surface
(membrane) of E. coli would be observed by SEM analysis.
To confirm if benzyl C8 and C14 hydraphile both affect the membrane
integrity of individual bacterial cells, we used scanning electron microscopy.
Here the TetR E. coli cells were treated with ½ [MIC] of benzyl C8 and C14
hydraphiles, loaded on to a membrane, fixed and stained before observing by
SEM (figure 4.6). The samples were observed at 10,000X to 50,000X
magnification.
Under the ‘amphiphile alone’ column of figure 4.6, membrane
background alone (top) and an aggregate formed by benzyl C14 hydraphile
(bottom) in the absence of bacteria was observed. Similar aggregates were
observed with benzyl C8 hydraphiles. In an untreated TetR E. coli cell, the
membrane is corrugated and no membrane disruption or aggregates is apparent.
When the TetR E. coli was treated with either hydraphiles or hydraphile +
tetracycline, three key features were observed with both benzyl C8 and C14
hydraphiles (figure 4.7).
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Figure 4.6. Scanning electron microscopy images of TetR E. coli
treated with benzyl C8 hydraphile (top panel) and benzyl C14
hydraphile (bottom panel). The column labeled ‘amphiphiles alone’
shows the nylon membrane (top) and benzyl C14 hydraphile
aggregate (bottom).
First, we observed uniform, well-formed aggregates of hydraphiles of
approximately 100-120 nm on the surface of E. coli (figure 4.8, a). Hydraphiles
may form uniform 100-200 nm aggregates before attaching and inserting to the E.
coli membranes. Alternatively, these aggregates may have also formed after the
disruption of E. coli membrane. In such a case these aggregates may comprise a
mixture of E. coli membrane lipids and hydraphiles.
Secondly, we observed irregular blisters on the surface of E. coli
membranes. These blisters were distinct from the hydraphile aggregates
observed. In figure 4.8, b, blisters and aggregates are both observed. It is known
that if cytoplasmic membrane is disrupted, the cytosolic content is released in the
periplasmic space, forming a blister/bulge of the outer membrane.41 Hence,
hydraphiles that disrupted the inner membrane could have formed the blisters
from the outer membrane.
Lastly, we observed some bacteria with membrane smoothening (figure
4.8, c). It is known that under osmotic stress, water uptake by bacteria cause
swelling of the bacterial cell.41 This swelling would cause the corrugated
membrane to stretch and become smooth. Taken together, these images show
that hydraphiles form aggregates that attach to the bacterial surface. These
hydraphiles could both transport ions as observed with membrane smoothening
and disrupt membranes as observed with membrane blisters. These results also
confirm that hydraphiles are membrane active compounds in bacterial cells. We
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are currently quantifying the number of cells that have the properties outline
above.

Figure 4.7. Scanning electron microscopy images of common traits
observed with TetR E. coli was treated with either benzyl C8
hydraphile and benzyl C14 hydraphile. The image on the left shows
a hydraphile aggregate (a), a membrane blister in the middle (b)
and the membrane smoothening on the right (c).
4.4.3. Increase in membrane permeability. We have confirmed that when
hydraphiles are added to TetR E. coli, it localizes in the cell membrane and
disrupts membrane integrity. This should result in an increase in membrane
permeability. Here we test if hydraphiles could increase the permeability of E.
coli. We also determined if hydraphiles could increase the permeability of
mammalian cells (HEK-293). In these studies, we used propidium iodide
localization and nucleic acid release to show that benzyl C8 - C14 hydraphiles
increase membrane permeability. Potassium release is also considered to be an
evidence of increased membrane permeability. Potassium transport is a known
function of hydraphiles. We have addressed K+ transport in chapter 5. Below is
the evidence for an increase in membrane permeability caused by hydraphiles.
4.4.3.1. Bacterial cell membrane permeability. We first tested the permeability of
TetR E. coli using a membrane impermeable stain propidium iodide (PI) and cell
viability stain fluorescein diacetate (FDA). PI does not permeate viable cells.
However, it is known to enter the cells when membrane integrity is
compromised or as a result of cell dead. Once PI localizes in the bacterial
cytoplasm, it intercalates with nucleic acids and its fluorescence intensity
increases dramatically. Hence, PI serves as a stain to probe cell membrane
permeability. However, cells that are PI positive may also be dead. We therefore
used FDA, a cell viability stain. Fluorescein diacetate is permeable to cell
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membrane but not fluorescent. Once it enters the cytoplasm of viable cells, FDA
is converted to fluorescein by endogenous esterase enzymes. The fluorescence
from fluorescein indicates viable cells.

Figure 4.8. Benzyl C8-C14 hydraphiles (1/2 [MIC]) mediated
permeability of propidium iodide and fluorescein diacetate in TetR
E. coli. E. coli alone, DMSO (0.5% v/v) and triton X-100 (0.1% v/v)
were used as controls.
We used TetR E. coli alone and TetR E. coli treated with 0.5% (v/v) DMSO
and 0.1 % (v/v) triton X-100 as controls. As expected, all the cell in E. coli alone
control were alive and showed fluorescence for FDA (yellow) and none for PI
(red). This shows that the membranes of live cells were not permeable to PI when
the TetR E. coli was untreated. DMSO was used as a solvent for hydraphiles. It
was necessary to confirm that the amount of DMSO added was inconsequential
because DMSO affects membrane permeability42,43 and biological activity.44 The
presence of DMSO in some cases mimics the action of water channels at
sufficiently high concentrations.45 After treating the TetR E. coli cells with 0.5%
DMSO, the results were similar to that of TetR E. coli alone control. We observed
only 2-3 cells that showed PI fluorescence. Triton X-100 is a well-known and
characterized detergent. When used at 0.1% v/v (1.6 mM), Triton X-100 disrupts
bacterial and mammalian cell membranes. We therefore used, Triton X-100 as a
control. In the presence of triton X-100, there was PI fluorescence increase and
cell viability decreased dramatically.
The highest concentration of hydraphile that showed synergy was at ½
[MIC]. A growth curve confirmed that at ½ [MIC] of benzyl C14 hydraphile there
was no inhibition of growth. We therefore tested all the hydraphiles at one-half
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the MIC concentration for their ability to increase TetR E. coli membrane
permeability. If any increase in permeability would be observed with ½ [MIC]
hydraphiles, it would be an effect of membrane localization rather than cell
death. FDA would qualitatively confirm cell viability as well. Previously
reported kinetics studies showed that hydraphiles at bactericidal concentration
could kill half the E. coli cell population in 9 minutes.36 Here, the TetR E. coli cells
were treated with hydraphiles, PI and FDA for 10 minutes.
The ½ [MIC] of benzyl C8, C10, C12, and C14 hydraphile, used here were 125
µM, 17.5 µM, 2.5 µM and 1 µM, respectively. As seen in figure 4.9, in the presence
of these concentrations of benzyl C8-C14 hydraphiles, the cell viability (FDA
panel, yellow) was comparable to that of E. coli alone controls. This confirms that
the ½ [MIC] concentration does not result in a decrease in cell viability. After
treatment with the hydraphiles, PI permeability (PI panel, red) was clearly
increased. The increase in PI staining was comparable to that of Triton X-100 at
0.1% or 1600 µM. It could be argued that the images do not confirm that the
viable cells are the same cells with increased cell membrane permeability. The
increase in cell membrane permeability could be attributed to the toxicity of
hydraphiles. On the contrary, the results from growth curves did not show any
inhibition of E. coli growth in presence of ½ [MIC] benzyl C14 hydraphile. We
thus confirmed the membrane disruption and increase in membrane
permeability using SEM and nucleic acid release, respectively.
4.4.3.2. Nucleic acid release data. An increase in bacterial membrane
permeability causes the release of the cytosolic content. The potassium
concentration in E. coli cytosol is ~200 mM and that of media is ~10 mM. Another
major component of bacterial cytoplasm are nucleic acids. Hence, when the
cytosolic membrane is disrupted, it causes leakage of both potassium ions and
nucleic acids. Hydraphiles are known to form cation channels that could
transport K+ ions. Ion transport by hydraphiles is not necessarily related to
membrane disruption and leakage. Benzyl C8-C14 hydraphiles do transport K+
ions and the analysis of ion transport is outlined in chapter 5.
We determined if 260 nm absorbing material (DNA and RNA) was
released from TetR E. coli after treatment with benzyl C14 hydraphile for 10
minutes. The results are outlined in figure 4.9 below. A UV/Vis
spectrophotometer was used to measure absorbance at 260 nm. The cell
concentration of TetR E. coli required for this experiment was 5.6 x 108 cells/mL.
The MIC of benzyl C14 hydraphile at this high cell concentration was 8 µM. We
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therefore determined nucleic acid release at 1, 2, 5 and 8 µM of benzyl C14
hydraphile concentrations. DMSO at 0.25% (v/v) was used as 0 µM data point.
The MIC concentration of benzyl C14 hydraphile induces cell death. At this MIC
concentration, nucleic acids are released into the cell surrounding. When sublethal concentration of benzyl C14 hydraphile (5 µM) was used, nucleic acid
release was still observed. The amount of nucleic acids released in the presence
of 5 µM benzyl C14 hydraphiles were half as much as observed with 8 µM C14
hydraphile. No nucleic acids were released at 1 or 2 µM of benzyl C14 hydraphile.
This study confirms that nucleic acid release correlates to increasing, but sublethal, concentration of benzyl C14 hydraphile.

Figure 4.9. Nucleic acid release from TetR E. coli after treatment
with benzyl C14 hydraphile for 10 minutes. The x-axis represents
the concentration of benzyl C14 hydraphile used and the y-axis
represents the absorbance at 260 nm. Experiment represents the
average of three trials and the error bar represents the standard
deviation in the results.
4.4.3.3. Permeability of HEK-293 cells. We previously confirmed that
hydraphiles could localize in the membrane of HEK-293 cells. It could be argued
that hydraphiles also localize in and disrupt mammalian cell membranes. We
therefore tested the effect of benzyl C8-C14 hydraphiles on the membrane
integrity of mammalian HEK-293 cells (figure 4.11). We used PI and FDA to
study the E. coli membrane permeability. The HEK-293 cells were cultured to
optimal conditions and treated with hydraphiles, PI and FDA for 2 hours before
confocal microscopic examination.
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Figure 4.10. Benzyl C8-C14 hydraphiles (1/2 [MIC]) mediated
permeability of propidium iodide and fluorescein diacetate in
HEK-293 cells. HEK-293 alone, DMSO (0.5%) and Triton X-100
(0.1%) were used as controls.
HEK-293, DMSO (0.5%) and Triton X-100 (0.1%) were used as controls.
For HEK-293 alone and DMSO, there was high cell viability and membranes
were impermeable. At 0.1% or 1.6 mM Triton X-100 (a detergent), it killed all the
HEK-293 cells and disrupted membranes showing high PI fluorescence. No FDA
fluorescence was observed in the presence of Triton X-100. However, the
viability was high and minimal PI fluorescence was observed with ½ [MIC] of
benzyl C8-C14 hydraphiles (figure 4.10). This shows that at ½ [MIC] hydraphiles
disrupt bacterial membrane but does not affect mammalian membranes. We
confirmed that even at 2 X [MIC] concentrations, hydraphiles do not affect HEK293 mammalian cell membrane integrity. High cell viability and no increase in
cell membrane permeability was observed for HEK-293 cells treated with at 2 X
[MIC] of benzyl C8-C14 hydraphiles for 2 hours (data not shown). A selectivity in
the ability of hydraphiles to increase the bacterial membrane permeability was
observed. A change in mammalian cell membrane permeability may be possible,
but at a much higher concentration of hydraphiles.
4.5.

Summary and conclusions.
Hydraphiles have been known to have antimicrobial properties that
correlates to their ability to transport cations. We recently reported that
hydraphiles could be used to increase antimicrobial potency against sensitive
strains of bacteria. Against Gram negative bacteria, the activity of hydrophobic
antibiotics (rifampicin and erythromycin) was enhanced more than hydrophilic
antibiotics. This suggests a mechanism involving increased membrane
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permeability. Hydraphiles also rescued antimicrobials potency against multidrug resistant Gram negative bacteria. The hypothesis involved inhibition of
efflux pump activity and increased membrane permeability by hydraphiles. To
our knowledge, no mechanistic studies for antimicrobial properties of synthetic
amphiphiles have been reported to date.
As reported here, hydraphiles localize in the membranes of both bacterial
and mammalian cells. Hydraphiles were also found in the cytoplasm of the
bacterial cells and the nucleus of the mammalian cell. This could be an effect of
cell death or an increase in the membrane permeability. The localization studies
do require higher magnification and resolution than is currently available to
confirm the localization in mammalian cells. We propose the use of highresolution microscopy to observe localization at different concentrations and
duration of treatment. As observed in the SEM study, hydraphiles clearly disrupt
the membrane of E. coli cells. Hydraphiles were observed to form aggregates of
100 – 200 nm in size. These aggregates fuse with the bacterial membrane
allowing for localization of hydraphiles in the membrane. This effect of
hydraphile on bacteria was previously undocumented. Once hydraphiles insert
in the membrane of bacteria, it exerts osmotic stress due to disruption of ion
gradient. Eventually the cytoplasmic membrane disrupts forming blisters
observed on the outer membrane of bacteria. TEM studies of a cross-section of a
hydraphile treated E. coli could be used to confirm these observations.
Hydraphiles increase the membrane permeability of E. coli cells. At ½
[MIC] of benzyl C8-C14 hydraphiles, PI fluorescence increased as was that of
fluorescein. This shows that hydraphiles at sub-lethal concentrations could
increase membrane permeability without decreasing the overall cell viability.
The increase in membrane permeability was confirmed by the leakage of
potassium ions and nucleic acids (260 nm absorbing material) from the cells. In
both of these experiments, only partial leakage of cytosolic content was observed
at ½ [MIC] of the hydraphiles used. This could account for the increase in the lag
phase observed for the E. coli growth curve (chapters 2 and 3). However,
bacterial growth was not ultimately inhibited. Increased membrane permeability
could allow for increased transport of antibiotics through the cell membrane.
This would increase antibiotic concentration in the cell cytoplasm that could be
observed as an increase in the antibiotic potency. Efflux pumps may still affect
antibiotic accumulation in cell cytoplasm. The effect of hydraphiles on efflux
pumps and the accumulation of antibiotic in the cell cytoplasm is addressed in
chapter 5.
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Interestingly, hydraphiles did not increase the permeability of HEK-293
mammalian cells, even at twice the MIC concentrations. Clearly there is a
difference in the hydraphile activity observed between bacterial and mammalian
cells. The composition of mammalian cell membrane and E. coli cell membranes
are dramatically different. The phospholipids such as phosphatidylglycerols
found in the bacterial membrane are acidic.46 The LPS of the Gram negative
bacteria also consists of anionic molecules.46 In Gram positive bacteria, the
teichoic acids or lipoteichoic acids are anionic in nature.46 It is well-known
known that many of the antimicrobial peptides, including colistin, interact with
bacteria because they are both amphiphilic and cationic.47 The cationic property
allows for selectivity between bacteria and mammalian cells. The mammalian
cells have zwitterionic phosphatidylcholine in the outer leaflet of the
membrane.48 They could have hydrophobic interactions with hydraphiles,
exerting cytotoxicity. However, since the acidic phospholipids are localized in
the inner leaflet of the mammalian membranes, some selectivity of hydraphiles
seems possible. Mammalian membranes contain cholesterol. In liposomal
studies, the addition of cholesterol to liposomes exhibited a change in hydraphile
activity related to changes in membrane thickness.34 Hence, it is not surprising
that hydraphiles show some selectivity in increasing cell membrane
permeability. The cytotoxicity of hydraphiles are addressed in chapter 5.
Colistin is currently considered as the antibiotic of last resort due to its
cytotoxicity. Resistance development to colistin has been recently reported.
Colistin binds to the lipidA component of Gram negative bacteria and disrupts
membrane integrity. It could be considered as a natural amphiphiles. Another
natural amphiphile, daptomycin disrupts the membranes of Gram positive
bacteria. Here, we have shown that hydraphiles disrupts membranes of Gram
negative bacteria. Hydraphiles may hold potential not only as an adjuvant but
also as antibiotics. The amphiphilic and cationic nature of hydraphiles is similar
to many of the cyclic antimicrobial peptides. Hydraphiles are completely
synthetic molecules. Its structure could be modified to understand the role of
hydrophobicity and charge to make it highly selective to bacteria. Studies with
synthetic amphiphiles with permanent positive charges are underway.
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4.6.

Experimental procedure.

4.6.1. Compounds and bacteria used. Benzyl C8 – C14 benzyl hydraphiles were
prepared by Gokel lab. To conduct the localization two new amphiphiles were
designed and prepared. Benzyl side arms were substituted for dansyl side arms
in dansyl C14 hydraphile. The purity of compounds were confirmed by the NMR
and mass spectrometry. FM4-64 FX and propidium iodide were acquired from
Thermo-Fischer. Fluorescein diacetate was acquired from Sigma-Aldrich.
The TetR E. coli strain used here was made by transforming competent E.
coli cells with pBR322 plasmid. This strain was used for combination studies in
chapter 3 and for localization, permeability, nucleic acid release and scanning
electron microscopy studies conducted here. The TetR E. coli was cultured in L. B.
Miller media containing 100 µg/mL Ampicillin.
4.6.2. Localization in bacterial cells. TetR E. coli was grown overnight from one
CFU in L.B. miller media containing 100 µg/mL Ampicillin. E. coli was knocked
back and grown to O.D. (600 nm) = 1.300 before use. Cells were centrifuged at
6500 RM (3000Xg) for 5 minutes and resuspended in PBS. Dansyl labeled C14
dansyl hydraphile (Cf = 2 µM) was added to 1990 µL of cells. For co-localization
study, FM4-64 FX (Cf = 10 µg/mL) were also added. The cells were incubated for
5 minutes at 200 RPM and 37°C. Cells were washed again at 6500 RPM (3000X g)
for 5 minutes and re-suspend the cells in fresh PBS. A 20 µL sample was loaded
on to clean glass slide and covered with coverslip. The slide was observed using
Zeiss LSM 700 microscope.
4.6.3. E. coli Membrane permeability using PI and FDA. To test the membrane
permeability of the TetR E. coli, the bacteria was first grown overnight from one
CFU in media containing 100 µg/mL Ampicillin at 37°C and 200RPM. TetR E. coli
was then knocked back to O.D. 600 nm = 0.550 before use. In a sterile test tube,
cells were added followed by either triton X-100, DMSO or compounds 1-4 at
half-MIC concentrations and incubated at 37°C and 200 RPM. The concentration
of DMSO was kept constant at 0.5% -by volume in each case. After 30 minutes of
incubation, the cells were washed by centrifugation at 3000xg for 5 minutes and
re-suspended in sterile phosphate buffered saline (PBS). Propidium iodide (30
µM, Thermo-Fischer) and fluorescein diacetate (60 µM, Sigma-Aldrich) were
added to the TetR E. coli cells in the PBS, mixed by vortexing and incubated at
37°C and 200 RPM. After 30 minutes, the cells were washed again by
centrifugation at 3000xg for 5 minutes. The pellet was suspended in a fresh PBS,
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loaded onto a clean glass slide, covered with a cover slip and observed under
Zeiss LSM 700 confocal microscope.
4.6.4. Localization and permeability of HEK-293 cells. HEK-293 cells were
donated by Dr. Michael Nichols. Cell lines were regularly maintained in growth
media containing DMEM (ATCC), 10% fetal bovine serum (FBS, ATCC) and 1%
penicillin-streptomycin solution (ATCC). Adherent HEK-293 cells were
trypsinized using 0.25% (w/v) trypsin-EDTA (Sigma-Aldrich), suspended in a
fresh media and diluted to get a concentration of 3 x 105 cells/ml. Cells were
seeded in a 96-well plate (100 µL/well) to get 3 x 104 cells/well. The plates were
incubated for 24 hours at 5% CO2 and 37°C to reach a confluency of 80-90%.
In a sterile 1.5 mL micro-centrifuge tube, dansyl C14 hydraphile and
dansyl C16 lariat ether (0.5% DMSO) were mixed with PBS. FM4-64 FX, DAPI and
PI were also added to PBS for co-localization study. The spent media in the plate
was replaced with 100 µL media containing dansyl labeled amphiphiles and
other stains. The cells were incubated at 37°C and 5% CO2 for 30 minutes before
observing under Zeiss LSM 700.
For permeability study, the cells were cultured as outlined above. HEK293 (90% confluent) were then seeded in a 96-well plate to get 30,000 cells/well.
After 24 hours of incubation at 37°C and 5% CO2, the spent media was replaced
with media (DMEM and 10% FBS) containing compound 1-4 at ½ X or 2 X [MIC].
Triton X-100 at 0.1%-by volume (1670 µM) and DMSO 0.5% -by volume were also
used as controls. After 2 hours of incubation, spent media was replaced with PBS
containing propidium iodide (30 µM) and fluorescein diacetate (60 µM) and
incubated at 37°C and 5% CO2. After 2 hour of incubation, the spend media was
replaced with fresh PBS and the cells were observed under Zeiss LSM 700
confocal microscope. The images were reported without any alterations. The gain
and the intensity in all the images were kept constant.
4.6.5. Scanning electron microscopy. To perform scanning electron microscopy
TetR E. coli was grown overnight from one CFU in L.B. miller media containing
100 µg/mL Ampicillin. E. coli was knocked back and grown to O.D. (600 nm) =
1.000 before use. For E. coli alone control, the filter membrane (0.45 µm) was
dipped in the E. coli culture. E. coli was treated with various concentration of C8
and C14 hydraphiles for 10 minutes before loading on to filter membrane. The
cells were fixed by transferring the filter membrane containing E. coli cells to
2.5% (v/v) glutaraldehyde (stock 25%) for 60 min. Cells were washed for 15
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minutes by transferring the membrane in PBS. The cells were stained by
transferring the membrane to 1%(v/v) OsO4 for 1 hour. Serial dehydration of the
sample was performed with 30%, 50%, 70%, 80%, 90%, 100%, 100% (v/v)
ethanol. Sample was dipped in each ethanol concentration for 10 minutes. The
cells were critical-point dried and sputter coated with gold before observing
under JOEL 6320F SEM. The images were acquired and reports without any
modifications.
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CHAPTER 5
Hydraphiles: Non-Resistant Molecules that Indirectly Inhibit Efflux Pump
Activity with Minimal Cytotoxicity

The data reported in this chapter has not been published yet but is covered
under two patent applications.
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5.1

Introduction.
Antimicrobial resistance is a major health concern.1 The urgency of
developing new antibiotics and approaches for the treatment of multi-drug
resistant bacterial infections cannot be overstated.2 This problem could be
addressed by the development of new antibiotics or by rescuing the efficacy of
existing antibiotics.3 To our knowledge Teixobactin is the only new class of
antibiotic currently in development.4 The interest in adjuvant for current
antibiotics has been growing with many new adjuvants in development. Only
one antibiotic was approved in 2015,5 and it was an antibiotic adjuvant (βlactamase inhibitor).6 Searching for and developing new antibiotics has proven to
be a daunting task.7 This is due to our inability to isolate and culture bacteria
from different sources such as soil. Therefore, antibiotic adjuvants provide a
unique opportunity. Adjuvants are molecules that inhibit the known resistance
mechanisms in bacteria and restore antibiotic potency. This circumvents the need
to discover new antibiotics and addresses the antibiotic resistance problem.
One of the three mechanisms8 through which bacteria develop resistance
is called efflux pumps.9 Efflux pumps are transmembrane proteins that export
antibiotics from the cell cytoplasm to its surrounding.10 This decreases the
accumulation of antibiotics in the cell cytoplasm and hence decreases their
potency. This allows for bacteria to develop other types of resistance, i.e.
mutation in target sites.11 Efflux pumps may also span only the cytoplasmic
membrane. Single-component efflux pumps export the antibiotic to the
periplasmic space of the Gram negative bacterial membrane. The concentration
of antibiotic in the periplasm increases until it matches the concentration of
antibiotic in the external media. Antibiotics could diffuse back into the cytoplasm
from the periplasmic space. However, the kinetics of these efflux pumps (for
example, tetA) favor a low cytoplasmic concentration of antibiotic.12 Efflux
pumps,13 along with bacterial membranes,14 present an attractive target for
development of adjuvant antibiotics.
Antibiotic efficacy in bacteria could be affected by multiple different
resistance mechanisms. However, such mechanisms work independently.
Inhibition of any one resistance mechanism could result in a dramatic recovery of
antimicrobial activity. For example, a 64-fold recovery in the Minimal Inhibitory
Concentration (MIC) of fluoroquinolones resulted from deletion of the MexABOprM efflux pump in a fluoroquinolone resistant Pseudomonas aeruginosa strain
that had also acquired resistance by a mutation in DNA gyrase.15 Hence, the
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inhibition of efflux pump activity and/or increasing permeability of antibiotic to
Gram negative bacteria could significantly increase the sensitivity of antibiotics.16
Five different approaches have been reported for increasing antibiotic
concentrations in the cell cytoplasm of efflux pump expressing Gram negative
bacteria.17 These are described in detail in Chapter 1 (page 7).18,19,20,21,22 Efflux
pump inhibitors (EPI) could be classified either as indirect or direct inhibitors.
Direct inhibitors are molecules that interact with the efflux pumps.23 The only
direct EPI that has reached clinical trials is PAβN.19 It is indicated for the
treatment of P. aeruginosa infection in the lungs. It recovers levofloxacin activity.
The majority of research focuses on direct efflux pump inhibitors revolves
around developing structural analogues of PAβN. To our knowledge, there is no
direct EPI available as a treatment for multidrug resistant Gram negative infections.
Compounds that cause a decrease in efflux pump activity, without directly
interacting with the efflux pumps, are called indirect EPIs. Compounds that
increase membrane permeability (polymyxin)24 and disrupt ion gradients
(CCCP) are considered indirect inhibitors of efflux pumps.21 However, resistance
to polymyxin has been recently reported in the U.S.25 Here, we report that
hydraphile synthetic ion channels cause indirect inhibition of efflux pumps.
Our lab has extensively studied and developed amphiphilic compounds
called hydraphiles.26 Hydraphiles are synthetic ion channels that exhibit many of
the same properties as protein channels.27 Numerous biophysical and
computational studies have confirmed that the hydraphiles of appropriate
lengths28 form non-rectifying channels that could transport cations, specifically
Na+ and K+.29 Planar bilayer studies confirmed open-close behavior similar to
that observed with known channel proteins.30,31 The antimicrobial properties of
hydraphiles are length dependent and associated with the disruption of ion
homeostasis in bacteria.32 Benzyl C12-C16 hydraphiles are better ion transporters
than shorter or longer analogs. Hydraphiles form channels in certain mammalian
cells (e.g. HEK-293).31 Their use in chemotherapy33 and altering plant root
morphology34 has also been reported.
In previous chapters we reported that hydraphiles, when used at sublethal concentrations, recover the potency of FDA approved antibiotics.
Antimicrobial potency recovery was observed with both sensitive35 and
multidrug resistant bacteria.36 More interestingly, efficacy was enhanced against
more problematic Gram negative bacteria. In particular, tetracycline and
ciprofloxacin activity was recovered against E. coli and K. pneumoniae. The E. coli
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expressed the tetA efflux pump providing tetracycline resistance, whereas the
patient-isolated K. pneumoniae incorporated multiple different efflux pumps
including tetA, RND and ABC efflux pumps. The recovery of antibiotic potency
was again dependent on the length of the hydraphiles used. The benzyl C14
hydraphile was the most efficient of the benzyl C8-C14 hydraphiles tested. We
showed that the hydraphiles could localize in the bacterial membrane and cause
membrane disruption. This increases membrane permeability. Hydraphiles did
localize in the membrane of mammalian cells, but membrane permeability did
not increase. Here, we test our hypothesis associated with efflux pump
inhibition. We also test for its applicability by determining the cytotoxicity of the
compounds and the ability of bacteria to develop resistance to hydraphiles.
Efflux pumps depend on cation antiport to transport antibiotics from the
periplasm or the cell cytoplasm. Hydraphiles have been shown to transport
cations through liposomes and mammalian membranes. We therefore rationalize
that since hydraphiles transport cations across a variety of membranes, they could also
transport cations in bacteria. This would disrupt the cation gradient required by
the efflux pumps for antibiotic antiport in bacteria. We previously reported that
the crown ether based lariat ethers caused depolarization of Bacillus subtilis
membranes.37 Hence, disruption of bacterial cation gradients by hydraphiles is
possible. We hypothesize that if hydraphiles form channels and transport ions in
bacteria, then efflux pump activity will be uncoupled from the cation gradient. Here, we
have tested this hypothesis.
We report that benzyl C8-C14 hydraphiles mediate the export of potassium
ions from bacteria. This potassium transport was dependent both on the
concentration and the length of hydraphiles used. A correlation was observed
between cation transport in bacteria, hydraphile chain length and the ability of
hydraphile to recover antibiotic potency. This correlation indicates an effect on
efflux pumps. We show that hydraphiles, at sub-lethal concentrations, decrease
the norA efflux pump activity and increase the accumulation of antibiotics in the
cell cytoplasm. Here, benzyl C14 and C12 hydraphiles were the most effective
compounds. The activity of these hydraphiles was comparable to known EPIs
CCCP (100 µM) and reserpine (41 µM), but at the much lower concentration of 4
µM.
E. coli was unable to develop resistance to benzyl C14 hydraphile beyond 4
µM, over 15 days of serial culturing. However, it did develop resistance to C11
lariat ether and to minocycline. Cytotoxicity studies showed that benzyl C8, C10,
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and C12 hydraphiles at ½ [MIC] decrease survival of HEK-293 cells but did not
affect HeLa and Cos-7 cell lines. The benzyl C14 hydraphile, at ½ [MIC] (1 µM),
showed approx. 100% survival with all the three cell lines used. Completion of
this study has allowed us to develop a platform for testing in vitro antimicrobial
activity, membrane permeability, efflux pump activity and cytotoxicity of
synthetic amphiphiles. We will use this platform to further study structural
derivatives that have greater efficacy and lower cytotoxicity. We are also
currently investigating in vivo toxicity and efficacy of the benzyl C14 hydraphile.
5.2

Bacteria used.
Two strains of bacteria were used to perform the studies described below.
We developed a strain of E. coli expressing the tetA efflux pump, called TetR E.
coli. The TetR E. coli was prepared by transforming competent E. coli cells with the
pBR322 plasmid38 using the heat shock technique. The resulting strain expressed
both the tetA efflux pump and the β-lactamase genes, providing resistance to
tetracycline and ampicillin. The tetA efflux pump provides resistance only to
tetracycline. Minocycline, a close tetracycline analog, was still active against TetR
E. coli. We have studied the activity of numerous classes of amphiphiles against
TetR E. coli. We recently reported the activity of bis-amino acid based compounds
against TetR E. coli.39 As reported in chapters 3 and 4, the TetR E. coli strain was
used to conduct studies with hydraphiles. At ½ [MIC] of benzyl C8-C14
hydraphiles, the activity of tetracycline was recovered against tetR E. coli. Here,
we have used tetR E. coli to perform cation transport and sequential culturing
experiments to determine resistance development.
Another strain of bacteria used in this report was Staphylococcus aureus
1199B. This bacteria was a donation from Dr. Glenn Kaatz at Wayne State
University. The S. aureus 1199B was initially isolated from a patient. S. aureus is a
Gram positive pathogen that is resistant to multiple antibiotics. The S. aureus
1199B overexpresses the norA efflux pump.40 Ethidium bromide and norfloxacin
are substrates for the norA efflux pump.41 This strain is also resistant to
ciprofloxacin due to a mutation in DNA gyraseA (A116E).40 We used the
fluorescence of the ethidium bromide-DNA complex to measure the activity of
the norA efflux pump in the presence of benzyl C8-C14 hydraphile and other EPI.
Numerous studies have used this approach to measure the activity of efflux
pumps in the presence or absence of EPIs.42 Combination studies were also
conducted with norfloxacin and hydraphiles against S. aureus 1199B.
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5.3

Compounds used.
The study outlined below uses four different hydraphiles: benzyl C8 –
benzyl C14 (compounds 1-4). The benzyl C8 and C10 hydraphiles are known to be
poor ion transporters as they may not span the bilayer membrane. However,
benzyl C12 and C14 hydraphiles are optimal to span the phospholipid bilayer and
have shown the superior ion transport from liposomes as compared to benzyl C8
and C10 hydraphiles. In combination studies against TetR E. coli and Klebsiella
pneumoniae the following trend was observed for their ability to recover
tetracycline activity: benzyl C14 hydraphile ≥ benzyl C12 hydraphile > benzyl C10
hydraphile > benzyl C8 hydraphile. All four hydraphiles were used to determine
ion transport (K+), efflux pump inhibition, antibiotic accumulation and
cytotoxicity. For the resistance development study only the benzyl C14
hydraphile was used. Hydraphiles were prepared in the Gokel lab and their
purity was confirmed using NMR and high resolution mass spectrometry.
In earlier work, the ion transport activity of hydraphile channels in
liposomes was standardized to gramicidin-D (compound 5), which was used as
control. We therefore used it as a control for the K+ transport experiments from
bacteria. The activity of gramicidin-D could be different in bacteria and
liposomes due to its requirement to dimerize in the membrane.43 In combination
studies gramicidin-D did not show recovery of tetracycline recovery against TetR
E. coli.

Figure 5.1. Structures of benzyl C8-C14 hydraphiles (1-4), ethidium
bromide (6), norfloxacin (7), reserpine (8) and CCCP (9).
S. aureus 1199B overexpresses the norA efflux pump. Ethidium bromide
(6) and norfloxacin (7) are substrates of the norA efflux pump.40,41 Compounds 6
and 7 were used for combination studies and efflux pump inhibition studies.
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Reserpine (8) and CCCP (9) are known efflux pump inhibitors. We used these
EPIs as controls to determine the effect of known EPIs on the norA efflux pump.
Minocycline is an antibiotic control used for probing resistance development by
TetR E. coli. CCCP, reserpine, daptomycin, gramicidin-D, minocycline, ethidium
bromide, and norfloxacin were acquired from Sigma-Aldrich and used as
received. DMSO was used as a solvent for all the compounds except for ethidium
bromide. Ethidium bromide was dissolved in dH2O.
5.4

Results and Discussion.

5.4.1. Hydraphiles transport potassium from bacteria. We have previously
reported that ion transport by hydraphiles (from liposomes) depended not only
on the concentration of the hydraphiles used but also on the length of spacer
chains.29,30 For example, at 12 µM, benzyl C12 and C14 hydraphiles exhibited
better sodium transport from DOPC liposomes than benzyl C8 and C10
hydraphiles. Notwithstanding, hydraphiles have never been shown to transport
cations from bacterial cells. An increase in membrane permeability may cause
release of cytosolic content including cations. It is therefore difficult to
distinguish membrane permeability from ion transport. Here, we have not
distinguished between these two possibilities, as their effect on bacterial cell
viability, ion concentration, and antimicrobial properties is indistinguishable.
However, various computational studies by others have shown that ions do flow
through the channels formed by hydraphiles.44
We determined the ability of benzyl C8-C14 hydraphiles (1-4) to transport
potassium ions from TetR E. coli. The potassium concentration of an E. coli cell
cytoplasm is 200 mM and that of phosphate buffer saline (PBS) is ~4.15 mM.
When hydraphiles are added to bacteria, non-rectifying channels form in the cell
membrane. As seen in the SEM study, the inner membranes are disrupted by
hydraphiles forming blisters (figure 4.7b, page 90). Hydraphiles also exert
osmotic stress on the bacteria causing them to swell and exhibit smoothening of
the outer membrane (figure 4.7c, page 90). This indicates that hydraphile
channels insert in both the outer membrane and inner membranes of E. coli. The
proton and potassium gradients in Gram negative bacteria are maintained across
the inner membrane.45 Hydraphiles may transport potassium ions from the cell
cytoplasm into the periplasmic space. When the potassium ion concentration
increases in the periplasmic space, ions could leak into the cell surrounding.
Hydraphiles in the outer membranes would also cause leakage of K+ into the cell
surrounding. As a result, the potassium concentration of the media (PBS)
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surrounding the tetR E. coli cells would increase. These change in the extracellular
potassium ion concentrations (∆[K+] mM) were measured using a potassium
selective electrode. Similar studies have been reported that measure K+ release
from bacteria using an ion selective electrode.46,47
Total potassium content of the TetR E. coli cells was determined by boiling
the bacteria at 100 °C. The total K+ content of TetR E. coli was used to determine
the percent of potassium released in the presence of hydraphiles or controls. This
was represented as ‘K+ efflux (% - total pool)’. Gramicidin-D and valinomycin
were used as controls.43 However, the requirement of gramicidin-D to dimerize
in the bacterial membrane may make it ineffective method for ion transport from
bacteria. Valinomycin acts as an ion carrier rather than a channel. We did not
expect to observe a change in K+ transport in the presence of valinomycin. The
results of potassium transport in the presence of hydraphiles and controls are
presented below in the format change in extracellular potassium concentration
(∆[K+] mM) and increase in potassium efflux (% - total pool).
A small change in potassium efflux (~5%) was observed when tetR E. coli
was untreated. Since the hydraphiles were dissolved in DMSO, we tested the
effect of 0.1% (v/v) DMSO on E. coli. In the presence of DMSO (0.1% v/v), the
change in the extracellular [K+] concentration was within experimental error of
the E. coli alone control. The volume of DMSO was limited at 0.1% v/v as higher
concentrations affected the activity of the electrode.
As expected, no change in K+ transport was observed in the presence of a
range of concentrations of valinomycin, (data not shown). In the presence of
gramicidin-D, at 30 µM, potassium transport was observed. Higher
concentrations of the ionophore were not tested owing to poor solubility.
Gramicidin-D (30 µM) causes an efflux of 50-60% of total potassium content of E.
coli cells (figure 5.2). In the liposomal experiments reported previously, the
activity of gramicidin-D was comparable to that of benzyl C14 hydraphile. In TetR
E. coli, the activity of gramicidin-D at 30 µM was similar to the benzyl C14
hydraphiles used at a concentration of 4-6 µM.
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Figure 5.2 (a). Potassium ion transport by benzyl C14 hydraphile at
2 µM, 4 µM, 6 µM and 8 µM. The x-axis represents time in minutes
and the change in extracellular potassium concentration is shown
on the y-axis. TetR E. coli alone, DMSO (0.1% v/v) and gramicidinD 30 µM are used as controls. Each data point, except for
gramicidin-D, represents an average of five trials. The error bars
represent the standard deviation in the results. Gramicidin-D
control was tested only once to confirm its well-known property.

Figure 5.2 (b). Potassium ion transport by benzyl C14 hydraphile at
2 µM, 4 µM, 6 µM and 8 µM. The bar graph represents the percent
of total potassium ions released from TetR E. coli cells after
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treatment with benzyl C14 hydraphile, and controls TetR E. coli
alone, DMSO and gramicidin-D. Each data point, except for
gramicidin-D, represents an average of five trials. The error bars
represent the standard deviation in the results. Gramicidin-D
control was tested only once to confirm its well-known property.
The experiment requires use of high concentrations of bacteria to observe
a change in electrical potential by the electrode. We therefore concentrated the
exponential stage bacteria to O.D.600 ~ 1.3 before use. At this concentration of
bacteria, the MIC of benzyl C14 hydraphile against E. coli was 8 µM. We therefore
tested the potassium transport ability of benzyl C8-C14 hydraphiles at 4 µM.
Concentration curves were determined for benzyl C8 hydraphile and
benzyl C14 hydraphile. When benzyl C14 hydraphile was added at 2 µM (1/4
[MIC]), approx. 10% K+ was released from the E. coli cytoplasm. This small
change in the extracellular [K+] was within the experimental error of E. coli alone
and DMSO controls. Benzyl C14 hydraphile transports potassium ion from TetR E.
coli cells at MIC (8 µM) and ½ [MIC] (4 µM) concentrations. Extracellular
potassium increased in the presence of benzyl C14 hydraphile at 8 µM, 6 µM and
4 µM (figure 5.2 a). At 8 µM of the benzyl C14 hydraphile, caused almost 100% of
the K+ content of E. coli to be release into the surrounding media (figure 5.2 b).
The ion release at this concentration was stabilized after 8 minutes (figure 5.2 a).
This is possibly due to the cell death or lysis caused by benzyl C14 hydraphile at
MIC concentrations. At 4 µM of the benzyl C14 hydraphile (1/2 [MIC]), approx.
40% of total potassium content of TetR E. coli was released. This was lower than
the known potassium ion channel, gramicidin-D at 30 µM. Potassium transport
changed little after addition of benzyl C14 hydraphile at 2 µM. However, the
change in extracellular K+ seemed to increase over 12 minutes.
Figure 5.3 shows the ability of benzyl C8 hydraphile to transport K+ from
E. coli at various concentrations. It has been reported that benzyl C8 hydraphile is
a poorer ion transporter compared to benzyl C14 hydraphile. The benzyl C8
hydraphile transports potassium ion from TetR E. coli and increased extracellular
K+ concentration at 250 µM, 125 µM and 62.5 µM (figure 5.3a). These
concentrations compare to the MIC, ½ [MIC] and ¼ [MIC] of benzyl C8
hydraphile used for combination studies. At 250 µM benzyl C8 hydraphile,
caused almost ~70 % of K+ content of TetR E. coli to be released into the
surrounding media (figure 5.3b) and the ion release was still increasing after 10
minutes (figure 5.3a). In comparison, benzyl C14 hydraphile released 100% of
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potassium content of TetR E. coli at the much lower concentration of 8 µM by 8
minutes. At 125 µM and 62.5 µM benzyl C8 hydraphile, ~50% and 40% of total
potassium content was released, respectively. This was comparable to the known
potassium ion channel gramicidin-D at 30 µM. This confirms that benzyl C8
hydraphile transports potassium ion at concentrations that showed the recovery
of tetracycline activity.

Figure 5.3 (a). Potassium ion transport by benzyl C8 hydraphile at 4
µM, 62.5 µM, 125 µM and 250 µM. Change in extracellular
potassium gradient (y-axis) over 12 minutes (x-axis) is shown in
graph. TetR E. coli alone, DMSO (0.1%) and gramicidin-D are used
as controls. Each data point, except for gramicidin-D, represents an
average of five trials. Error bars have been omitted for clarity.
Gramicidin-D control was tested only once to confirm its wellknown property.
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Figure 5.3 (b). The bar graph represents the percent of total
potassium ions released from E. coli cells after treatment with
benzyl C8 hydraphile at 4 µM, 62.5 µM, 125 µM and 250 µM. TetR E.
coli alone, DMSO (0.1% v/v) and gramicidin-D at 30 µM were used
as controls. Each data point, except for gramicidin-D, represents an
average of five trials.
When benzyl C8 hydraphile was added at 4 µM (1/4 [MIC]), the change in
concentration was comparable to that of DMSO (0.1% v/v) control. The
benzyl C14 hydraphile at 4 µM released ~ 40% of cytosolic potassium from E. coli.
This shows that the benzyl C14 hydraphiles is a more potent ion transporter that
benzyl C8 hydraphile. A comparison among benzyl C8, C10, C12 and C14
hydraphiles for ion transport from bacteria is shown below in figure 5.4. The
graph also shows a comparison of ion transport by hydraphiles to the antibiotic
recovery by hydraphiles, observed against the same strain of E. coli.
K+
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Figure 5.4. Comparison of benzyl C8-C14 hydraphiles to transport
potassium ions (open circles) and recovery of tetracycline activity
(open squares) against TetR E. coli. Potassium release is expressed in
percent of total potassium content of TetR E. coli released (y-axis,
left) and tetracycline recovery in fold enhancement (y-axis, right).
The x-axis shows the number of carbon atoms in the spacer chains
of hydraphiles. This is a theoretical comparison of two sets of data,
hence no error bars are indicated.
We compared the ion transport ability of hydraphiles to tetracycline
efficacy recovery against TetR E. coli. A chain length dependence was observed
for both potassium transport and tetracycline recovery (figure 5.4). We used a
sub-lethal concentration of the most active compound (benzyl C14 hydraphile) for
comparison of tetracycline recovery and potassium ion transport. We have
previously shown that at ½ [MIC] of benzyl C14 hydraphile there was no
inhibition of E. coli growth (figure 3. 2, page 53). At 4 µM, the benzyl C14 and C12
hydraphiles released approximately 40% and 25% of the total E. coli potassium
ion content from the cell cytoplasm to the cell surrounding, respectively (figure
5.4). These are the most efficient compounds at both release of potassium ions
and recovery of tetracycline activity. It also became clear that the ion transport
from bacteria and the increase in antibiotic potency by hydraphiles is dependent
on the spacer chain length: C14 > C12 > C10 ≥ C8. It is possible that benzyl C14
hydraphile is optimal for hydraphiles to span a bilayer membrane of E. coli to
perform its function of ion transport and membrane disruption. Using shorter
spacer chain lengths would fail to span the membrane, transport ions or disrupt
membranes efficiently. This activity is also dependent on the concentration of
amphiphile used as observed with benzyl C8 and C14 hydraphiles (figures 5.2 and
Chapter 5

119

M. B. Patel

5.3). Use of higher concentration of benzyl C8 and C10 hydraphiles could result in
ion transport and tetracycline recovery. However, these would likely be an effect
of membrane disruption caused by aggregation of hydraphiles in the membrane
rather than formation of an ion selective pore. Hydraphile aggregation was
observed in membrane localization and SEM studies.
It is also known that potassium ion is released when the membrane
integrity of bacteria is affected. However, a range of studies have been reported
that demonstrate the ability of hydraphiles to form channels and transport ions.
We cannot distinguish channel formation by hydraphiles from membrane
disruption in bacteria. Both of these could occur as is known for natural
amphiphiles such as colistin and daptomycin.48 Hydraphiles could similarly
transport sodium ions and protons.
5.4.2. Efflux pump inhibition. Hydraphiles have recovered the activity of
tetracycline and ciprofloxacin against efflux pump expressing TetR E. coli and K.
pneumoniae. If the cation gradients are disrupted by hydraphile as proved above,
then the activity of efflux pumps should also be inhibited. This is indirect
inhibition of efflux pumps. For direct inhibition the hydraphile would have to
interact with the efflux pump protein. This seems less likely because efflux
pumps are highly selective for their substrates. For example, the tetA efflux
pump is selective for only tetracycline. Minocycline, a close tetracycline analog is
neither recognized nor effluxed by the tetA pump. We therefore hypothesized
that if hydraphile inhibit the activity of efflux pumps, then the efflux pump
substrate would accumulate in the cell cytoplasm.
To test our hypothesis, we used the S. aureus 1199B strain overexpressing
the norA efflux pump. Ethidium bromide (EtBr) is one of the substrates of the
norA efflux pump. EtBr could intercalate with DNA once it enters and
accumulates in the bacterial cell cytoplasm. The EtBr-DNA complex has a
fluorescence intensity 10,000-fold greater than EtBr alone. We therefore utilized
fluorescence intensity from DNA-EtBr complex as an indication of the
localization of EtBr. Transport and localization of EtBr could be used to measure
the effect of hydraphiles on the norA efflux pump.
Before we determined the effect of hydraphiles on the norA efflux pump
of S. aureus 1199B, we determined the MICs of benzyl C8-C14 hydraphiles,
reserpine and CCCP. Surprisingly, benzyl C12 hydraphile (MIC ≤ 1 µM) activity
was similar to that of benzyl C14 hydraphile (MIC = 1 µM). Both benzyl C12 and
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C14 hydraphiles were more active than benzyl C8 and C10 hydraphiles. MIC of
EtBr, CCCP and reserpine were 16 µM, ≤ 4 µM and > 128 µM, respectively. We
next performed combination studies to observe if benzyl C8-C14 hydraphiles
recovered ethidium bromide activity against S. aureus 1199B. The results are
presented in Table 5.1 below. The MICs were conducted in 2-fold serial dilutions.
The results reported below were replicated in three different experiments.
Table 5.1. Recovery of ethidium bromide activity against S. aureus 1199B
Amphiphile
used

[Amphiphile] µM

[EtBr] µM

Fold
enhancement

No amphiphile
C8 hydraphile
C8 hydraphile
C10 hydraphile
C10 hydraphile
C12 hydraphile
C12 hydraphile
C14 hydraphile
C14 hydraphile

32 (¼[MIC])
64 (½[MIC])
4 (¼[MIC])
8 (½[MIC])
0.25 (¼[MIC])
0.5 (½[MIC])
0.25 (¼[MIC])
0.5 (½[MIC])

16
16
8
16
1
16
2
4
0.5

n/a
1-fold
2-fold
1-fold
16-fold
1-fold
8-fold
4-fold
32-fold

In the presence of ½ [MIC] of benzyl C8, C10, C12 and C14 hydraphiles, the
activity of EtBr was recovered by 2, 16, 8 and 32-fold, respectively. In contrast to
the recovery of tetracycline activity against TetR E. coli, benzyl C14 hydraphile
showed the highest recovery of EtBr in S. aureus 1199B. S. aureus is a Gram
positive bacteria with only one membrane and thick cell wall. It has been
reported that hydraphiles are more active against Gram positive bacteria. Hence,
it is not surprising that a greater recovery of EtBr by benzyl C14 hydraphile is
observed against S. aureus 1199B. At ¼ [MIC] of benzyl C8-C14 hydraphiles, only
1- to 4-fold recovery of EtBr was observed. Studies with a combination of
hydraphiles and norfloxacin are under way.
Combination studies proved that benzyl C8-C14 hydraphiles could recover
antibiotic potency against norA efflux pump expressing S. aureus 1199B. Next we
determined the ability of hydraphiles to inhibit the activity of norA efflux
pumps. Here, the S. aureus 1199B cells were preloaded with EtBr using 100 µM
CCCP. CCCP is a known efflux pump inhibitor. Addition of CCCP dissipates
proton motive force, which inhibits the activity of norA pumps and allow
accumulation of EtBr in the cell cytoplasm. The cells were then washed to
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remove extracellular EtBr and CCCP. The EtBr loaded cells were re-suspended in
Mueller-Hinton II (MHII) media, which contains dextrose hydrolyzed from
starch. Dextrose acts as an energy source for the regeneration of proton motive
force. The cells were then treated with 4 µM of benzyl C8-C14 hydraphiles. The
MIC of benzyl C14 hydraphile was observed at ~ 8 µM against S. aureus 1199B at
O.D.600 ~ 0.800 used for this experiment. If hydraphiles inhibit the activity of
efflux pumps, then there should be a no or only small change in the fluorescence
intensity of EtBr-DNA complex. The experiment was performed in triplicates
and the error bars in figure 5.5 and 5.6 represents standard deviation.
As seen in figure 5.5 below, in the presence of benzyl C10, C12 and C14
hydraphiles at 4 µM, there is only minor change in the fluorescence of EtBr. This
indicates an inhibition of efflux pump activity. This inhibition was similar to that
of known efflux pump inhibitors such as CCCP (100 µM) and reserpine (41 µM).
When the concentration of CCCP and reserpine was decreased to 4 µM,
inhibition of norA activity by known EPIs was ~30% lower than that of
hydraphiles. If the efflux pump activity is not inhibited, EtBr would be released
or effluxed from the cell cytoplasm, resulting in a decrease in the fluorescence
intensity. The benzyl C8 hydraphile had only a minor effect on the efflux pump
activity at 4 µM. These results confirm the inhibition of efflux pump activity by
hydraphiles.

Figure 5.5. Hydraphiles inhibit the activity of efflux pumps. Release
of ethidium bromide from S. aureus 1199B after treatment with
reserpine, CCCP, benzyl C8-C14 hydraphiles (4 µM). The x-axis
represents time in minutes and the y-axis represents fractional
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fluorescence. The results represent the average of three
independent trials and the error bars represent the standard
deviation.
Increase in membrane permeability and inhibition of efflux pump activity
in bacteria should result in cytoplasmic accumulation of antibiotics. We used S.
aureus 1199B to determine if, in the presence of hydraphiles, EtBr accumulation
in the cell cytoplasm increased. EtBr was added to the S. aureus 1199B cells
followed by hydraphiles or the controls. The change in fluorescence was
observed for 20 minutes using a fluorimeter. If the hydraphiles allow for EtBr
accumulation in the cell cytoplasm, then the fluorescence intensity would
increase.
As seen in figure 5.6 below, after the addition of benzyl C14 and C12
hydraphile (4 µM) the accumulation of EtBr increased in the cell cytoplasm of S.
aureus 1199B. Note that the EtBr accumulation by benzyl C12 hydraphile at 4 µM
was similar to that of known efflux pump inhibitors CCCP (100 µM) and
reserpine (25 µg/mL or 41 µM). The accumulation of EtBr in the presence of
benzyl C14 hydraphile (4 µM) was greater than twice as much observed with
CCCP and reserpine. However, at 4 µM the activity of CCCP and reserpine was
much lower than either benzyl C14 or C12 hydraphiles. There was no change in
the EtBr fluorescence intensity observed in the presence of benzyl C8 and C10
hydraphiles (4 µM). The hydraphiles with shorter spacer chain lengths do not
span the membrane. As indicated by their higher MICs, these compounds might
also inhibit the efflux pump activity at higher concentrations. The studies
conducted with S. aureus 1199B data show that hydraphiles indirectly inhibit the
efflux pump activity and cause antibiotics to accumulate in the cell cytoplasm.
Hydraphiles are at least comparable to, and better in some cases, than wellstudied and reported efflux pump inhibitors such as CCCP and reserpine.
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Figure 5.6. Hydraphiles increase substrate accumulation in
bacteria. Accumulation of ethidium bromide in the presence of
reserpine, CCCP, benzyl C8-C14 hydraphiles (4 µM) in S. aureus
1199B expressing norA efflux pump. The x-axis represents time in
minutes and y-axis represents normalized fluorescence. The results
represent the average of three independent trials and the error bars
represent the standard deviation.
Both the accumulation and release of EtBr from S. aureus 1199B in the
presence of hydraphiles could be affected by (1) the disruption of membrane
integrity, which allows for greater EtBr accumulation and/or (2) uncoupling of
the norA efflux pump from ion gradient caused by non-rectifying hydraphile
channels. We reported that the membrane permeability of bacterial cells alone
was increased by sub-lethal concentrations of hydraphiles. The results in figure
5.4 show that hydraphiles could transport potassium ions from bacteria in a
chain length dependent manner. Hence, hydraphiles increase bacterial
membrane permeability and disrupt cation gradients, causing inhibition of efflux
pumps and increased accumulation of antibiotics in the cell cytoplasm. This
results in increased efficacy of antibiotics against resistant bacteria.
5.4.3. Resistance to hydraphiles. One of the major concerns with antibiotic
development is the emergence of resistance by bacteria to new molecules. As a
result, newer antibiotics are usually limited in use and saved for emergency
purposes only. Compounds that target membranes are usually less prone to
resistance development by bacteria. For example, polymyxins (colistin) has been
developed and in clinical use for > 50 years. However, resistance to polymyxin
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was only identified recently.25 It is known that developing resistance to a
membrane active compound would require multiple changes in membrane
composition/synthesis pathways and is energetically unfavorable.49 The
antibiotic resistance problem could be addressed by developing antibiotics that
are less prone to resistance development. It is obvious that hydraphiles are
membrane targeting (localizing) molecules. However, it is unknown if bacteria
could develop resistance to synthetic molecules, specifically synthetic
amphiphiles. We therefore determined if TetR E. coli could develop resistance to
benzyl C14 hydraphile, our most potent efflux pump inhibitor and adjuvant. We
used minocycline as a positive control. Lariat ether are structurally similar to
hydraphile and also showed antimicrobial recovery. We therefore used C11 lariat
ether as a control.
We first used the mutant prevention concentration (MPC) to test
resistance development. To determine the MPC, L.B. Agar plates containing
different concentrations of either benzyl C14 hydraphile (8, 4, 2, 1, 0.5, 0.25 and
0.125 µM) or minocycline were prepared. A culture of TetR E. coli was incubated
over the plate for 3 days at 37 ºC. The highest concentration that prevents the
growth of bacteria (colony forming units) is considered the MPC. Growth was
observed with hydraphiles at concentrations as high as 8 µM. However, the same
cells failed to grow in the L.B. media containing the same or lower concentration
(4 µM) of hydraphile. This shows that the E. coli was not resistant to benzyl C14
hydraphile but the MPC was not a good technique for determination of
resistance development to synthetic amphiphiles.
The technique known as the sequential culturing method was used to
determine if bacteria would develop resistance to benzyl C14 hydraphile, C11
lariat ether, or minocycline. In this experiment, the bacteria were treated with
increasing fractional MIC concentrations of compounds tested, for 15 days. Each
day, the highest concentration of the compound that showed growth were used
to determine MICs. A sample of the bacteria grown in the presence of
amphiphiles were preserved for future studies. The results from the sequential
culturing method are shown in figure 5.7 below.
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Figure 5.7. Resistance development by TetR E. coli to benzyl C14
hydraphile (diamonds), C11 lariat ether (squares) and minocycline
(triangles). The x-axis represents time in days and the y-axis
represents increase in MIC (in folds). The results were reproduced
independently in 2 trials and the average of the MIC on each day is
indicated in the graph above. MICs were conducted in serial
dilutions; hence no error bars are represented. The errors were
within the single dilution.
As seen in figure 5.7, TetR E. coli readily developed resistance to
minocycline between 4-6 days. Resistance increase during the 15-day experiment
and the MIC of minocycline MIC is eventually increased by 40-fold. This
experiment does not distinguish between efflux pump or a mutation in target
binding site as the resistance mechanism.
The bacteria did not develop resistance past 4 µM to benzyl C14
hydraphile during 15 days. Hydraphiles are synthetic molecules and bacteria
lack enzymes to catalyze its break-down. Further, hydraphiles target membrane,
altering the membrane composition to prevent hydraphile binding or insertion
and therefore would require major changes in biochemical pathways. This would
be energetically unfavorable. However, such membrane active compounds are
associated with cytotoxicity or mutagenicity. The issue of ctotoxicity is addressed
below.
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The development of resistance by E. coli to C11 lariat ether was surprising.
Lariat ether still contains one macrocycle, but might be active as a carrier or
might aggregate in the membrane to function as a channel. It is possible that if
lariat ethers require to form an aggregate in the membrane, then a small change
in the membrane composition could inhibit lariat ether activity. If lariat ethers
have a cytoplasmic target, the target site could be mutated to recognize and
export lariat ethers. In either case, resistance development to C11 lariat ethers by
TetR E. coli indicates a complete different mechanism of action or membrane
targets than benzyl C14 hydraphile.
5.4.4. Cytotoxicity to hydraphiles. Membrane active compounds are known to
have cytotoxicity to mammalian cells. The use of either colistin and CCCP is
limited due to its cytotoxicity.50 The presumed membrane penetration
mechanism of action of hydraphiles may be similar to that of colistin and CCCP.
Thus, toxicity is an issue. It was previously reported that LD50 of benzyl C14
hydraphile against CaCO2 cells was 2.6 µM. Other hydraphiles were not tested
and their effect on renal epithelial cell lines was not established. In particular,
renal toxicity is a common issue with amphiphilic molecules.51 For our
hydraphiles to be an effective adjuvant antibiotic, selectivity between bacterial
and mammalian cells should be as high as possible. We hypothesize that since
hydraphiles are amphiphilic molecules, cytotoxicity to kidney cells may be observed. At
the concentration used for combination studies, i.e. sub-MIC, the toxicity should
be limited. Some membrane active compounds are also associated with
mutagenicity. We recently reported DNA gel electrophoresis data that showed
hydraphiles at MIC concentrations does not bind DNA.52 Hydraphile-DNA
complexation was observed, but at much higher concentrations than its MIC
against E. coli.
To assess the cytotoxicity of benzyl C8-C14 hydraphiles, we used three
mammalian epithelial cell lines: HEK-293, HeLa and Cos-7. HEK-293 and Cos-7
are human embryonic kidney and monkey kidney cells, respectively. HeLa is a
cervix epithelial cell line. Previous studies determined that the activity of
hydraphiles was similar to that of CCCP, an EPI, and colistin, a membrane
disruptor. We therefore used colistin and CCCP as controls. We determined the
viability of all three cell lines in the presence of benzyl C8-C14 hydraphiles (1-4).
Figure 5.8 and figure 5.9 shows the percent survival of HEK-293, HeLa and Cos-7
cells in the presence of ½ [MIC] and MIC concentrations of benzyl C8-C14
hydraphiles, colistin and CCCP observed against TetR E. coli. The commercial
XTT assay (Sigma-Aldrich) was used to determine the viability of mammalian
Chapter 5

127

M. B. Patel

cells in the presence or absence of hydraphiles. The XTT assay depends on the
enzymatic conversion of a tetrazolium dye in a vital cell to a colored formazan
product. The absorbance of the colored formazan derivative is then used to
quantitate the number of live cells. Untreated cells were used as controls. Cells
alone were considered as 100% survival and viability in the presence of
hydraphiles was calculated as percent survival.

Figure 5.8. Cytotoxicity of benzyl C8-C14 hydraphile, colistin and
CCCP at MIC concentrations against HEK-293, HeLa and Cos-7
cells. The x-axis represents the compounds used and the y-axis
represents the percent of cells survived in presence of the
respective compounds used. The percent survival is the average of
three independent trials that contained three replicates per trial.
This indicates a total of 9 data points. The error bars represent
standard deviation in three trials.
As seen in figure 5.8, benzyl C14 hydraphile had almost 70% survival
against HEK-293 cells at MIC concentration (figure 5.8). At MIC concentrations,
benzyl C8-C12 hydraphiles had 20-30% survival against HEK-293 cells. HeLa and
Cos-7 showed 80-100% survival against all the hydraphiles used at MIC
concentrations. Hence, at MIC concentrations hydraphiles showed toxicity to one
out of three epithelial cell lines tested. At MIC concentration, benzyl C14
hydraphile and colistin showed similar toxicity to HEK-293 cells. CCCP was
found to be toxic to all cell lines and showed 50-80% survival. The concentrations
used for our synergy studies were at ½ [MIC] and lower. We therefore assessed
the survival of mammalian cells at ½ [MIC] of hydraphiles.
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Figure 5.9. Cytotoxicity of benzyl C8-C14 hydraphile, Colistin and
CCCP at ½ [MIC] concentrations against HEK-293, HeLa and Cos-7
cells. The x-axis represents the compounds used and the y-axis
represents the percent of cells that survived in the presence of the
respective compounds. The percent survival is the average of three
independent trials that contained three replicates per trial. This
indicates a total of 9 data points. The error bars represent the
standard deviation for three trials.
Again, cytotoxicity from hydraphiles was only observed against HEK-293
cells. At the ½ [MIC] value of benzyl C8-C14 hydraphiles used for the
combination studies, we observed cytotoxicity to the HEK-293 cells (figure 5.9).
Survival of HEK-293 cells in the presence of ½ [MIC] of benzyl C14 hydraphile
was 85-100%. The survival of HEK-293 cells in the presence of ½ [MIC] of benzyl
C12, C10 and C8 hydraphile increased to 60-80% (figure 5.9) from 20-30% (figure
5.8) survival at the MIC concentration. Cos-7 and HeLa cells showed 100%
survival in the presence of hydraphiles. CCCP, a known EPI, was cytotoxic to all
three cell lines. Cytotoxicity of colistin to HEK-293 cells was also observed. At the
low concentrations of hydraphiles and colistin used for the recovery of
tetracycline activity, there was minimal to no cytotoxicity observed to the
mammalian epithelial cell lines. The benzyl C14 hydraphile at ¼ [MIC]
concentration showed an average of 96% HEK-293 survival and recovered the
tetracycline efficacy by 3-fold against resistant bacteria. The data show that
benzyl C14 hydraphile, when used at 500 nM, is non-cytotoxic to HEK-293 cells
and also recovers the antibiotic activity in resistant bacteria. Further studies with
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other hydraphile derivatives could reveal structures with even lower
cytotoxicity.
5.5.

Summary and conclusions
Hydraphiles and other synthetic amphiphiles have been known for
decades. Most of the studies involving this class of molecules have been focused
on developing new structures53 and assessing their effect on ion transport.54
Many studies have also reported their activity as antibiotics. These studies use
diverse methods and very large range of bacterial strains and some yeast. None
of these studies goes beyond simple survey. To the extent that conclusions can be
drawn, it appears that activity is greater against Gram positive bacteria than
Gram negative bacteria.55 This is the first report that shows synthetic
amphiphiles can be used to recover the efficacy of antibiotics against efflux
pump expressing multidrug resistant bacteria or ‘Superbugs’. We have shown
that hydraphiles can recover the activity of tetracycline and fluoroquinolones
(ciprofloxacin, norfloxacin) against two Gram negative and one Gram positive
bacteria. One of these bacteria is K. pneumoniae, which was isolated from a
patient, and is an urgent threat to public health. This bacterium is resistant to
almost all known classes of antibiotics and the treatment of last resort is colistin.
However, colistin has cytotoxicity issues. The recovery of antimicrobial efficacy
by hydraphiles could make this infection treatable. In addition, a new use of
colistin at sub-lethal concentrations, in combination with other antibiotics, could
circumvent the cytotoxicity issue.
We report here that hydraphiles increase membrane permeability and
inhibit efflux pump activity that allows for the accumulation of antibiotics in the
cell cytoplasm. We first reported that hydraphiles could localize in the cell
membrane of bacteria and mammalian cells. Hydraphiles were also found in the
cell cytoplasm of bacteria and the nuclei of mammalian cells. This could be an
effect of cell death or increased membrane permeability. Localization in the
membrane and cation transport by hydraphiles resulted in both membrane
disruption and osmotic stress as observed with SEM images. This function
allows for an increase in the permeability of bacterial cell membranes. In
contrast, the permeability of mammalian cell membranes did not change even at
4 times greater than the concentration used for the antibiotic combination
studies. This could be due to the differences between the membrane composition
of bacterial and mammalian cells.
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Hydraphiles were shown to transport potassium ions through E. coli cell
membranes. At ½ [MIC], all four benzyl C8-C14 hydraphiles could transport
cations, causing disruption of the cation gradient. A correlation between ion
transport, recovery of antimicrobial potency and spacer chain length was
observed. Changes in the cation gradient are expected to alter the activity of
efflux pumps. NorA efflux pump activity was inhibited and the substrate
accumulation was increased in the presence of hydraphiles. The efflux pump
inhibition by hydraphiles is indirect as observed with CCCP rather than direct
inhibition as observed with PAβN or reserpine. An advantage of the membraneacting amphiphile approach is that bacteria cannot easily develop resistance to
amphiphiles that transport ions and disrupt membranes. Of course, bacteria may
still develop resistance to hydraphiles, but this may be a relatively slow process.
We have shown that E. coli cannot develop resistance to hydraphiles for over 15
days.
The inhibition of efflux pumps by hydraphiles and other natural
amphiphiles is caused by disruption of ion gradients and/or membrane
integrity. However, this raises the issue of cytotoxicity and bioavailability. Our
preliminary results show that hydraphiles are bioavailable through IV
administration for over 2 hours. The cytotoxicity of the most effective
hydraphiles at sub-MIC concentrations was minimal. Cytotoxicity was observed
against only one cell line, HEK-293. When ½ [MIC] concentrations of hydraphiles
were tested, the survival of all three cell lines increased. More structural studies,
currently underway in the lab, could reveal compounds with greater
bioavailability and even lower cytotoxicity. Cytotoxicity from hydraphiles was
lower than CCCP but its efficacy to inhibit efflux pump and recover antibiotic
potency was far superior.
Overall, we report a non-resistant adjuvant platform that could be used
with both existing and novel molecules to recover antimicrobial potency against
life-threatening bacterial infections. As a result of these studies, we have
identified benzyl C14 hydraphile as a lead compound that acts a membrane
disruptor and an efflux pump inhibitor. At ½ [MIC], it recovers antimicrobial
potency and shows 80-100% survival of three different mammalian cell lines. We
are currently performing in vivo cytotoxicity and efficacy studies with these
molecules.
In vivo toxicity and efficacy studies in mouse model are already
underway. The preliminary data are promising. We are working to increase the
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in vitro efficacy of hydraphiles to recover antimicrobial potency and further
decrease the mammalian cytotoxicity. Changes in the number of positive charges
and/or alkyl chain lengths may provide for compounds with greater selectivity.
Lariat ethers also provide an attractive opportunity for developing antibiotic
adjuvants. Lariat ethers are easier to synthesize and show lower cytotoxicity than
hydraphiles (data not shown). A methyl iodide derivative of lariat ether that has
permanent positively charges showed almost 40-fold recovery at 15 µM (data not
shown). These studies are still underway.
All the studies reported in this dissertation establish a platform to conduct
details mechanistic and antimicrobial studies in the Gokel lab. The lab already
has the ability to conduct organic synthesis. Hence, a structure activity
relationship could be easily performed. One such study was recently published
by our group using bis-amino acid based compounds.39 These compounds were
non-cytotoxic and also rescued tetracycline activity against TetR E. coli. These
compounds are also amphiphilic. Hence, synthetic amphiphiles represent a
promising new approach for developing antibiotics, efflux pump inhibitors and
membrane disruptors.
5.6.

Experimental procedure.

5.6.1. Compounds used. Benzyl C8 – C14 hydraphiles were prepared by the
Gokel laboratory as reported before. The purity of each compounds were
confirmed by the NMR and high resolution mass spectrometry. Reserpine,
CCCP, colistin and ethidium bromide were acquired from Sigma-Aldrich and
used as received.
5.6.2. Bacteria used. Two strains of bacteria were used for experiments outlined
in this chapter. The TetR E. coli strain used here was made by transforming
competent JM109 E. coli cells with pBR322 plasmid. This strain was used for ion
transport and resistance development studies conducted here. The TetR E. coli
was cultured in L. B. Miller media containing 100 µg/mL Ampicillin.
S. aureus 1199B was provided by Dr. Glenn Kaatz at Wayne State
University. This strain was used for efflux pump inhibition and substrate
accumulation studies. The S. aureus 1199B was cultured in cation adjusted MHII
media containing 10 µg/mL ethidium bromide.
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5.6.3. Potassium transport. A calibration curve was first established using
known concentration of potassium chloride. Calibration curve was used to
acquire the equation for the slope and R2 = 0.998. The experiment was conducted
with TetR E. coli. E. coli was grown overnight from one CFU. Cells were knocked
back to O.D. = 0.600 before use. Cells were centrifuged at 2000xg and
resuspended in sterile PBS. The O.D. of cells was adjusted to 1.300. To measure
the K+ leakage, 1998 µL E. coli suspended in PBS were added to a plastic cup
containing magnetic stirrer. The stir plate was turned on to mix the sample and
the potassium selective electrode (Orion, Thermo Scientific) was immersed in the
sample so that just the membrane was covered in the sample. The voltage (mV)
was stabilized for 6-8 minutes. The temperature of the sample was kept constant
at 25°C. The electrode was lifted and 2 µL of the either of the hydraphiles or
Gramicidin-D were added. The DMSO concentration was kept constant at 0.1%
(v/v). The electrode was immersed back in the solution. Multiple concentrations
were tested for each compound. The mV reading was recorded every 30 seconds
for 15 minutes. The concentration of potassium ion released (mM) and Δ [K+]
mM were calculated using the equation from the calibration curve.
To determine the total potassium pool of TetR E. coli, 2 mL of cells were
heated at 100ºC for 30 minutes on a heat block. After 30 minutes the sample was
cooled down to room temperature for 60 minutes. After 60 minutes the mV
reading was recorded and Δ [K+] mM was calculated. The experiment was
performed in triplicates and standard deviation in the experiment was
calculated.
5.6.4. Efflux pump inhibition. Efflux pump inhibition studies were conducted
with S. aureus 1199B in a 96-well microtiter plate with black wells and glass
bottom. S. aureus 1199B were grown overnight from one CFU. Cells were
knocked back to O.D.600 = 0.550 before use. In a 1.5 mL micro-centrifuge tube, cell
were spun down at 17,000 x g for 3 minutes. Cell were re-suspended in fresh
MHII media containing 10 µg/mL ethidium bromide and 100 µM CCCP. The
O.D. 600 was adjusted to 1.000. The cells were vortexed and incubated at the room
temperature for 20 minutes to load cells with ethidium bromide. After 20
minutes, the cells were centrifuged at 17,000 xg for 3 minutes. The supernatant
was discarded and the cells were stored on ice. The tubes were warmed to room
temperature for 5 minutes and MHII media was added to the tubes and O.D. 600
was adjusted to 0.800. 100 µL of ethidium bromide loaded cells were added to
each well containing either C8-C14 hydraphiles, CCCP or reserpine. The content
were mixed by pipetting up and down once and the fluorescence was recorded
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immediately using Biotek Cytation 3 plate reader (Dr. Lon Chubiz lab).
Excitation of 530 nm and emission of 600 nm was used. Reading were collected
every minute for 20 minutes. The results were reproduced two more times and
standard deviation was calculated. The results were graphed against time.
5.6.5. Ethidium bromide accumulation. Efflux pump inhibition studies were
conducted with S. aureus 1199B in a 96-well microtiter plate with black wells and
glass bottom. S. aureus 1199B were grown overnight from one CFU. Cells were
knocked back to O.D.600 = 0.550 before use. While the cells grew to the optimal
conditions, hydraphiles, CCCP and reserpine stock concentrations were
prepared. Mid-log phase cells were centrifuged at 17,000 xg for 3 minutes and resuspended in fresh MHII media. The O.D.600 was adjusted to 0.800. In each well
200 µL of cells were added followed by 10 µg/mL of ethidium bromide and 1 µL
of C8-C14 hydraphiles, reserpine or CCCP. The contents of the well were mixed
by pipetting up and down once. Immediately fluorescence was measured using
the Biotek Cytation 3 plate reader (Dr. Lon Chubiz lab). Excitation of 530 nm and
emission of 600 nm was used. Reading were collected every minute for 20
minutes. The results were reproduced two more times and standard deviation
was calculated. The results were graphed against time.
5.6.6. MIC and Synergy. MIC experiments were performed as described in the
Clinical and Laboratory Standards Institute (CLSI) standard microdilution
protocols. Bacteria was grown overnight from one CFU in media without
antibiotics. S. aureus 1199B was grown in MHII media containing 10 µg/mL
ethidium bromide. On the day of experiment, bacteria were knocked back to
O.D. 600 nm = 0.550 in the same media. These exponential phase bacteria were
then diluted in antibiotics free media to get 4 x 108 CFU/mL. In a 96-well, plate
either L.B. Miller or MHII media was added followed by serially diluted
compounds or ethidium bromide. All the hydraphiles were dissolved in DMSO
and the final concentration of DMSO in each well was kept constant at 0.5%
(v/v). For the combination experiments, first the hydraphile or control was
added to the media in the well followed by the antibiotics. The contents of the
well were mixed before adding 20 µL of bacteria to get 4 x 105 CFU/mL per well.
The plates were incubated at 37 °C, 200RPM for 24 hours before collecting results
on the Biotek Cytation 3 plate reader. No more than three plates were stacked on
top of each other at a time. Optical density of the wells was determined at λ=600
nm. Media alone control was considered as 100% inhibition. Any inhibition
greater than 80% was considered as the MIC. The results were reproduced three
times before reporting.
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5.6.7. Resistance development to hydraphiles. The ability of TetR E. coli to
develop resistance to benzyl C14 hydraphiles and minocycline was determined
using sequential culturing method. This method tests the ability of bacteria to
develop resistance by inducing constant selective pressure of sub-lethal dose of
antibiotics over 15 days. This procedure also accounts for only point mutations.
The TetR E. coli was grown overnight from one colony in L.B. media. E. coli was
knocked back to O.D. 600 nm = 0.100 in a 2 mL L.B. media and grown to O.D. =
0.550. L.B. media was added to the test tubes, followed by the antibiotic and then
the E. coli and incubated at 37 °C, 200 RPM for 24 hours. Five different
concentrations of hydraphiles and minocycline were set up: 0.25x, 0.5x, 1x, 2x,
and 4x [MIC]. Any cultures that grew at higher than the MIC levels were
passaged on antibiotic-free L.B. Agar plates and the MIC is determined. The
samples were also stored for future use. The cells were diluted from the second
highest concentration that allowed growth at 1:100 in fresh media containing
0.25x, 0.5x, 1x, 2x, 2.5x and 4x [MIC]. Test tubes were incubated at 37 °C, 200
RPM for 24 hours. Any cultures that grew at higher than the MIC levels were
passaged on antibiotic-free L.B. Agar plates and the MIC was determined. The
procedure was continued for 15 days. The results are represented in graphical
format of MIC vs. days.
5.6.8. Mammalian cell cytotoxicity. HeLa (ATCC CCL-2) cells were acquired
from ATCC. Cos-7 (ATCC CRL-1651) cells were donated by Dr. C. Dupureur and
HEK-293 cells were donated by Dr. M. Nichols. Cell lines were regularly
maintained in growth media containing DMEM (ATCC), 10% fetal bovine serum
(FBS, ATCC) and 1% penicillin-streptomycin solution (ATCC). Adherent HEK293, HeLa and Cos-7 cells were trypsinized using 0.25% (w/v) trypsin-EDTA
(Sigma-Aldrich), suspended in a fresh media and diluted to get a concentration
of 3 x 105 cells/ml. Cells were seeded in a 96-well plate (100 µL/well) to get 3 x
104 cells/well. The plates were incubated for 24 hours at 5% CO2 and 37°C to
reach a confluency of 80-90%.
In a sterile 1.5 mL micro-centrifuge tube, benzyl C8-C14 hydraphile, CCCP
and colistin (0.5% DMSO) were mixed with assay media (DMEM + 10% FBS) and
serially diluted by 2-fold each to get 2[MIC], [MIC], ½[MIC] and ¼[MIC]
concentrations. A control containing 0.5% DMSO was also prepared. After 24
hours, the spent media in the 96-well plate containing HEK-293, HeLa and Cos-7
cells (90% confluency) was replaced with 100 µL media containing the benzyl C8C14 hydraphile, CCCP and colistin at various concentrations. The cells were
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incubated at 37°C and 5% CO2 for 24 hours before performing XTT assay (SigmaAldrich). The XTT assay was performed according to the manufacturer’s
protocol. After 24 hours of treatment with compounds, the media was replaced
with PBS and 25 µL XTT was added to each well. The XTT assay works by the
reduction of tetrazolium compound by alive cells to the colored soluble
formazan product. The absorbance of the product was measured at 450 nm (XTT)
and 690 nm (background). Percent survival was calculated by comparing the
average absorbance of cells treated with benzyl C8-C14 hydraphile, CCCP and
colistin to that of cells alone. Three replicates were performed for each treatment.
Average percent survival and standard deviation were calculated.
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5.7.
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